Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3016417	p-amylp	u/l (u/l)	32415	78635	0.00%
3016417	p-amylp	— (—)	9805	16457	100.00%	Distribution not available
3016417	s-amylp	u/l (u/l)	198	218	0.00%
3016417	pa-amyl	u/l (u/l)	73	167	0.00%
3016417	s-amylp	— (—)	56	61	100.00%	Distribution not available
3016417	-amylp	u/l (u/l)	43	60	0.00%	Distribution not available
3016417	-amylp	— (—)	12	13	100.00%	Distribution not available
3016417	pa-amyl	— (—)	7	10	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Unspecified privation

1096

3287

4.10

321.59

3.1

2.4

66.58

52.85

u/l

0.16

955

2839

Diseases of the digestive system

3225

16016

2.17

321.22

3.6

2.4

42.48

46.15

u/l

0.22

2791

13643

Chronic gastritis

2126

8982

2.64

320.99

3.1

2.3

32.18

48.51

u/l

1.29

1827

7615

GI-bleeding

2363

10450

2.50

320.31

3.5

2.4

43.38

49.26

u/l

0.25

2072

8902

Pure hypercholesterolaemia

4933

18502

1.90

319.65

2.8

2.4

46.60

48.46

u/l

0.08

4171

15818

Recurrent or chronic depression

2922

9855

2.29

319.11

2.8

2.4

34.70

40.25

u/l

2.12

2501

8560

Other diseases of pancreas

788

1904

5.36

316.53

7.2

1.8

310.73

32.74

u/l

1.77

702

1624

Asthma, unspecified (mode), excluding more controls

3549

14154

2.10

315.62

2.7

2.3

34.87

45.67

u/l

1.73

2996

12145

Malignant neoplasm

6082

21317

1.78

315.60

2.9

2.4

38.11

45.27

u/l

0.96

5333

18113

Dentinal caries

1802

7073

2.83

313.97

4.5

2.4

65.10

40.80

u/l

0.45

1590

6129

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

2022

8393

2.63

312.75

3.0

2.3

33.47

41.61

u/l

1.42

1729

7272

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

2763

11431

2.31

311.27

3.3

2.3

38.32

43.03

u/l

0.45

2454

9658

Alcohol use disorder, ICD-based

3020

14883

2.20

309.72

3.5

2.5

41.46

51.61

u/l

0.76

2560

12809

Ascites

700

1554

5.68

309.47

4.1

1.9

35.84

41.18

u/l

0.58

635

1303

Heart failure, not strict

5067

19948

1.86

308.62

3.5

2.4

53.18

46.33

u/l

0.20

4352

17035

Benign neoplasm of colon, rectum, anus and anal canal

4277

20230

2.06

307.65

2.8

2.4

45.66

47.35

u/l

0.08

3670

17230

Pain in throat and chest

7004

20211

2.28

307.65

2.9

2.4

32.96

49.28

u/l

3.16

6048

17349

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

2700

4603

3.13

307.65

2.7

1.8

52.27

49.23

u/l

0.06

2344

3837

Renal failure

3203

13364

2.41

307.65

4.3

2.4

59.35

45.33

u/l

0.43

2834

11360

Renal tubulo-interstitial diseases

6656

25799

2.13

307.65

3.5

2.3

50.08

43.79

u/l

0.33

5793

21946

Diseases of liver

2889

11666

2.81

307.65

3.8

2.4

51.75

46.60

u/l

0.12

2542

9976

Symptoms and signs involving the digestive system and abdomen

9194

16762

3.01

307.65

3.1

2.0

52.32

42.53

u/l

0.49

8064

13959

Parasetamol

5768

16494

1.87

307.65

2.9

2.2

51.69

42.46

u/l

0.42

4985

14173

Symptoms and signs involving the circulatory and respiratory systems

7258

21265

1.79

307.65

2.8

2.4

33.22

50.27

u/l

3.45

6244

18225

Cholecystectomy

5931

23278

2.49

307.65

3.5

2.3

44.28

44.63

u/l

0.03

5270

19723

Personality disorders, excluding more controls

2001

7722

2.87

307.65

2.9

2.3

38.38

41.63

u/l

0.23

1691

6716

Cystitis

6207

20488

1.97

307.65

2.7

2.3

48.64

43.26

u/l

0.18

5320

17459

Cholelithiasis

7044

21186

2.56

307.65

3.4

1.9

40.11

33.21

u/l

2.50

6213

17862

Disorders of lipoprotein metabolism and other lipidaemias

5707

20168

1.89

307.65

2.8

2.4

36.14

47.58

u/l

1.84

4840

17268

Complications of procedures, not elsewhere classified

5539

27672

1.83

307.65

3.1

2.4

74.15

40.15

u/l

1.43

4768

23672

Diarrhoea and gastroenteritis of presumed infectious origin

5444

24697

2.15

307.65

3.3

2.4

43.48

45.44

u/l

0.12

4739

21073

Explicit Sepsis

3004

13537

2.31

307.65

3.8

2.3

81.11

40.50

u/l

0.83

2606

11518

Complications of surgical and medical care, not elsewhere classified

6849

28771

1.80

307.65

3.1

2.4

67.22

40.09

u/l

1.39

5878

24616

Dialysis, with operation codes

1399

3809

4.68

307.65

6.2

2.4

47.23

38.21

u/l

0.77

1282

3290

General symptoms and signs

8718

22092

2.10

307.65

3.1

2.2

37.31

47.85

u/l

1.29

7570

18826

Neoplasms

5305

15839

1.88

307.65

2.9

2.3

37.30

43.86

u/l

0.89

4649

13487

Acute pancreatitis (for exclusion)

2012

6381

3.80

307.65

6.7

2.3

175.36

33.51

u/l

3.22

1814

5484

Other antidepressants

7480

22339

1.84

307.65

2.8

2.4

44.31

46.72

u/l

0.12

6367

19248

Transplanted organ and tissue status

1135

2867

5.19

307.65

6.8

2.4

50.92

53.28

u/l

0.04

1044

2486

Asthma, excluding more controls

5348

15680

1.91

307.65

2.6

2.3

32.84

47.47

u/l

3.56

4529

13486

Cholelithiasis, broad definition with cholecystitis

7337

21518

2.57

307.65

3.4

1.9

40.08

33.20

u/l

2.64

6462

18152

Other bacterial diseases

7593

25396

2.24

307.65

3.4

2.3

57.63

40.98

u/l

0.80

6552

21669

Exposure to unspecified factor

7400

30513

2.01

307.65

2.8

2.4

38.39

46.01

u/l

1.06

6348

26119

Nephropathy related operations

1342

3717

4.61

307.65

6.4

2.5

46.24

50.49

u/l

0.12

1235

3205

Examination and observation for other reasons

6178

13736

3.06

307.65

3.1

2.3

52.42

45.92

u/l

0.22

5332

11844

Artificial opening status

854

1500

9.37

307.65

3.2

2.3

29.42

68.82

u/l

0.67

817

1283

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

6250

20736

1.88

307.65

2.9

2.4

37.80

41.63

u/l

0.70

5471

17624

Other anxiety disorders

3626

14215

2.47

307.65

3.0

2.4

44.87

42.50

u/l

0.07

3127

12243

Acute tubulo-interstitial nephritis

4262

20102

2.01

307.65

3.1

2.3

41.64

42.20

u/l

0.03

3658

17040

6656

22632

1.96

307.65

3.0

2.3

51.82

44.77

u/l

0.25

5700

19393

Persons encountering health services for other counselling and medical advice, not elsewhere classified

8622

26237

1.99

307.65

3.0

2.3

39.10

47.11

u/l

0.84

7516

22354

Bacterial Sepsis

3338

13152

2.48

307.65

3.5

2.3

52.57

42.17

u/l

0.32

2868

11181

Depression

7166

27098

1.93

307.65

2.9

2.4

40.20

46.50

u/l

0.39

6079

23329

Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)

1273

3205

4.99

307.65

2.1

2.2

31.93

52.50

u/l

0.75

1163

2699

Medical observation and evaluation for suspected diseases and conditions

5026

13858

1.96

307.65

2.8

2.3

34.57

45.80

u/l

2.54

4275

11946

Diverticular disease of intestine

5630

16534

2.47

307.65

2.7

2.4

40.79

51.76

u/l

0.86

4849

14020

Substance abuse, excluding more controls

4284

16994

2.39

307.65

3.4

2.4

50.25

49.91

u/l

0.01

3643

14694

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

6249

20732

1.88

307.65

2.9

2.4

37.80

41.64

u/l

0.70

5471

17619

Chronic pancreatitis

1323

3281

5.14

307.65

8.1

1.9

194.49

33.94

u/l

1.64

1144

2823

Persons encountering health services for specific procedures and health care

8509

27255

2.07

307.65

3.3

2.3

45.52

42.96

u/l

0.11

7313

23304

Special screening examination for infectious and parasitic diseases

2191

6273

2.87

307.65

2.3

33.65

48.29

u/l

1.84

1919

5430

Persons encountering health services for specific procedures, not carried out

1085

2134

7.20

307.65

4.1

2.3

114.14

61.33

u/l

0.35

945

1843

Mental and behavioural disorders due to alcohol, excluding acute intoxication

3291

16084

2.22

307.65

3.5

2.5

55.63

47.70

u/l

0.21

2784

13858

Diaphragmatic hernia

2798

12219

2.55

307.65

2.9

2.4

45.64

43.49

u/l

0.09

2414

10403

4648

20283

2.22

307.65

3.6

2.4

76.23

39.78

u/l

1.24

3975

17459

Neurotic, stress-related and somatoform disorders

6643

25860

1.94

307.65

2.9

2.4

40.56

45.18

u/l

0.25

5694

22200

Hernia of abdominal wall, postoperative

1414

3345

4.88

307.65

3.5

1.5

40.40

37.44

u/l

0.18

1254

2749

Benign neoplasm of colon, rectum, anus and anal canal

4026

12701

2.47

307.65

2.8

2.3

46.59

44.63

u/l

0.09

3460

10716

Any mental disorder

8024

23469

1.80

307.65

2.8

2.4

41.37

47.98

u/l

0.44

6807

20185

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

7124

28182

1.93

307.65

3.1

2.4

40.33

45.38

u/l

0.52

6174

24064

Abdominal and pelvic pain

9442

16756

3.11

307.65

3.1

2.0

54.53

42.53

u/l

0.65

8272

13957

Headache

4619

19720

2.08

307.65

2.9

2.2

31.97

48.61

u/l

3.42

3977

16792

Pain in joint

4217

11306

2.66

307.65

2.6

2.1

40.38

41.57

u/l

0.08

3565

9556

Other septicaemia

2582

11363

2.44

307.65

4.0

2.2

88.69

39.83

u/l

0.87

2247

9651

Human immunodeficiency virus [HIV] disease resulting in other conditions

499

469

43.36

307.65

2.5

3.1

27.74

141.10

u/l

0.61

494

418

Oxycodone

2625

10363

2.71

307.65

3.7

2.1

56.32

50.62

u/l

0.11

2301

8846

Nausea and vomiting

2252

6364

3.98

307.65

3.9

1.9

33.94

38.79

u/l

1.81

1989

5253

Implicit bacterial Sepsis

2952

11577

2.59

307.65

3.6

2.3

54.68

41.29

u/l

0.38

2541

9845

Benzodiazepine use

7048

29782

1.77

307.65

2.8

2.5

37.87

46.57

u/l

1.42

5958

25587

Abnormalities of breathing

6152

21154

1.81

307.65

2.8

2.4

37.35

48.96

u/l

1.36

5271

18126

Fever of other and unknown origin

4267

16985

2.54

307.65

3.7

2.2

52.13

48.26

u/l

0.13

3774

14448

Other soft tissue disorders, not elsewhere classified

6899

23306

1.94

307.65

2.9

2.4

56.86

42.12

u/l

0.59

5924

19984

Pain, not elsewhere classified

2042

8279

2.72

307.65

3.4

2.1

41.03

47.98

u/l

0.25

1767

7035

Codeine or tramadol medication

8310

27184

1.78

307.65

2.8

2.4

42.45

46.14

u/l

0.23

7081

23348

Mood disorders

7751

28147

1.92

307.65

2.8

2.4

40.13

46.03

u/l

0.39

6555

24209

Diseases of oesophagus, stomach and duodenum

8260

26295

2.04

307.65

3.1

2.3

44.71

44.93

u/l

0.01

7133

22490

Human immunodeficiency virus [HIV] disease

503

520

30.25

307.65

2.5

3.0

27.70

130.44

u/l

0.61

498

462

Malaise and fatigue

4257

13343

2.97

307.65

3.3

2.2

36.18

51.07

u/l

1.14

3654

11313

Constipation

6260

24618

1.94

307.65

2.9

2.4

32.77

48.25

u/l

3.76

5359

21014

Malignant neoplasm, wide definition for exclusion

6250

20740

1.88

307.65

2.9

2.4

37.80

41.64

u/l

0.70

5471

17628

Other functional intestinal disorders

3072

13524

2.34

307.65

3.1

2.3

39.81

50.59

u/l

0.59

2673

11452

Metabolic disorders

6951

23499

1.95

307.65

3.1

2.4

36.64

45.85

u/l

1.63

5934

20149

All anxiety disorders

4773

18610

2.23

307.65

2.9

2.4

45.02

42.29

u/l

0.10

4094

16005

Intestinal infectious diseases

7038

29674

1.96

307.65

3.2

2.3

41.71

45.45

u/l

0.33

6118

25295

Gastrointestinal diseases

4741

8301

3.08

307.65

2.8

1.5

48.16

33.54

u/l

0.84

4126

6919

Mental and behavioural disorders due to alcohol

3711

18252

2.13

307.65

3.4

2.5

52.65

46.37

u/l

0.19

3159

15741

ILD medications: prednisolone, methylprednisolone, prednisone

7883

26398

1.77

307.65

3.2

2.3

44.62

45.44

u/l

0.05

6843

22495

Pneumonia, organism unspecified

6407

26333

1.86

307.65

3.0

2.4

54.72

42.76

u/l

0.46

5479

22577

Dental caries

2089

8080

2.86

307.65

4.4

2.4

60.59

49.79

u/l

0.18

1837

7002

Persons encountering health services in other circumstances, wide

9056

26405

1.88

307.65

3.0

2.3

40.70

46.99

u/l

0.59

7846

22489

ILD medications

8123

26861

1.74

307.65

3.2

2.3

40.83

45.18

u/l

0.45

7059

22885

Disorders of gallbladder, biliary tract and pancreas

9703

23414

3.00

307.65

4.1

1.9

75.46

33.17

u/l

4.38

8598

19777

Any gastric operation

7545

11397

3.65

307.65

3.0

1.5

47.11

35.75

u/l

1.03

6598

9318

L04AD Calcineurin inhibitors

1155

3262

4.49

307.65

6.4

2.4

39.19

53.24

u/l

0.47

1073

2818

Cholangitis (primary sclerosing, PSC)

776

1475

7.32

307.65

8.0

1.8

43.58

33.39

u/l

1.83

741

1247

Malignant neoplasm of digestive organs

3059

12068

2.81

307.65

3.8

2.3

48.07

51.00

u/l

0.09

2817

10184

Bacterial infection, other or unspecified

4587

16033

2.91

307.65

3.7

2.3

53.37

41.34

u/l

0.50

3969

13614

Other diseases of biliary tract

944

2184

5.63

307.65

8.5

1.8

99.67

33.07

u/l

1.15

875

1839

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

6973

28379

1.82

307.65

3.0

2.4

53.11

43.17

u/l

0.40

5960

24345

Codeine

7120

20009

2.08

307.65

2.8

2.2

44.14

48.94

u/l

0.24

6045

17140

4476

19676

2.27

307.65

3.6

2.4

76.72

39.87

u/l

1.20

3832

16932

First line medication for Crohn's disease

8185

25697

1.83

307.65

3.2

2.2

36.78

45.52

u/l

1.63

7157

21848

Benign neoplasm: Colon

3440

11689

2.46

307.65

2.8

2.3

49.15

43.86

u/l

0.25

2940

9865

Anxiety disorders

6708

26103

1.94

307.65

2.9

2.4

40.46

45.07

u/l

0.26

5752

22400

Pain (limb, back, neck, head abdominally)

5678

11873

2.56

307.65

2.8

2.1

43.71

41.50

u/l

0.10

4896

10012

Septicaemia

2884

12595

2.40

307.65

3.9

2.2

83.15

39.50

u/l

0.87

2504

10710

Alcohol use disorder, Swedish definition

4308

18729

2.33

307.65

3.7

2.4

79.77

39.94

u/l

1.26

3674

16132

Mood disorders, excluding more controls

7260

22853

2.06

307.65

2.9

2.4

40.43

48.13

u/l

0.49

6144

19682

Opioids

7902

20360

2.17

307.65

3.0

2.1

40.96

48.70

u/l

0.52

6806

17434

Mood [affective] disorders

7740

28118

1.92

307.65

2.8

2.4

40.15

46.05

u/l

0.39

6548

24180

Anaemias

2116

3391

4.69

307.65

4.0

1.8

40.58

44.38

u/l

0.34

1874

2926

Other diseases of intestines

8693

24096

2.25

307.65

2.9

2.4

37.05

46.91

u/l

1.56

7586

20520

All pneumoniae

7231

28628

1.84

307.65

3.0

2.4

52.32

43.16

u/l

0.38

6191

24532

Acute pancreatitis

2012

5557

4.41

307.65

6.7

1.9

175.36

33.54

u/l

3.22

1814

4738

Pain in limb

6081

22315

2.12

307.65

2.9

2.4

41.11

41.97

u/l

0.06

5225

19134

Psychiatric diseases

7829

23064

1.78

307.65

2.7

2.4

41.52

48.16

u/l

0.44

6650

19838

Substance abuse

4284

20707

2.13

307.65

3.4

2.5

50.25

46.55

u/l

0.12

3643

17849

Anxiety disorders, excluding more controls

6349

21263

2.12

307.65

2.9

2.4

41.13

48.97

u/l

0.44

5442

18319

Anxiety (asthma-related co-morbidities)

4714

16905

2.38

307.65

2.9

2.4

43.37

42.78

u/l

0.02

4042

14574

Tramadol

7051

18252

2.73

307.65

3.5

2.2

35.88

48.09

u/l

1.96

6049

15633

Other diseases of the digestive system

2393

10441

2.54

307.65

3.5

2.4

43.37

49.34

u/l

0.25

2102

8885

Pneumonias (Asthma/COPD co-morbidities)

7185

28533

1.84

307.65

3.0

2.4

52.49

43.12

u/l

0.39

6149

24449

Other diseases of urinary system

7098

23730

1.77

307.65

2.7

2.4

44.94

44.50

u/l

0.02

6078

20291

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

6656

22632

1.96

307.65

3.0

2.3

51.82

44.77

u/l

0.25

5700

19393

Mental and behavioural disorders due to psychoactive substance use

4385

21140

2.10

307.65

3.3

2.5

49.79

46.32

u/l

0.11

3735

18218

Implicit Sepsis

5459

21220

2.16

307.65

3.2

2.3

44.78

42.86

u/l

0.08

4707

18055

Paralytic ileus and intestinal obstruction

2174

7340

3.39

307.65

3.6

2.3

36.03

59.28

u/l

1.27

1943

6206

GASTRO-related operations

7545

11397

3.65

307.65

3.0

1.5

47.11

35.75

u/l

1.03

6598

9318

Depression medications

2268

4011

3.05

307.65

2.7

1.9

56.18

50.31

u/l

0.10

1944

3468

Intestinal stricture

2544

10101

2.86

307.65

3.5

2.4

35.98

50.34

u/l

1.01

2292

8606

Asthma

5501

16579

1.87

307.65

2.6

2.3

32.82

46.85

u/l

3.63

4648

14246

Other or unspecified ileus, impaction or obstruction

1539

5007

3.55

307.65

3.7

2.3

37.08

50.75

u/l

0.75

1392

4242

Condition for Implicit Sepsis (Organ dysfunction codes)

5972

24037

1.92

307.65

3.1

2.3

44.53

42.44

u/l

0.10

5130

20530

Depression or dysthymia

5052

15035

1.99

307.65

2.8

2.4

44.03

49.08

u/l

0.19

4265

13031

Influenza and pneumonia

7569

28722

1.83

307.65

3.0

2.4

51.42

43.13

u/l

0.35

6483

24609

Certain infectious and parasitic diseases

7556

19719

2.03

307.65

2.9

2.1

44.71

42.98

u/l

0.09

6555

16732

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

4164

10790

3.50

307.65

3.7

2.3

63.64

43.62

u/l

0.55

3744

9106

Colorectal cancer, excluding all cancers (controls excluding all cancers)

2381

7591

3.53

307.65

2.4

2.2

34.92

44.47

u/l

0.81

2145

6412

Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers)

1440

5132

3.19

307.44

2.4

2.2

35.02

48.49

u/l

0.75

1329

4318

Selective serotonin reuptake inhibitors

6965

22430

1.71

306.54

2.7

2.4

46.55

46.66

u/l

0.00

5924

19325

Bleeding

5532

23666

1.80

305.61

3.3

2.4

50.11

44.36

u/l

0.26

4774

20150

Asthma, unspecified (mode)

3628

14930

2.05

303.59

2.7

2.3

34.69

45.14

u/l

1.75

3058

12796

Use of hypnotics and sedatives

7265

26247

1.67

302.10

2.8

2.5

38.05

46.62

u/l

1.29

6212

22550

Noninfective enteritis and colitis

3337

17156

2.09

301.76

3.2

2.5

38.48

45.01

u/l

0.66

2940

14700

Symptoms and signs involving cognition, perception, emotional state and behaviour

6481

27899

1.71

300.19

2.7

2.5

35.00

46.54

u/l

2.24

5499

23949

Colectomy operation

1445

5284

3.20

298.92

3.3

2.4

39.91

46.64

u/l

0.32

1311

4503

Asthma (mode)

5293

16674

1.83

297.32

2.6

2.3

33.34

47.00

u/l

3.45

4465

14332

Acute renal failure

1605

6215

2.94

294.00

3.9

2.4

73.32

38.46

u/l

0.64

1407

5297

Infections, IBD-co-morbidities

1373

3397

3.28

292.01

4.0

2.3

44.59

48.60

u/l

0.13

1203

2958

Fall on same level

7855

28132

1.62

290.03

2.8

2.4

37.79

46.95

u/l

1.51

6678

24158

Low back pain

5038

22608

1.81

289.33

2.8

2.4

45.56

45.81

u/l

0.01

4300

19456

Care involving use of rehabilitation procedures

4236

22562

1.89

287.98

2.9

2.3

39.15

43.98

u/l

0.48

3607

19218

Benign neoplasm of other and ill-defined parts of digestive system

1340

4777

3.22

287.33

3.5

2.2

80.90

47.91

u/l

0.80

1161

4033

Intestinal adhesions without obstruction

799

2079

4.74

287.24

3.7

2.2

38.61

63.74

u/l

0.55

730

1779

Hypertension, essential

5295

17589

1.81

286.77

3.3

2.3

45.26

43.83

u/l

0.05

4539

15147

Dorsalgia

6936

23412

1.67

286.08

2.8

2.4

46.27

46.62

u/l

0.02

5931

20121

Viral hepatitis, IBD co-morbidity

623

1338

5.77

285.01

3.2

2.4

30.93

56.20

u/l

1.15

554

1179

Inflammatory bowel disease treatment related agents

7793

28475

1.62

284.84

2.9

2.4

44.50

44.84

u/l

0.02

6774

24271

Complications of medical and surgical care

4857

27037

1.81

284.14

3.1

2.4

72.63

40.66

u/l

1.11

4171

23107

Benign neoplasm: Colon

3491

18268

2.02

282.94

2.8

2.4

48.80

45.62

u/l

0.14

2985

15583

Other disorders of urethra and urinary system

4558

19465

1.85

281.09

2.8

2.3

34.96

42.34

u/l

1.86

3861

16566

Cholangitis (primary sclerosing, PSC), with reimbursement 202

360

490

14.81

280.19

6.4

2.4

46.95

130.30

u/l

0.40

352

415

Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)

762

1954

4.79

279.01

7.3

2.2

103.51

38.24

u/l

0.85

681

1632

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum, excluding all cancers (controls excluding all cancers)

868

2477

4.22

272.01

2.2

31.10

56.67

u/l

0.71

819

2079

ILD medications: immunosuppressive drugs

4182

22826

1.86

271.45

3.7

2.3

40.79

45.19

u/l

0.41

3712

19465

Adenocarcinoma and papilloma adenocarcinoma of rectum, excluding all cancers (controls excluding all cancers)

848

2390

4.29

270.84

2.2

31.23

57.38

u/l

0.70

799

2007

Colitis, primary sclerosing

309

375

19.60

267.36

6.2

2.1

40.66

162.91

u/l

0.47

303

317

Colorectal cancer

1738

7320

2.67

266.02

2.5

2.4

34.30

55.07

u/l

1.08

1614

6188

Dyspnoea

5825

27638

1.69

265.37

2.9

2.4

40.46

45.18

u/l

0.38

4998

23606

Care involving dialysis

777

2110

4.59

264.64

7.2

2.4

52.25

62.88

u/l

0.17

705

1824

Hypertensive diseases (excluding secondary)

3677

11453

1.97

261.59

3.5

2.2

48.91

40.76

u/l

0.27

3168

9874

Need for other prophylactic measures

652

1592

5.50

261.46

3.5

2.5

38.67

70.61

u/l

0.54

557

1372

Hernia

6194

26375

1.67

260.94

2.8

2.5

52.27

44.48

u/l

0.28

5379

22520

Kidney transplant status

620

1461

5.78

260.86

8.8

2.5

61.60

72.16

u/l

0.11

577

1273

Aplastic and other anaemias

2952

14562

2.07

256.90

3.4

2.4

38.81

48.03

u/l

0.73

2550

12384

Adjustment and management of implanted device

1378

5302

2.94

254.40

2.6

2.3

34.94

37.31

u/l

0.57

1173

4499

Lower back pain or/and sciatica

6778

30363

1.61

253.92

2.8

2.5

47.11

43.31

u/l

0.23

5795

26017

Any event in cancer register

6084

22608

1.67

251.28

2.8

2.4

36.61

42.28

u/l

1.40

5338

19190

Other medical care

2668

13204

2.12

251.23

3.3

2.3

39.75

43.98

u/l

0.28

2349

11210

Covid-19 confirmed case

2065

9565

2.37

250.73

3.5

2.4

35.69

44.57

u/l

0.93

1742

8177

Other pulmonary diagnosis

5523

16744

1.72

249.77

2.7

2.3

38.12

46.70

u/l

1.04

4712

14382

Oedema, not elsewhere classified

2039

9336

2.35

248.20

3.2

2.2

37.82

54.76

u/l

0.85

1764

7925

Excluding asthma or asthma-COPD overlap

5514

16744

1.72

247.81

2.7

2.3

38.01

46.70

u/l

1.06

4697

14382

ILD differential diagnosis

5487

16674

1.72

245.83

2.7

2.3

37.58

47.00

u/l

1.19

4679

14332

Asthma (only as main-diagnosis), excluding more controls

4523

15680

1.80

245.79

2.6

2.3

33.37

47.47

u/l

3.26

3825

13486

COPD differential diagnosis

5487

16676

1.72

245.74

2.7

2.3

37.58

47.00

u/l

1.19

4679

14334

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

1188

4357

3.18

244.44

4.5

2.5

34.37

49.69

u/l

0.77

1057

3768

Other and unspecified anaemias

2708

13486

2.09

244.01

3.2

2.4

35.97

47.47

u/l

1.10

2339

11472

COPD/asthma/ILD related infections

7005

22658

1.61

243.84

2.8

2.3

43.99

44.76

u/l

0.03

5967

19415

COPD/asthma related infections

7005

22658

1.61

243.84

2.8

2.3

43.99

44.76

u/l

0.03

5967

19415

Other anaemias

2732

13615

2.09

243.65

3.2

2.4

35.93

47.41

u/l

1.11

2357

11578

Cardiovascular diseases (excluding rheumatic etc)

4347

14506

1.81

240.68

3.3

2.2

45.71

41.57

u/l

0.15

3776

12477

Benign neoplasms

4933

16693

1.74

239.48

2.8

2.3

37.64

43.72

u/l

0.81

4254

14231

Any reimbursement code in KELA

4006

11211

1.87

238.94

2.9

1.9

36.94

49.56

u/l

1.45

3457

9609

Personality disorders

2001

9341

2.34

237.22

2.9

2.5

38.38

44.92

u/l

0.40

1691

8076

Asthma (only as main-diagnosis)

4636

16579

1.76

236.58

2.6

2.3

33.24

46.85

u/l

3.34

3914

14246

Poisoning by drugs, medicaments and biological substances

1814

8159

2.45

236.39

3.3

2.5

32.82

44.89

u/l

1.17

1552

7026

Hypertensive diseases

5227

18099

1.71

234.67

3.3

2.3

47.07

43.49

u/l

0.14

4481

15595

Hypertension

5224

18087

1.71

234.41

3.3

2.3

47.08

43.50

u/l

0.14

4478

15583

Other disorders of fluid, electrolyte and acid-base balance

2002

9046

2.32

233.13

4.0

2.3

32.88

54.31

u/l

1.55

1705

7724

Asthma-related infections

3804

21705

1.82

231.95

2.8

2.5

35.02

46.15

u/l

1.57

3235

18612

Asthma, hospital admission 2, infections

3804

21705

1.82

231.95

2.8

2.5

35.02

46.15

u/l

1.57

3235

18612

Alcohol dependence

1944

9058

2.35

231.92

3.6

2.5

39.90

49.14

u/l

0.49

1656

7832

1091

3911

3.19

231.34

3.5

2.2

34.06

49.86

u/l

0.69

944

3348

Poisoning by medicine

1662

7296

2.52

229.77

3.3

2.5

32.23

46.05

u/l

1.24

1428

6293

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3929

23018

1.80

229.38

3.2

2.4

77.21

41.39

u/l

0.99

3358

19651

Asthma (diagnoses ohter than nonallergic)

5592

30543

1.63

227.75

2.6

2.5

33.82

46.43

u/l

2.97

4727

26162

Chronic kidney disease

1940

9045

2.33

227.75

5.0

2.4

47.90

46.57

u/l

0.05

1742

7675

Provisional assignment of new diseases of uncertain etiology

2996

16321

1.96

227.71

3.3

2.4

34.50

45.84

u/l

1.42

2574

14020

Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)

1291

5074

2.84

227.07

2.7

2.2

38.61

37.49

u/l

0.12

1153

4270

Codes for special purposes

2997

16344

1.96

227.00

3.3

2.4

34.49

45.82

u/l

1.41

2575

14039

Convulsions, not elsewhere classified

1622

6943

2.50

226.99

3.3

2.2

32.86

49.79

u/l

1.58

1391

5919

Disorders of adult personality and behaviour

2063

9919

2.26

226.23

2.9

2.5

35.99

44.40

u/l

0.65

1737

8576

Need for immunization against other single viral diseases

339

546

10.96

224.52

3.2

2.5

29.83

128.70

u/l

0.60

321

472

Gingivitis and periodontal diseases

6004

19728

1.63

224.50

2.7

2.3

37.03

47.76

u/l

1.63

5080

16969

Functional dyspepsia

1881

8775

2.34

223.61

3.2

2.3

43.17

40.04

u/l

0.16

1625

7461

Oral corticosteroids

6885

27609

1.57

222.72

2.8

2.4

38.48

45.00

u/l

0.79

5954

23552

Other reaction to severe stress, and adjustment disorders

2455

12615

2.08

222.01

2.9

2.4

50.96

40.80

u/l

0.22

2095

10898

Other headache syndromes

2911

15863

1.96

220.84

2.8

2.5

38.02

48.12

u/l

0.77

2505

13614

Implicit viral Sepsis

1390

5749

2.70

220.12

3.8

2.3

41.92

37.72

u/l

0.27

1204

4903

Viral Sepsis

1392

5763

2.69

219.96

3.8

2.3

41.90

37.71

u/l

0.27

1205

4913

Colorectal adenocarcinoma

1440

6076

2.66

219.85

2.4

35.02

46.68

u/l

0.77

1329

5150

Other external causes of accidental injury

5636

17765

1.65

218.34

2.7

2.4

45.83

43.07

u/l

0.12

4850

15206

Speech therapy

1944

9311

2.30

217.69

2.8

2.4

39.65

43.26

u/l

0.17

1676

7934

Hypothyroidism (congenital or acquired)

1592

3762

2.57

215.09

2.5

1.8

35.44

43.37

u/l

1.75

1367

3252

Other dorsopathies, not elsewhere classified

6748

23529

1.57

214.34

2.7

2.4

36.79

46.57

u/l

1.42

5768

20224

Mucosal proctocolitis

1087

4076

3.06

212.75

3.5

2.5

38.67

50.24

u/l

0.48

985

3520

Endocrine, nutritional and metabolic diseases

5467

17510

1.65

212.14

3.0

2.2

43.63

42.67

u/l

0.04

4643

15217

Hypothyroidism and >3 levothyroxin purchases

1575

3739

2.56

211.33

2.5

1.8

35.44

43.46

u/l

1.76

1352

3229

Hypothyroidism, levothyroxine purchases

1575

3739

2.56

211.33

2.5

1.8

35.44

43.46

u/l

1.76

1352

3229

Heart failure and antihypertensive medication

1741

5115

2.44

211.32

3.0

2.3

33.54

42.81

u/l

1.68

1493

4445

Cardiovascular diseases

4051

12926

1.78

210.42

3.0

2.1

49.13

41.55

u/l

0.27

3523

11101

Unspecified jaundice

466

1012

5.69

210.40

6.6

1.9

47.50

46.14

u/l

0.05

422

843

Autoimmune diseases related-to ILD

5448

31021

1.61

210.01

2.9

2.5

46.99

44.58

u/l

0.12

4724

26495

Diseases of arteries, arterioles and capillaries (FINNGEN)

1722

5381

2.43

209.34

3.3

2.2

40.68

44.06

u/l

0.26

1461

4643

Other heart diseases

3147

11524

1.90

206.93

3.0

2.2

36.67

40.51

u/l

0.80

2709

9911

Other diseases of liver

1349

5694

2.67

206.08

3.4

2.4

35.22

36.72

u/l

0.34

1170

4869

Dizziness and giddiness

4666

23696

1.67

206.06

2.7

2.4

36.79

47.43

u/l

1.41

3949

20282

Benign neoplasm: Colon, unspecified

1508

6604

2.49

206.05

2.9

2.2

47.44

45.36

u/l

0.06

1261

5581

Panic disorder

1122

4321

2.89

205.06

3.1

2.3

77.48

39.15

u/l

0.43

947

3743

Other/unspecified dorsalgia

2526

13393

2.00

205.06

2.9

2.4

36.96

50.35

u/l

1.11

2125

11497

Benign neoplasm of other and ill-defined parts of digestive system

1340

5691

2.66

202.71

3.5

2.3

80.90

46.64

u/l

0.88

1161

4848

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

1457

6380

2.52

202.31

3.6

2.2

42.46

46.15

u/l

0.18

1312

5380

Other diseases of intestine

910

3182

3.27

201.81

3.2

2.3

39.44

54.32

u/l

0.48

810

2714

Irritable bowel syndrome

1797

8543

2.27

201.70

2.8

2.3

31.13

45.45

u/l

1.87

1530

7270

Specific personality disorders

1705

7987

2.33

200.47

2.8

2.5

36.88

45.70

u/l

0.53

1447

6903

Gastro-oesophageal reflux disease

4154

22597

1.71

200.45

2.8

2.3

35.86

45.87

u/l

1.56

3523

19288

Accidents

5538

17765

1.62

199.23

2.7

2.4

46.16

43.07

u/l

0.14

4766

15206

Falls/tendency to fall

7249

24682

1.52

198.35

2.8

2.4

43.63

46.14

u/l

0.13

6178

21196

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3621

21683

1.76

197.59

3.2

2.4

75.76

42.72

u/l

0.80

3092

18525

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

2022

10145

2.15

197.09

3.0

2.5

33.47

43.38

u/l

1.04

1729

8736

Erysipelas

3322

17685

1.81

195.86

3.0

2.3

59.34

42.14

u/l

0.37

2842

15069

Asthma, hospital admissions 3, pneumonia

2311

12144

2.04

195.71

2.9

2.5

37.33

43.78

u/l

0.52

1965

10379

Asthma-related pneumonia or sepsis

2311

12144

2.04

195.71

2.9

2.5

37.33

43.78

u/l

0.52

1965

10379

Preparatory care for dialysis

487

1193

5.58

195.71

7.1

2.5

57.71

77.68

u/l

0.19

440

1025

Alcohol abuse, main dg, excluding more controls

1078

4168

2.88

195.65

3.9

2.5

32.62

44.57

u/l

1.69

929

3652

Asthma-related pneumonia

2303

12114

2.03

194.47

2.9

2.5

37.37

43.82

u/l

0.52

1959

10352

Malignant neoplasm of rectum

806

2718

3.53

194.17

2.1

2.4

31.09

38.14

u/l

1.80

760

2302

Diseases of pulp and periapical tissues

2255

11813

2.04

192.90

3.7

2.4

55.99

49.63

u/l

0.11

1976

10197

Substance use, excluding alcohol

1423

6304

2.49

192.33

3.4

2.4

64.33

40.84

u/l

0.32

1227

5436

Antihypertensive medication - note that there are other indications

4001

13105

1.74

192.10

2.9

2.2

49.41

40.84

u/l

0.31

3440

11358

Injuries to the head

6922

30919

1.51

191.98

2.8

2.4

37.03

46.24

u/l

1.98

5881

26503

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

821

2815

3.46

191.92

2.2

2.4

30.99

55.04

u/l

0.79

774

2387

Other noninfective gastroenteritis and colitis

1707

8151

2.28

190.80

3.2

2.4

37.77

42.78

u/l

0.37

1493

6917

Benign neoplasms

6307

23617

1.54

188.92

2.7

2.5

39.31

46.56

u/l

0.82

5417

20209

Adenocarcinoma and papilloma adenocarcinoma of rectum

795

2702

3.50

188.87

2.1

2.4

31.13

55.89

u/l

0.78

748

2291

Suicide or other Intentional self-harm

1745

8456

2.24

187.94

3.1

2.5

34.36

44.97

u/l

0.89

1488

7277

Other viral hepatitis

623

1837

4.14

187.47

3.2

2.6

30.84

67.40

u/l

0.81

555

1603

Bronchitis

6741

30313

1.51

187.33

2.9

2.4

38.41

45.99

u/l

0.67

5809

25897

Inflammatory bowel disease

2174

11406

2.05

186.53

3.3

2.5

39.80

43.28

u/l

0.32

1938

9788

Alcohol-induced chronic pancreatitis

627

1875

4.15

185.81

7.7

2.4

305.23

39.09

u/l

1.27

544

1647

Ulcer of lower limb, not elsewhere classified

1042

4104

2.90

185.19

3.7

2.4

32.47

50.84

u/l

0.92

871

3515

Diseases of oral cavity, salivary glands and jaws

5861

19875

1.57

184.63

2.7

2.3

45.83

47.61

u/l

0.07

4950

17081

Syncope and collapse

2621

12846

1.91

183.67

2.9

2.2

34.16

50.75

u/l

1.74

2242

10880

Viral hepatitis

689

2190

3.77

183.43

3.1

2.7

31.18

62.48

u/l

0.83

612

1910

Haemorrhage from respiratory passages

2098

10074

2.06

183.18

2.8

2.4

39.27

57.34

u/l

1.20

1820

8581

Other specific joint derangements/joint disorders

4812

20754

1.62

182.29

2.5

41.28

43.48

u/l

0.16

4067

17880

2818

15964

1.85

182.09

2.9

2.5

34.39

42.07

u/l

0.99

2410

13737

Autoimmune diseases excluding thyroid diseases

6766

25769

1.51

181.11

3.3

2.3

47.03

45.13

u/l

0.10

5840

22115

Emotionally unstable personality disorder

981

3780

2.93

180.64

2.8

2.3

40.35

50.43

u/l

0.28

827

3265

Symptoms and signs involving the urinary system

4695

23429

1.62

180.17

2.8

2.5

51.74

44.76

u/l

0.19

4087

19952

Total colectomy

465

1165

5.24

179.57

3.5

2.5

44.17

81.58

u/l

0.44

436

997

Total colectomy operation

465

1165

5.24

179.57

3.5

2.5

44.17

81.58

u/l

0.44

436

997

Soft tissue disorders

6675

23709

1.51

178.86

2.7

2.4

51.89

43.16

u/l

0.30

5758

20327

Dysphagia

1360

6052

2.42

178.82

3.0

1.9

33.12

39.76

u/l

2.88

1167

5017

7244

26610

1.48

178.73

2.8

2.4

37.87

46.01

u/l

1.18

6215

22764

Autoimmune diseases excluding thyroid diseases, strict definition

6582

25111

1.51

178.27

3.3

2.3

47.48

45.27

u/l

0.12

5679

21556

Nutritional anaemias

2972

16884

1.81

177.39

3.1

2.4

38.41

46.37

u/l

0.70

2554

14376

Genitourinary diseases

3913

11891

1.71

175.41

3.0

2.4

45.85

46.60

u/l

0.02

3400

10189

Nonorganic sleeping disorders, excluding more controls

1188

5068

2.56

173.58

2.8

2.4

31.56

39.13

u/l

3.65

1011

4401

Ulcerative colitis

1721

8545

2.18

173.53

3.4

2.5

40.83

45.84

u/l

0.36

1538

7322

Other diseases of anus and rectum

1781

8908

2.14

173.44

2.8

2.3

33.44

55.47

u/l

1.59

1529

7548

Obesity, other/unspecified

2219

12006

1.98

173.12

2.5

63.56

39.48

u/l

0.53

1845

10379

Infections of the skin and subcutaneous tissue

3563

21888

1.70

172.37

3.3

2.5

55.35

44.73

u/l

0.23

3049

18819

Chronic viral hepatitis

538

1527

4.35

171.91

3.1

2.6

31.45

73.79

u/l

0.78

475

1342

Alcohol-induced acute pancreatitis

416

998

5.64

171.17

9.1

2.5

86.41

87.58

u/l

0.01

371

878

Other symptoms and signs involving cognitive functions and awareness

2669

14321

1.85

170.36

2.6

2.4

31.44

50.70

u/l

2.60

2249

12229

Follow-up examination after treatment for conditions other than malignant neoplasms

2944

11111

1.82

169.91

2.6

2.2

59.90

41.99

u/l

0.33

2468

9576

Chronic periodontitis

1071

4443

2.70

169.22

4.4

2.4

49.20

41.96

u/l

0.32

943

3859

765

2678

3.25

169.21

2.4

2.2

30.12

34.75

u/l

1.89

651

2287

Asthma, including avohilmo

7369

30336

1.46

167.81

2.5

34.87

46.68

u/l

2.54

6227

26051

Alcoholic liver disease

786

2832

3.23

167.07

4.5

2.5

36.39

38.91

u/l

0.26

698

2442

Heartburn

692

2303

3.37

165.63

3.2

1.9

35.70

39.79

u/l

0.46

609

1926

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

1237

5513

2.48

165.51

3.3

2.5

31.00

46.40

u/l

1.08

1067

4765

Iron deficiency anaemia

2536

14344

1.86

164.56

3.0

2.4

39.34

48.37

u/l

0.67

2178

12215

Cholecystitis

936

3684

2.82

163.88

4.1

1.8

57.86

33.06

u/l

0.99

826

3110

Bipolar affective disorders

1296

5893

2.39

163.55

2.8

2.4

33.88

40.83

u/l

1.00

1101

5144

Any operation in hilmo

296

178

9.02

162.94

2.6

1.3

197.93

34.64

u/l

0.49

244

142

L04AA Selective immunosuppressants

1525

7447

2.25

162.37

5.2

2.4

40.35

45.00

u/l

0.31

1381

6370

Heart failure,strict

3101

13365

1.77

162.34

2.8

2.4

42.14

48.29

u/l

0.40

2638

11433

Bacterial pneumonia, not elsewhere classified

2403

11941

1.89

161.67

2.9

2.3

35.29

45.09

u/l

1.02

2068

10208

Diseases of the skin and subcutaneous tissue

6593

22969

1.48

161.53

2.7

2.4

46.02

47.33

u/l

0.04

5628

19697

Other and unspecified iron deficiency

2030

10917

1.99

161.23

3.0

2.4

40.68

41.88

u/l

0.07

1747

9275

Venous thromboembolism

3260

19431

1.71

160.87

2.9

2.4

47.33

45.62

u/l

0.07

2815

16543

Appendectomy

4055

25224

1.62

160.55

2.6

2.5

37.68

45.10

u/l

1.00

3530

21628

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)

498

1394

4.26

160.16

6.2

2.2

41.94

38.09

u/l

0.27

454

1155

Benign neoplasm: Rectum, anus and anal canal

1197

5325

2.46

159.84

2.7

2.2

35.13

48.32

u/l

0.76

1029

4483

Schizophrenia or delusion, excluding more controls

1841

9511

2.04

159.20

2.6

2.4

29.39

43.68

u/l

3.56

1565

8255

Budesonide

1029

4313

2.67

159.05

2.8

2.3

37.33

49.25

u/l

0.53

904

3697

Bacterial pneumoniae

2505

12667

1.85

158.89

2.8

2.3

35.54

44.93

u/l

1.03

2149

10832

Other heart diseases, wide

5736

24372

1.51

158.74

2.8

2.5

35.46

45.77

u/l

1.93

4936

20946

Benign neoplasm: Rectum

1085

4650

2.58

158.49

2.7

2.2

33.71

49.82

u/l

0.85

940

3921

External causes of morbidity and mortality

4379

14027

1.62

158.45

2.6

2.3

47.42

38.99

u/l

0.35

3742

12013

Generalized anxiety disorder

1049

4422

2.60

157.89

2.8

2.3

42.47

39.91

u/l

0.11

898

3824

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

5881

27677

1.49

156.59

3.4

2.4

63.76

40.80

u/l

0.94

5131

23611

Cardiac arrhythmias

3822

15948

1.65

155.91

2.7

2.3

35.98

45.95

u/l

1.67

3299

13876

Diseases of pulp and periapical tissues, including avohilmo

6843

25081

1.46

155.81

2.7

2.4

41.30

47.25

u/l

0.35

5868

21491

Dental pulpitis 4

6851

25134

1.46

155.13

2.7

2.4

41.22

47.25

u/l

0.35

5874

21536

Dental pulpitis 1

6850

25143

1.46

154.85

2.7

2.4

41.20

47.25

u/l

0.35

5871

21544

Other gastritis (incl. Duodenitis)

1480

7252

2.21

154.63

3.5

2.3

36.38

47.83

u/l

0.59

1290

6162

Other bacterial intestinal infections

1204

5484

2.41

152.27

3.8

2.3

46.33

45.92

u/l

0.01

1056

4658

Factors influencing health status and contact with health services

2043

5320

2.01

151.57

2.6

2.1

61.69

42.48

u/l

0.39

1770

4545

IBD patients in KELA-register

1572

7933

2.14

151.31

3.4

2.5

40.19

45.74

u/l

0.38

1410

6806

Behavioural syndromes associated with physiological disturbances and physical factors

2020

11071

1.94

150.24

2.9

2.5

32.38

42.77

u/l

1.54

1719

9508

Dorsopathies

6576

23640

1.46

150.21

2.7

2.4

34.28

46.48

u/l

2.58

5624

20320

Continuous positive airway pressure

1219

4779

2.37

148.80

3.1

2.3

36.05

52.35

u/l

1.31

1032

4208

Fibrosis and cirrhosis of liver

622

2111

3.52

148.66

4.1

2.3

31.89

39.96

u/l

2.09

563

1817

5-aminosalicylic acid

1467

7269

2.18

148.38

3.2

2.5

38.41

47.99

u/l

0.72

1306

6238

Persons encountering health services for examination and investigation

4279

13861

1.60

147.94

2.7

2.3

46.10

45.80

u/l

0.01

3671

11947

Other nutritional deficiencies

3852

24505

1.60

147.72

2.7

2.5

51.52

44.33

u/l

0.22

3200

21088

Parodontitis

5414

27650

1.50

146.48

2.9

2.5

42.69

45.23

u/l

0.21

4622

23694

Parodontitis or operation codes

5418

27660

1.50

146.24

2.9

2.5

42.69

45.23

u/l

0.21

4626

23700

Episodal and paroxysmal disorders

7041

25868

1.43

145.82

2.6

2.5

33.95

46.07

u/l

2.90

6037

22165

Conjunctivitis

4523

26511

1.54

145.74

2.5

39.07

42.44

u/l

0.38

3872

22696

Chronic periodontitis, including avohilmo

5388

27644

1.50

145.23

2.9

2.5

42.73

45.24

u/l

0.21

4600

23691

Symptoms and signs involving the skin and subcutaneous tissue

4098

27021

1.57

145.15

2.7

2.5

41.99

43.74

u/l

0.10

3543

23094

Neurological diseases, wide definition

2072

5520

1.97

144.51

2.6

2.3

57.75

49.22

u/l

0.14

1782

4811

Secondary malignant neoplasm of respiratory and digestive organs, excluding all cancers (controls excluding all cancers)

1075

4786

2.47

143.71

3.4

2.2

34.94

49.02

u/l

0.73

966

4044

Chronic lower respiratory diseases

7482

29459

1.41

143.38

2.6

2.5

33.60

47.30

u/l

3.78

6335

25307

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

588

1957

3.48

143.22

3.3

2.7

26.07

40.81

u/l

4.20

507

1716

Inflammatory bowel disease, strict (require KELA)

1572

8107

2.09

142.31

3.4

2.5

40.19

45.42

u/l

0.36

1410

6974

Extracorporeal dialysis

532

1699

3.81

141.71

6.6

2.5

57.86

67.35

u/l

0.11

483

1468

Invasive ventilation

598

2034

3.47

141.66

3.3

2.4

37.48

62.81

u/l

0.54

512

1732

Disorders of conjunctiva

4921

28344

1.51

140.57

2.5

41.65

44.73

u/l

0.25

4216

24264

Other acute lower respiratory infections

3178

19089

1.66

140.37

3.0

2.5

43.76

45.00

u/l

0.04

2727

16347

Abnormal findings on examination of blood, without diagnosis

2705

15361

1.74

139.28

3.2

2.5

46.83

48.51

u/l

0.04

2331

13103

Superficial injury of head

1464

7420

2.13

139.03

3.0

2.4

32.16

45.60

u/l

1.26

1234

6373

Hernia of abdominal wall

2711

16525

1.73

138.84

3.0

2.5

36.90

47.59

u/l

1.02

2366

14169

ILD medications: azathioprine

1055

4743

2.44

137.82

3.4

2.2

51.31

47.48

u/l

0.09

955

4052

Type 2 diabetes, wide definition

4679

20702

1.53

137.42

2.9

2.2

33.58

37.40

u/l

0.65

3840

17832

Chronic rhinitis, nasopharyngitis and pharyngitis

2020

11408

1.88

136.77

2.6

2.5

32.31

39.10

u/l

4.86

1715

9805

Atrial fibrillation and flutter

1976

7047

1.93

136.42

2.8

2.2

38.36

43.92

u/l

0.68

1715

6072

Acute bronchitis

2474

14462

1.76

136.29

3.0

2.4

33.16

47.30

u/l

1.61

2126

12340

Other and unspecified mood [affective] disorders

564

1880

3.42

136.01

2.8

2.3

26.84

37.92

u/l

4.05

491

1627

Cerebrovascular diseases (FINNGEN)

1945

7621

1.93

135.93

2.9

2.2

41.05

43.12

u/l

0.20

1667

6547

Migraine

2961

15641

1.68

135.69

2.6

2.4

39.80

43.49

u/l

0.19

2567

13398

Dental pulpitis 4, only avohilmo

6855

25897

1.42

135.28

2.7

2.4

41.38

46.91

u/l

0.32

5852

22216

Assault

952

4154

2.53

133.81

3.3

2.7

35.00

50.84

u/l

0.77

811

3625

Sciatica+with lumbago

3031

18125

1.66

133.61

2.9

2.4

43.62

47.33

u/l

0.17

2599

15600

Bacterial pneumonia (organism specified)

2625

14520

1.73

133.51

2.9

2.4

35.57

48.90

u/l

1.22

2253

12387

Heart failure, strict

3284

15040

1.65

133.49

2.8

2.5

41.71

51.43

u/l

0.63

2789

12847

Memory loss

701

2679

3.02

133.33

2.5

2.4

31.02

40.50

u/l

2.83

575

2295

Persistent mood disorders

1284

6304

2.20

133.32

2.8

2.3

34.88

38.38

u/l

0.69

1078

5394

COPD (mode)

1789

7695

1.96

132.33

2.9

2.3

32.16

47.49

u/l

1.78

1496

6610

Oesophageal varices

395

1095

4.58

131.96

5.0

2.4

28.59

40.63

u/l

2.19

356

936

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

3285

20820

1.62

131.68

2.4

2.5

36.05

43.76

u/l

1.57

2802

17843

Injuries to the thorax

2628

16096

1.72

131.51

3.1

2.5

37.57

47.19

u/l

0.94

2258

13770

Noninfectious colitis NAS

960

4243

2.51

131.42

3.4

2.4

37.76

48.40

u/l

0.44

842

3612

Dental pulpitis 1, only avohilmo

6844

26008

1.41

130.49

2.6

2.4

41.31

46.87

u/l

0.32

5842

22310

Cutaneous abscess, furuncle and carbuncle

1620

8683

2.00

130.43

3.7

2.5

34.37

45.66

u/l

1.17

1396

7477

Other and unspecified nonorganic psychotic disorders

1307

6513

2.17

130.37

2.6

29.54

48.19

u/l

1.73

1126

5647

Gout

1640

8011

1.99

129.69

3.1

2.5

49.99

51.82

u/l

0.05

1437

6877

Alcohol abuse, main dg

1078

5022

2.36

129.58

3.9

2.6

32.62

50.50

u/l

1.08

929

4344

Azathioprine

1055

4868

2.37

129.46

3.4

2.4

51.31

48.30

u/l

0.07

955

4178

Used for control exclusion in common control thyroid runs

6625

24309

1.42

129.37

3.0

2.3

37.50

45.42

u/l

1.27

5664

20872

Mental and behavioural disorders due to sedatives or hypnotics

570

1990

3.34

128.46

3.9

2.5

29.06

39.42

u/l

2.75

482

1726

Hypothyroidism, drug reimbursement

815

2305

2.68

127.33

2.4

1.8

36.08

46.36

u/l

1.48

691

1976

Unspecified haematuria

2384

12234

1.76

126.94

2.7

2.5

40.68

48.07

u/l

0.48

2082

10436

Disturbances of skin sensation

1728

9535

1.94

126.85

2.8

2.5

31.08

44.67

u/l

1.84

1507

8167

Benign neoplasm: Sigmoid colon

1035

4770

2.36

126.81

2.6

2.2

31.63

49.47

u/l

1.08

894

4041

Benign neoplasm: Colon, unspecified

1508

8002

2.04

126.28

2.9

2.4

47.44

53.95

u/l

0.19

1261

6826

Abnormalities of heart beat

2000

11384

1.83

126.07

2.9

2.3

33.34

51.99

u/l

1.76

1705

9715

Gastroduodenal ulcer

1520

8026

2.01

126.07

3.5

2.3

71.44

47.58

u/l

0.34

1319

6818

Unspecified kidney failure

679

2612

2.94

125.91

4.0

2.3

41.85

37.68

u/l

0.52

592

2203

Gout, idiopatic and unspecified

1431

7461

2.07

125.85

3.1

2.5

52.25

54.87

u/l

0.06

1252

6358

All-cause Heart Failure

3196

14762

1.63

125.85

2.8

2.5

42.03

51.64

u/l

0.60

2713

12604

Diseases of the respiratory system

4144

13815

1.55

125.81

2.5

2.3

45.47

44.17

u/l

0.04

3507

11844

Exposure to other specified factors

4356

28137

1.50

125.73

2.7

2.5

43.07

45.59

u/l

0.16

3758

24131

Ventral hernia

1477

7792

2.04

125.09

3.1

2.4

40.93

45.13

u/l

0.20

1305

6664

Acute upper respiratory infections of multiple and unspecified sites

4479

23098

1.50

125.06

3.0

2.4

32.99

46.43

u/l

2.98

3899

19774

Obesity and other hyperalimentation

3607

23774

1.56

124.65

2.6

2.5

53.39

44.17

u/l

0.28

2981

20478

Diseases of arteries, arterioles and capillaries

3791

18879

1.56

124.57

3.1

2.5

62.22

44.50

u/l

0.44

3224

16107

Obesity

3589

23674

1.56

124.01

2.6

2.5

53.49

44.22

u/l

0.28

2967

20403

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

2722

10586

1.70

123.85

3.1

2.2

57.85

41.19

u/l

0.29

2359

9108

Neurological diseases

5601

19977

1.45

123.57

2.6

2.4

42.88

46.31

u/l

0.14

4788

17183

Other diseases of hard tissues of teeth

3712

18388

1.56

123.41

2.9

2.4

37.08

48.66

u/l

1.63

3180

15850

Other specified and unspecified personality disorders

703

2794

2.84

122.26

3.1

2.4

29.42

56.01

u/l

0.93

601

2424

Allergic conjunctivitis

3372

21877

1.58

122.20

2.4

2.5

36.20

43.45

u/l

1.52

2878

18768

Bacterial intestinal infections, IBD co-morbidities

1181

5821

2.21

122.08

3.8

2.4

47.57

45.25

u/l

0.06

1036

4963

DVT of lower extremities and pulmonary embolism

2409

14680

1.72

121.75

2.9

2.4

49.43

47.24

u/l

0.07

2072

12513

Injuries to the abdomen, lower back, lumbar spine and pelvis

2305

13833

1.74

121.65

3.0

2.4

72.42

42.49

u/l

0.47

1975

11817

Autoimmune diseases

6890

25912

1.39

121.26

3.1

2.3

42.63

45.12

u/l

0.16

5894

22235

Other CVD (FINNGEN)

744

2329

2.77

120.98

3.4

2.2

39.22

40.55

u/l

0.12

643

2001

Unspecified fall

2835

17907

1.64

120.50

2.9

2.4

36.53

46.41

u/l

1.22

2423

15304

Atrial fibrillation and flutter with reimbursement

1608

5484

1.99

120.46

2.6

2.2

37.51

43.48

u/l

0.64

1378

4721

Acute alcohol intoxication, ICD10

1279

6518

2.12

120.14

3.8

2.5

32.97

48.52

u/l

1.27

1110

5641

Ulcerative colitis, NAS

975

4517

2.37

118.84

3.6

2.4

42.71

48.27

u/l

0.21

876

3876

Acute alcohol intoxication

1546

8400

1.96

118.68

3.6

2.5

32.48

49.32

u/l

1.26

1334

7246

Polyarthropathies

4109

18657

1.52

118.64

2.9

2.5

39.63

44.04

u/l

0.44

3524

16053

Intracranial trauma

3446

17002

1.57

117.60

2.8

2.4

50.45

47.09

u/l

0.09

2931

14660

Cirrhosis of liver, NAS

431

1364

3.87

116.82

4.4

2.4

28.49

40.85

u/l

2.76

388

1169

Chronic periapical parodontitis

1267

6499

2.10

116.25

4.2

2.4

72.71

52.34

u/l

0.23

1123

5633

Injury, poisoning and certain other consequences of external causes

3479

11357

1.58

116.08

2.5

2.3

50.50

38.75

u/l

0.40

2976

9768

Cough

2297

13421

1.72

115.97

2.6

2.3

41.81

49.60

u/l

0.41

1958

11447

Problems related to lifestyle

709

2890

2.71

115.57

3.8

2.3

28.98

55.28

u/l

0.95

595

2485

Malignant neoplasm of pancreas

490

1674

3.44

115.13

7.2

2.3

121.93

34.37

u/l

0.73

450

1419

Parodontitis and operation codes

4955

27482

1.45

115.07

2.9

2.5

42.81

45.48

u/l

0.21

4239

23556

Mental and behavioural disorders due to use of other stimulants, including caffeine

308

788

4.97

114.84

3.0

2.7

25.31

35.18

u/l

3.84

265

690

Other and unspecified effects of external causes

1681

9475

1.89

114.64

2.6

2.5

74.78

42.65

u/l

0.35

1429

8119

Glomerular disorders in diseases classified elsewhere

803

3498

2.57

114.45

7.1

2.4

52.50

51.66

u/l

0.02

700

3007

Gout, FINNGEN

1640

9186

1.90

114.42

3.1

2.5

49.99

51.73

u/l

0.05

1437

7860

Disorders of eyelid, lacrimal system and orbit

4866

27174

1.45

114.23

2.6

2.5

40.34

45.70

u/l

0.54

4155

23241

Myalgia

1413

7562

2.00

113.92

2.9

2.3

66.64

38.94

u/l

0.40

1236

6468

Direct fill therapy

927

4288

2.39

113.85

4.6

2.4

45.02

48.39

u/l

0.09

822

3705

Dental caries 1

4768

17039

1.47

113.78

2.6

2.3

45.07

49.90

u/l

0.17

4008

14651

Dialysis

365

1059

4.24

113.13

8.4

2.4

40.44

39.43

u/l

0.07

327

906

Visual disturbances

2726

17476

1.63

113.07

2.8

2.5

32.74

47.66

u/l

2.28

2329

14956

Dental caries, including avohilmo

4760

17031

1.47

112.97

2.6

2.3

45.09

49.91

u/l

0.17

4002

14644

Spondylopathies

4638

19767

1.47

112.65

2.7

2.4

46.39

46.96

u/l

0.02

3936

16986

Statin medication

4233

16322

1.50

112.51

3.1

2.5

36.29

44.28

u/l

1.48

3608

14157

Overexertion and strenuous or repetitive movements

737

3118

2.66

112.41

2.6

2.5

30.59

53.22

u/l

0.87

611

2704

Visual disturbances and blindness

2903

18898

1.61

112.26

2.8

2.5

32.55

47.03

u/l

2.45

2472

16161

Early onset COPD, excluding more controls

1195

6066

2.10

112.05

3.2

2.4

32.51

50.51

u/l

1.61

1006

5256

Pulmonary heart disease, diseases of pulmonary circulation

1841

10730

1.82

111.80

2.9

2.4

49.06

49.45

u/l

0.01

1579

9129

Dental pulpitis 2

4299

15151

1.50

111.37

2.6

2.3

46.75

51.39

u/l

0.15

3632

13041

Gout, unspecified

1182

6032

2.12

110.99

3.1

2.5

44.09

59.94

u/l

0.49

1040

5149

Injuries to the knee and lower leg

7069

30440

1.36

110.96

2.7

2.5

41.17

45.35

u/l

0.39

6006

26113

Dental pulpitis 2, only avohilmo

4371

15458

1.49

110.95

2.6

2.3

46.18

51.17

u/l

0.16

3690

13311

Hypokalaemia

761

3274

2.58

110.76

3.8

2.3

32.43

53.23

u/l

0.80

652

2787

Asthma, hospital admissions , main diagnosis only

4817

30947

1.44

109.91

2.6

2.5

33.12

46.21

u/l

3.59

4076

26517

Benign neoplasm: Pancreas

246

551

5.86

109.28

4.9

1.9

244.63

35.26

u/l

1.35

222

454

Other inflammatory liver diseases

524

1911

3.19

109.27

4.3

2.3

122.17

39.24

u/l

0.46

463

1653

Subjective visual disturbances

1504

8341

1.93

109.16

2.8

2.4

32.67

43.97

u/l

1.20

1286

7114

Retention of urine

1856

9146

1.81

108.96

3.0

2.5

70.52

45.14

u/l

0.30

1609

7773

Calculus of kidney and ureter

1761

10238

1.83

108.13

2.5

34.45

51.71

u/l

1.31

1538

8747

Acetic acid derivatives and related substances

1785

5194

1.87

108.03

2.5

2.6

33.92

38.83

u/l

0.98

1522

4492

Non-selective monoamine reuptake inhibitors

2214

13218

1.70

107.82

2.8

2.4

33.15

46.94

u/l

1.69

1844

11335

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

1077

5381

2.17

107.24

3.5

2.5

40.35

46.28

u/l

0.29

966

4653

Other disorders of eye and adnexa

928

4396

2.32

107.12

3.4

2.3

30.76

48.92

u/l

1.01

795

3767

Dental caries 3

5013

18281

1.44

107.00

2.6

2.4

44.86

48.91

u/l

0.15

4220

15737

Pulmonary embolism

1704

9854

1.84

106.61

2.9

2.4

47.88

50.91

u/l

0.07

1463

8387

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

3552

22533

1.52

106.29

2.9

2.5

47.00

46.63

u/l

0.01

3095

19162

Pulmonary heart disease

1704

9863

1.84

106.27

2.9

2.4

47.88

50.70

u/l

0.07

1463

8394

Phobic anxiety disorders

828

3736

2.39

106.04

2.9

2.3

49.16

40.52

u/l

0.31

699

3254

Spondylosis

3040

17270

1.57

105.67

2.6

2.4

40.34

48.69

u/l

0.63

2547

14847

Urolithiasis

1862

11056

1.78

105.66

2.6

34.26

52.50

u/l

1.57

1626

9454

Secondary hypertension

537

1975

3.00

105.49

6.1

2.3

38.78

41.74

u/l

0.41

491

1719

Injuries to the ankle and foot

3968

25279

1.48

105.09

2.9

2.5

51.41

44.37

u/l

0.23

3364

21774

Disorders of thyroid, IBD co-morbidities

1098

3942

2.14

104.40

2.4

2.3

40.40

47.39

u/l

0.50

942

3435

Hypo-osmolality and hyponatraemia

1011

4974

2.19

103.71

3.9

2.4

33.45

50.13

u/l

1.04

851

4262

Sleep disorders

1323

7163

1.98

103.31

2.8

2.5

31.06

43.91

u/l

1.24

1130

6171

Diseases of the eye and adnexa

5151

18583

1.42

103.14

2.8

2.4

35.54

44.33

u/l

1.94

4397

16061

Ulcerative colitis (strict definition, require KELA)

1101

5620

2.12

103.13

3.5

2.5

40.13

45.84

u/l

0.29

986

4851

STROKE

3347

15661

1.54

103.10

2.8

2.4

39.72

46.92

u/l

0.88

2843

13510

Other disorders of skin and subcutaneous tissue

3822

24437

1.48

102.95

3.0

2.4

33.16

45.68

u/l

2.95

3230

20894

Hyperkinetic disorders, excluding more controls

565

2099

2.83

102.92

2.4

2.3

30.10

42.22

u/l

2.33

483

1829

Nonorganic sleeping disorders

1188

6233

2.05

102.38

2.8

2.5

31.56

44.58

u/l

1.04

1011

5358

Chronic periodontitis, complicated

671

2847

2.67

102.27

4.1

2.5

37.76

54.51

u/l

0.50

584

2468

Nonalcoholic fatty liver disease

676

2888

2.65

101.39

3.0

2.4

31.62

55.59

u/l

0.84

592

2509

Other maltreatment syndromes

309

863

4.41

101.28

3.6

2.6

40.11

94.45

u/l

0.50

263

753

Mental disorders, not otherwise specified

612

2492

2.75

101.05

2.9

2.4

29.63

57.08

u/l

0.82

530

2142

Mental and behavioural disorders due to opioids

347

1045

4.00

100.93

3.2

2.6

26.99

34.09

u/l

2.52

301

902

Diseases of the musculoskeletal system and connective tissue

3500

11808

1.53

100.81

2.6

2.3

49.88

43.80

u/l

0.18

3016

10177

Alcohol withdrawal state with delirium

525

1997

3.03

100.77

4.7

2.5

30.87

63.72

u/l

0.79

453

1742

Polyuria

1305

7104

1.97

100.35

2.8

2.4

33.12

45.99

u/l

1.16

1109

6045

Outcome of delivery

1102

3398

2.15

99.79

2.1

2.5

37.14

36.83

u/l

0.02

927

2874

Benign neoplasm: Ascending colon

741

3295

2.47

99.67

2.8

2.2

48.87

53.69

u/l

0.10

640

2784

Obesity related asthma

1922

11687

1.74

99.64

2.7

2.5

35.27

50.86

u/l

1.09

1603

10064

Infections with a predominantly sexual mode of transmission

1804

10771

1.76

99.39

2.7

2.5

36.87

41.98

u/l

0.46

1571

9286

Other intervertebral disc disorders

4834

21383

1.42

99.34

2.7

2.4

41.85

46.51

u/l

0.40

4105

18408

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

1165

6141

2.04

99.15

3.4

2.5

39.87

48.33

u/l

0.49

1042

5292

Benign neoplasm: Stomach

607

2485

2.73

98.81

3.0

2.1

48.02

55.77

u/l

0.12

519

2097

Glomerular diseases

1126

5894

2.07

98.32

6.0

2.5

59.66

46.56

u/l

0.38

994

5072

Osteopathies and chondropathies

3107

19979

1.53

98.13

3.2

2.4

34.49

46.46

u/l

1.98

2644

17059

Mixed and other personality disorders

595

2430

2.75

97.77

3.5

2.4

32.79

60.00

u/l

0.78

503

2117

Benign neoplasm: Rectum, anus and anal canal

1197

6418

2.01

97.30

2.7

2.4

35.13

45.68

u/l

0.71

1029

5466

Benign neoplasm: Rectum

1085

5646

2.09

96.94

2.7

2.4

33.71

46.85

u/l

0.84

940

4811

All influenza

1435

8105

1.87

96.86

3.1

2.4

32.94

45.28

u/l

1.26

1233

6969

Acute upper respiratory infections

6130

28934

1.36

96.78

2.8

2.4

47.09

44.49

u/l

0.11

5281

24713

Fenamates

1003

3308

2.18

96.44

2.5

2.6

68.18

41.11

u/l

0.36

849

2870

Heart failure and bmi 25plus

1842

7572

1.77

96.30

2.8

2.5

37.93

51.52

u/l

0.64

1575

6441

KRA_PSY_EATING, excluding more controls

505

1892

2.89

95.85

2.7

2.0

31.55

37.60

u/l

1.16

428

1624

Abnormal serum enzyme levels

1643

9561

1.80

95.72

2.9

2.5

56.72

55.07

u/l

0.03

1443

8212

Unspecified mental disorder

2394

15464

1.62

95.61

2.6

31.21

44.34

u/l

2.84

2024

13333

Migraine with aura

1412

7971

1.87

95.30

2.7

2.4

31.18

44.56

u/l

1.51

1221

6830

Adverse effects, not elsewhere classified

1204

6510

1.98

94.65

2.6

2.4

33.15

43.95

u/l

0.81

1024

5571

Concussion

2849

16470

1.55

94.35

2.9

2.5

36.80

47.56

u/l

1.36

2432

14204

Hyperlipidaemia, other/unspecified

2051

12127

1.68

93.99

2.8

2.4

53.70

52.39

u/l

0.03

1728

10360

Dermatitis and eczema

6320

31541

1.35

93.65

2.7

2.5

35.01

46.46

u/l

3.01

5400

27013

Abnormalities of gait and mobility

767

3566

2.38

93.49

2.7

2.4

52.79

38.67

u/l

0.50

628

3028

Other disorders of veins

2261

14512

1.63

93.42

2.4

34.20

42.33

u/l

1.56

1929

12385

Dental caries 1 and operation codes

5206

19628

1.40

93.21

2.6

2.4

36.75

50.45

u/l

1.97

4404

16863

Crohn disease

857

4153

2.25

92.92

3.4

2.5

41.66

49.33

u/l

0.28

769

3565

Other disorders of kidney and ureter

816

3901

2.30

92.48

3.6

2.4

61.09

51.09

u/l

0.18

733

3327

Other dialysis

286

813

4.45

92.37

8.5

2.4

41.32

96.47

u/l

0.47

255

705

Fracture of rib(s), sternum and thoracic spine

1665

9952

1.77

92.29

3.2

2.5

39.10

51.67

u/l

0.74

1439

8528

Colon adenocarcinoma, excluding all cancers (controls excluding all cancers)

657

2863

2.51

92.19

2.8

2.2

39.81

36.61

u/l

0.23

592

2396

Adenocarcinoma and ductal carcinoma of pancreas, excluding all cancers (controls excluding all cancers)

267

717

4.54

92.11

9.1

2.1

175.26

35.37

u/l

0.61

247

588

Cardiomyopathy

1035

5386

2.06

91.20

2.6

2.5

58.28

64.90

u/l

0.10

891

4672

Migraine without aura

1173

6348

1.96

90.91

2.6

2.3

52.19

45.73

u/l

0.13

1016

5452

Hard cardiovascular diseases

4401

20471

1.42

90.54

2.8

2.5

53.78

46.07

u/l

0.19

3738

17560

Viral pneumonia

778

3667

2.31

90.43

3.1

2.4

33.19

53.21

u/l

0.90

675

3171

Other Crohn's disease

509

2011

2.86

89.75

3.4

2.4

39.40

60.51

u/l

0.42

462

1731

Gout, strict definition

1003

5208

2.08

89.71

3.0

2.5

46.32

62.76

u/l

0.42

868

4437

Dental caries 1, only avohilmo

4754

17724

1.41

89.43

2.6

2.4

35.54

52.12

u/l

2.32

3990

15262

Insomnia

1004

5217

2.08

89.43

2.8

2.5

30.96

46.84

u/l

1.08

864

4499

Diabetes, varying definitions

5970

27061

1.35

89.26

3.4

2.3

49.17

42.68

u/l

0.22

4942

23430

Collagenous colitis

617

2680

2.59

88.97

2.9

2.3

36.08

56.05

u/l

0.57

540

2288

Diabetes mellitus

5991

27153

1.35

88.82

3.4

2.3

49.14

42.64

u/l

0.22

4952

23513

Malignant neoplasm of colon

888

4440

2.18

88.66

2.7

2.4

37.46

38.20

u/l

0.06

812

3779

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

1576

9254

1.77

88.58

2.8

2.4

31.96

41.68

u/l

1.13

1317

7983

Deposits [accretions] on teeth

488

1826

2.90

88.51

4.8

2.3

36.61

39.37

u/l

0.35

436

1600

Acute appendicitis

3991

27214

1.43

88.04

2.6

2.5

37.60

46.72

u/l

1.37

3456

23332

Non-allergic asthma (mode), excluding more controls

1091

5771

1.98

87.65

2.6

2.2

30.72

49.81

u/l

1.61

927

4946

Dental caries 3, only avohilmo

5007

18900

1.39

87.19

2.6

2.4

35.19

51.04

u/l

2.40

4211

16294

Diseases of appendix

4257

28354

1.41

87.17

2.6

2.5

37.24

46.27

u/l

1.45

3685

24297

Intracranial injury

3128

20971

1.49

87.16

2.8

2.5

36.97

47.05

u/l

1.36

2641

17985

Dental caries 3 and operation codes

5395

20673

1.37

87.10

2.7

2.4

36.34

49.74

u/l

2.07

4555

17774

Appendicitis, broad definition

4222

28218

1.41

86.47

2.6

2.5

37.20

46.35

u/l

1.47

3654

24180

In situ neoplasms

1773

10399

1.70

86.45

2.5

2.2

73.04

36.41

u/l

0.45

1506

8721

Hypertensive heart and/or renal disease

1368

6028

1.85

86.21

3.0

2.2

43.43

51.14

u/l

0.21

1159

5173

Hepatocellular carcinoma, excluding all cancers (controls excluding all cancers)

220

539

4.97

85.73

4.4

2.2

31.71

34.56

u/l

0.53

196

433

Other specified and unspecified disorders of eye and adnexa

334

1091

3.66

85.48

3.5

2.4

31.82

38.64

u/l

0.75

283

918

Schizophrenia or delusion

1841

11495

1.68

85.42

2.6

29.39

46.28

u/l

2.86

1565

9902

COPD

2407

13095

1.58

85.22

2.9

2.5

32.96

54.96

u/l

2.47

2024

11242

Vascular disorders of the intestines

414

1506

3.08

85.06

3.4

2.2

42.96

36.95

u/l

0.35

366

1274

Type 2 diabetes

5687

25635

1.35

84.62

3.2

2.3

50.58

43.17

u/l

0.24

4713

22196

Gastric ulcer

997

5248

2.03

84.58

3.5

2.3

86.06

38.79

u/l

0.50

859

4447

Mental and behavioural disorders due to cannabinoids

275

798

4.13

84.49

2.9

2.6

197.45

40.87

u/l

0.46

243

699

Chronic sinusitis

2441

16272

1.56

84.10

2.5

44.44

43.96

u/l

0.02

2045

13987

Schizophrenia, schizotypal and delusional disorders

1841

11541

1.67

84.01

2.6

29.45

46.22

u/l

2.84

1563

9944

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

5441

26846

1.35

83.41

2.8

2.5

49.38

42.87

u/l

0.21

4707

22946

Progressive vascular leukoencephalopathy

277

823

4.13

83.00

2.2

30.57

39.19

u/l

1.36

232

688

Benign neoplasm: Pancreas

246

683

4.65

82.76

4.9

2.3

244.63

35.86

u/l

1.34

222

570

Open wound of head

2800

18951

1.51

82.53

3.0

2.5

36.01

50.80

u/l

2.08

2383

16294

Non-allergic asthma (mode)

1091

5894

1.94

82.14

2.6

2.3

30.72

49.07

u/l

1.57

927

5048

Undetermined asthma, excluding more controls

737

3524

2.24

81.60

2.6

2.2

29.65

53.94

u/l

1.13

626

3026

Primary_lymphoid and hematopoietic malignant neoplasms

1189

6682

1.88

81.45

2.8

2.3

35.70

45.53

u/l

0.72

1026

5644

Coxibs

1653

5229

1.75

81.32

2.4

2.6

34.00

38.75

u/l

1.45

1424

4526

Other special examinations and investigations of persons without complaint or reported diagnosis

3838

13860

1.44

81.07

2.9

2.3

48.42

45.80

u/l

0.07

3253

11947

Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)

374

1323

3.17

80.89

4.7

2.1

39.01

38.37

u/l

0.05

340

1098

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

1087

5396

1.93

80.65

2.3

2.5

36.38

51.09

u/l

0.57

926

4664

Allergic asthma (mode), excluding more controls

1332

7587

1.80

80.59

2.4

2.2

33.57

50.69

u/l

1.55

1132

6547

Soft tissue disorders related to use, overuse and pressure

1504

9075

1.75

80.28

2.6

2.4

49.22

42.76

u/l

0.24

1255

7763

Other arrhythmias

3547

19466

1.44

79.80

2.5

2.4

33.63

47.14

u/l

2.16

3011

16671

Polyneuropathies and other disorders of the peripheral nervous system

1224

7014

1.86

79.70

3.6

2.5

54.47

45.63

u/l

0.19

1028

6025

Sequelae of external causes of morbidity and mortality

1422

8500

1.77

79.22

3.3

2.4

64.11

43.29

u/l

0.44

1216

7247

Benign neoplasm: Transverse colon

565

2472

2.52

79.18

3.0

2.2

74.98

37.07

u/l

0.52

498

2085

Undetermined asthma

737

3566

2.22

79.13

2.6

2.2

29.65

53.01

u/l

1.08

626

3060

Ulcerative ileocolitis

337

1155

3.41

78.84

3.7

2.4

37.93

81.00

u/l

0.53

310

993

Coagulation defects, purpura and other haemorrhagic conditions

1112

6220

1.91

78.46

2.9

2.4

49.59

45.82

u/l

0.07

980

5303

Somatoform disorder

962

5145

2.00

78.15

3.0

2.3

34.90

38.19

u/l

0.42

818

4402

Other diseases of upper respiratory tract

6542

26594

1.31

77.80

2.5

47.54

45.01

u/l

0.11

5572

22800

Other chronic obstructive pulmonary disease

2285

12645

1.56

77.65

2.9

2.5

33.10

55.80

u/l

2.45

1916

10841

Inflammatory diseases of female pelvic organs

3352

18046

1.45

77.11

2.5

2.3

34.67

39.13

u/l

1.18

2845

15312

Allergic asthma (mode)

1332

7684

1.78

77.07

2.4

2.2

33.57

50.59

u/l

1.57

1132

6634

Ischaemic heart disease, wide definition

4258

19709

1.39

76.97

2.9

2.5

55.65

47.09

u/l

0.21

3644

16882

Faecal incontinence

489

2023

2.64

76.94

2.3

1.8

32.28

38.85

u/l

1.37

413

1668

Pain and other conditions associated with female genital organs and menstrual cycle

1132

6105

1.87

76.76

2.4

2.3

40.15

36.02

u/l

0.22

973

5203

Hypertensive Heart Disease

1202

5591

1.85

76.41

2.9

2.2

43.96

51.92

u/l

0.19

1009

4793

Benign neoplasm: Small intestine

287

913

3.71

76.19

3.7

2.1

52.69

40.88

u/l

0.45

262

757

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

2702

12652

1.51

76.17

2.6

2.3

42.72

43.06

u/l

0.01

2328

10670

Fracture of skull and facial bones

1220

7058

1.83

76.16

3.0

2.5

36.72

47.33

u/l

0.75

1050

6113

Other chronic obstructive pulmonary disease, including avohilmo

2790

16143

1.49

75.86

2.8

2.5

33.96

51.07

u/l

2.27

2338

13810

Paracetamol of NSAID medication

1060

2810

1.97

75.61

2.3

2.4

79.84

38.29

u/l

0.44

897

2446

Second line medication for Crohn's disease

3112

22189

1.45

75.41

2.8

2.5

40.32

45.63

u/l

0.43

2734

18975

Glucagon-like peptide-1 (GLP-1) analogues

2959

17142

1.47

75.29

2.8

2.5

40.52

50.15

u/l

0.81

2458

14745

Acute appendicitis, no complications

3114

22141

1.45

75.28

2.6

38.71

45.58

u/l

0.72

2692

19047

Shoulder lesions

4292

19504

1.38

74.95

2.7

2.5

37.92

42.79

u/l

0.64

3645

16749

Diabetes medication

5889

27772

1.32

74.91

3.4

2.3

50.06

43.02

u/l

0.24

4851

24044

Disorders resulting from impaired renal tubular function

297

984

3.65

74.71

5.2

2.4

67.62

85.39

u/l

0.12

271

834

Insulin, intermediate and long-acting

2959

20543

1.46

74.61

4.4

2.4

62.26

44.25

u/l

0.31

2337

17734

Syphilis

239

695

4.26

74.26

3.1

2.6

33.44

106.72

u/l

0.56

218

611

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

634

2131

2.35

74.13

2.7

2.3

35.44

39.52

u/l

1.00

573

1865

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

471

1965

2.68

74.02

3.2

2.4

29.46

63.09

u/l

0.77

396

1673

Non-ischemic cardiomyopathy

1595

8127

1.69

73.95

2.8

2.4

46.88

47.61

u/l

0.02

1362

6988

Hypotension

898

4789

2.01

73.81

3.2

2.4

37.75

37.85

u/l

0.01

774

4041

Benign neoplasm: Sigmoid colon

1035

5790

1.92

73.50

2.6

2.4

31.63

46.50

u/l

1.11

894

4950

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

5438

25575

1.33

73.34

3.5

2.3

50.45

43.18

u/l

0.22

4451

22142

Volume depletion

528

2315

2.48

73.07

4.3

2.4

34.13

60.96

u/l

0.70

453

1976

Vocal cord dysfunction

750

3469

2.13

73.02

2.7

2.2

37.60

45.65

u/l

0.58

631

3027

Transport accidents

2421

14629

1.51

72.82

2.7

2.4

63.66

43.42

u/l

0.32

2090

12517

Agoraphobia

255

775

3.83

72.35

2.7

2.3

41.14

41.62

u/l

0.01

225

658

Abnormal findings on diagnostic imaging of lung

2466

16537

1.51

72.35

2.8

2.4

47.81

48.52

u/l

0.02

2158

14068

Other and unspecified polyneuropathies, also in other diseases

1062

6013

1.89

72.22

3.6

2.5

58.95

47.14

u/l

0.23

886

5166

Paroxysmal tachycardia

1236

6104

1.79

71.82

2.5

2.2

37.86

42.51

u/l

0.54

1037

5235

Umbilical hernia

1450

8921

1.71

71.79

2.7

2.5

38.60

47.41

u/l

0.51

1261

7684

Benign neoplasm: Caecum

552

2492

2.43

71.79

3.0

2.2

74.18

37.10

u/l

0.51

494

2096

Asthma and allergy, excluding more controls

745

3701

2.10

71.32

2.4

2.2

31.99

52.07

u/l

0.93

630

3208

Cerebrovascular diseases

3928

20881

1.39

71.14

2.7

2.5

42.68

47.62

u/l

0.37

3324

17829

Other CVD

1026

5766

1.89

71.11

3.2

2.4

36.89

45.81

u/l

0.51

883

4886

Symptoms and signs involving speech and voice

1782

11543

1.62

71.05

2.6

2.4

53.94

41.74

u/l

0.27

1516

9847

Asthma and allergy

745

3715

2.10

70.57

2.4

2.2

31.99

51.99

u/l

0.93

630

3224

Temporomandibular joint disorders

720

3587

2.10

70.24

2.8

2.1

36.89

39.64

u/l

0.24

638

3017

Ulcerative colitis (strict definition, all Crohn cases excluded)

875

4716

1.99

69.69

3.3

2.5

38.93

47.71

u/l

0.40

779

4068

Trochanteric bursitis

806

4234

2.05

69.61

2.5

2.2

48.54

39.04

u/l

0.23

664

3585

Ovarian cyst

2119

8099

1.57

69.56

2.5

2.3

33.36

37.10

u/l

1.29

1795

6910

Right hemicolectomy

407

1640

2.82

69.49

3.5

2.4

42.53

40.20

u/l

0.12

372

1386

Pain in thoracic spine

881

4763

1.97

69.17

3.1

2.3

30.38

53.05

u/l

1.44

751

4089

Cerebral palsy and other paralytic syndromes

697

3493

2.16

69.10

3.0

2.5

30.15

52.42

u/l

0.98

603

2998

Voice disturbances

1469

9176

1.69

68.79

2.6

2.4

58.02

42.84

u/l

0.28

1247

7826

Type 2 diabetes, definitions combined

5310

24526

1.32

68.75

2.8

2.3

50.64

43.60

u/l

0.21

4439

21216

Lung cancer and mesothelioma

986

4687

1.90

68.43

2.8

2.3

33.40

42.86

u/l

3.61

870

4016

Enterocolitis due to Clostridium difficile

633

3076

2.24

68.25

4.6

2.4

37.62

52.90

u/l

0.47

562

2624

Spinal stenosis

2677

14737

1.47

68.21

2.7

2.4

43.70

50.03

u/l

0.33

2276

12624

Assault by bodily force

496

2189

2.49

68.14

3.2

2.6

31.70

59.47

u/l

0.71

431

1914

Superficial injury of lower leg

1359

8334

1.71

68.08

2.6

2.4

57.56

42.65

u/l

0.36

1158

7142

Chronic hepatitis, not elsewhere classified

278

933

3.54

67.99

3.7

2.2

33.08

36.24

u/l

0.62

249

795

Exclusions for E4_PCOS_CONSORTIUM

4055

19014

1.37

67.74

2.5

2.4

35.38

41.24

u/l

1.15

3486

16262

Insulin medication

3223

20048

1.42

67.66

4.3

2.4

59.75

45.23

u/l

0.27

2564

17310

Post-traumatic stress disorder

478

2072

2.50

67.65

3.0

2.2

123.46

38.81

u/l

0.42

422

1781

Other joint disorders

5218

21437

1.32

67.54

2.5

49.50

44.57

u/l

0.14

4452

18440

Other diseases of gallbladder

312

1114

3.20

67.26

3.1

1.8

44.31

32.96

u/l

0.40

276

947

Type 2 diabetes, strict (exclude DM1)

5324

24687

1.32

67.15

2.8

2.4

50.60

43.55

u/l

0.21

4450

21354

Adenocarcinoma and ductal carcinoma of pancreas

267

884

3.63

67.08

9.1

2.2

175.26

35.45

u/l

0.61

247

737

Migraine without aura and triptan purchases

906

4991

1.93

66.74

2.6

2.4

35.88

46.67

u/l

0.53

789

4296

Explicit bacterial Sepsis

586

2796

2.27

65.94

3.2

2.2

34.17

39.06

u/l

0.75

498

2381

Cardiomyopathy, other and unspecified

496

2225

2.45

65.76

2.5

40.94

61.48

u/l

0.47

426

1931

Other complications of surgical and medical care, not elsewhere classified

599

2895

2.26

65.75

3.0

2.3

35.45

54.81

u/l

0.61

533

2470

Fracture of lower leg, including ankle

2968

21401

1.42

65.67

2.8

2.5

37.86

44.88

u/l

0.85

2478

18303

Fracture of lumbar spine and pelvis

1162

6909

1.78

65.64

3.0

2.3

36.15

44.77

u/l

0.52

992

5890

Cardiodefibrillation

1863

12385

1.57

65.48

2.4

2.5

36.03

50.76

u/l

1.35

1609

10605

Later onset COPD, excluding more controls

1037

4609

1.85

65.23

2.6

2.3

34.16

42.63

u/l

1.94

864

3933

Crohn's disease NAS

440

1885

2.60

65.16

3.6

2.3

36.85

62.24

u/l

0.50

394

1621

Myocardial infarction, without ST-elevation

2000

12437

1.54

65.05

2.7

2.5

35.68

51.02

u/l

1.40

1674

10627

Ischemic heart diseases

4239

20121

1.35

65.03

2.9

2.5

55.77

46.77

u/l

0.22

3616

17245

Erosion of teeth, including avohilmo

1024

5683

1.83

64.68

3.1

2.4

35.50

37.30

u/l

0.34

875

4913

Cellulitis

1195

7195

1.75

64.65

3.5

2.5

98.33

47.38

u/l

0.40

1011

6170

Sleep disorders (combined)

5518

28416

1.30

64.62

2.5

41.41

45.12

u/l

0.27

4659

24432

Other diseases of blood and blood-forming organs, wide

1223

7423

1.74

64.49

3.2

2.4

33.08

44.82

u/l

1.11

1088

6329

Migraine with aura and triptan purchases

854

4673

1.94

64.41

2.7

2.4

30.95

47.69

u/l

0.98

732

4020

Fall on and from stairs and steps

1390

8712

1.68

64.10

2.8

2.5

33.12

43.29

u/l

1.12

1202

7452

Other inflammation of eyelid

766

4075

2.03

63.93

2.6

2.4

38.20

49.93

u/l

0.48

655

3473

COPD, hospital admissions

2285

13407

1.50

63.54

2.9

2.5

33.15

48.53

u/l

1.70

1913

11467

Benign neoplasm: Stomach

607

2998

2.23

63.47

3.0

2.4

48.02

54.21

u/l

0.11

519

2552

Speech and linguistic disorders, excluding more controls

431

1717

2.53

63.27

2.4

2.3

28.20

37.77

u/l

2.03

380

1471

COPD, early/later onset

2299

13483

1.49

63.21

2.9

2.5

33.05

48.45

u/l

1.72

1927

11533

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

1138

5652

1.77

63.00

2.7

2.2

35.14

38.96

u/l

0.84

993

4743

Peripheral artery disease

2208

12242

1.50

62.97

3.2

2.4

71.81

43.74

u/l

0.40

1837

10442

Carcinoma in situ of skin of other and unspecified parts of face

406

1701

2.62

62.60

2.8

2.1

30.86

33.77

u/l

0.82

350

1401

Diabetes, insulin treatment (Kela reimbursement)

5637

27232

1.29

62.49

3.5

2.4

49.87

42.80

u/l

0.23

4610

23567

Disorder of lipoprotein metabolism, unspecified

737

3892

2.03

62.45

2.8

2.4

40.21

52.75

u/l

0.44

622

3321

Lumbar disc prolapse

3420

20174

1.38

62.43

2.7

2.5

41.93

46.62

u/l

0.35

2908

17390

L04AX Other immunosuppressants

2959

21597

1.41

62.42

2.8

2.5

40.81

45.80

u/l

0.37

2594

18458

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

314

1173

3.06

62.42

6.8

2.4

36.58

35.56

u/l

0.07

293

978

Benign neoplasm: Ascending colon

741

3941

2.04

62.27

2.8

2.4

48.87

50.58

u/l

0.04

640

3362

Other diseases of stomach and duodenum

410

1739

2.63

62.16

4.0

2.2

40.24

39.72

u/l

0.04

370

1481

Malignant neoplasm of other and unspecified female genital organs, excluding all cancers (controls excluding all cancers)

220

681

3.94

61.98

2.3

2.0

31.69

34.57

u/l

0.41

190

565

Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)

596

2932

2.18

61.66

3.0

2.2

58.21

55.65

u/l

0.03

531

2457

Vascular diseases of the intestine

272

950

3.31

61.38

3.5

2.3

43.43

36.72

u/l

0.26

249

788

Benign neoplasm: Duodenum

193

551

4.24

61.13

3.9

2.1

58.12

43.62

u/l

0.35

179

450

Paralytic ileus

257

869

3.38

60.94

4.1

2.3

30.77

41.96

u/l

1.26

225

735

Symptoms and signs concerning food and fluid intake

556

2676

2.23

60.76

3.1

2.1

34.13

58.75

u/l

0.74

468

2238

Persons with potential health hazards related to communicable diseases

2031

13819

1.51

60.68

3.0

2.5

32.96

41.38

u/l

1.50

1792

11881

Hepatic failure, not elsewhere classified

270

949

3.33

60.65

4.6

2.4

35.45

40.46

u/l

0.42

243

816

Carcinoma in situ of other and unspecified digestive organs

191

545

4.25

60.62

2.7

2.0

39.09

35.17

u/l

0.30

163

443

Malignant neoplasm of other and unspecified parts of biliary tract, excluding all cancers (controls excluding all cancers)

160

403

4.89

60.54

9.6

2.1

48.01

36.22

u/l

0.62

155

324

Inflammatory disease of uterus

811

4460

1.94

60.50

2.5

2.2

32.23

35.72

u/l

0.91

681

3770

Type 2 diabetes, definitions combined, including avohilmo

5291

24631

1.30

60.43

2.8

2.3

49.98

43.61

u/l

0.19

4416

21324

Social phobias

475

2160

2.37

59.98

3.0

2.4

61.73

38.48

u/l

0.55

398

1870

Emotional disorders starting during childhood or adolecense, excluding more controls

262

871

3.21

59.95

2.5

2.1

27.51

34.25

u/l

2.11

217

740

Other disorders of teeth and supporting structures

1108

6670

1.74

59.65

3.9

2.4

81.58

51.69

u/l

0.30

952

5777

Fracture of shoulder and upper arm

1885

12811

1.53

59.38

2.7

2.5

43.33

44.53

u/l

0.05

1618

10978

Amiodarone users

584

2911

2.19

59.37

2.6

2.5

40.72

36.56

u/l

0.46

511

2480

Obsessive-compulsive disorder

388

1632

2.59

58.97

2.5

2.4

29.08

39.42

u/l

2.50

339

1400

COPD, hospital admission 2, with asthma infections

1602

8958

1.59

58.93

3.1

2.4

32.51

53.71

u/l

1.51

1349

7657

Dental operations, only avohilmo

4048

15737

1.35

58.84

2.6

2.4

37.87

51.44

u/l

1.51

3462

13506

Parodontitis or/and operation codes

3550

15808

1.37

58.82

3.0

2.6

42.89

39.67

u/l

0.27

3043

13550

Kela-code for severe mental illness

1999

13768

1.50

58.82

2.6

31.25

45.01

u/l

2.53

1683

11884

Other diseases of pleura

2251

14007

1.47

58.76

2.9

2.5

44.02

47.86

u/l

0.13

1936

11945

Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)

729

3663

1.98

58.71

2.8

2.1

33.11

37.87

u/l

1.23

643

3066

Acute peritonitis

409

1779

2.56

58.70

5.2

2.4

40.64

65.90

u/l

0.45

357

1523

Injuries to unspecified part of trunk, limb or body region

594

2988

2.16

58.62

2.8

2.4

29.37

54.47

u/l

0.94

520

2568

Anogenital herpesviral [herpes simplex] infection

412

1796

2.53

58.54

2.7

2.4

34.21

62.83

u/l

0.55

362

1542

Benign neoplasm: Adrenal gland

420

1847

2.51

58.53

2.7

2.2

31.95

38.14

u/l

1.26

377

1547

Streptococcal septicaemia

480

2225

2.35

58.49

3.2

2.2

33.16

37.84

u/l

0.69

414

1898

Early syphilis

137

321

5.79

58.46

2.1

3.0

32.08

46.37

u/l

0.52

132

277

Other disorders of lacrimal gland

1775

11977

1.54

58.39

2.8

2.4

44.68

43.95

u/l

0.03

1533

10204

Other arthrosis

2883

15043

1.41

58.22

2.5

43.97

46.31

u/l

0.14

2476

12912

Insulin, combination of fast acting with intermediate-acting or long-acting

3223

22175

1.38

58.12

4.3

2.4

59.75

44.36

u/l

0.29

2564

19120

Major coronary heart disease event excluding revascularizations

3414

17649

1.37

58.06

2.8

2.5

57.15

46.90

u/l

0.20

2921

15096

Cystic kidney disease

256

898

3.36

57.95

4.1

2.5

42.55

86.27

u/l

0.39

242

771

Rash and other nonspecific skin eruption

604

3072

2.14

57.84

2.5

2.3

36.40

54.85

u/l

0.61

521

2619

Injuries to the shoulder and upper arm

4461

29154

1.31

57.81

2.7

2.5

42.56

45.90

u/l

0.27

3798

24997

Asthma/COPD (KELA code 203)

5250

29331

1.29

57.58

2.5

36.27

47.06

u/l

2.04

4430

25201

Myocardial infarction

2649

13744

1.43

56.94

2.8

2.5

63.73

49.58

u/l

0.22

2259

11791

Colon adenocarcinoma

657

3455

2.05

56.86

2.8

2.4

39.81

39.33

u/l

0.03

592

2925

Injuries to the wrist and hand

5399

31208

1.28

56.59

2.7

2.5

52.13

43.70

u/l

0.28

4653

26736

Finngen Rheumatological endpoints

5562

25256

1.28

56.59

2.6

2.5

49.89

41.20

u/l

0.30

4739

21736

Other and unspecified dermatitis

2652

19327

1.41

56.53

2.8

2.4

36.63

47.43

u/l

1.48

2290

16547

Coronary atherosclerosis

3587

17488

1.36

56.48

2.8

2.5

38.38

47.57

u/l

1.50

3045

14988

Monoamine oxidase A inhibitors

684

3649

2.00

56.26

2.5

2.3

38.21

37.17

u/l

0.08

574

3152

Malignant neoplasm of mesothelium and soft tissue, excluding all cancers (controls excluding all cancers)

384

1651

2.56

56.14

2.5

2.2

39.74

67.21

u/l

0.44

336

1374

Viral pneumonia (unknown virus, not influenza)

421

1887

2.46

56.14

3.3

2.5

37.21

64.40

u/l

0.55

364

1617

Sequelae with surgical and medical care as external cause

1080

6588

1.74

56.02

3.4

2.4

45.54

44.18

u/l

0.04

925

5626

Cholera

308

1207

2.92

55.99

2.8

2.2

46.64

40.23

u/l

0.24

266

1035

Acute sinusitis

2772

18974

1.40

55.56

2.7

2.5

45.87

40.19

u/l

0.49

2342

16307

Malignant neoplasm of small intestine, excluding all cancers (controls excluding all cancers)

211

675

3.66

55.52

3.5

2.0

40.53

44.29

u/l

0.14

195

560

Cervicalgia

1100

6737

1.71

55.49

2.7

2.4

34.09

49.89

u/l

1.26

941

5786

Non-small cell lung cancer, adenocarcinoma, excluding all cancers (controls excluding all cancers)

342

1403

2.69

55.37

2.8

2.2

32.44

37.37

u/l

0.62

299

1170

Injuries to the hip and thigh

2366

15518

1.44

55.10

2.7

2.5

35.88

48.87

u/l

1.41

1977

13258

Dental operations

3816

14896

1.34

54.62

2.6

2.4

39.42

52.15

u/l

1.23

3280

12757

Early onset COPD

1195

7516

1.67

54.49

3.2

2.5

32.51

55.11

u/l

1.33

1006

6472

Adenomyosis (Endometriosis of uterus)

781

4391

1.90

54.47

2.5

2.4

37.46

37.66

u/l

0.01

669

3733

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

272

1017

3.08

54.27

2.6

2.4

35.04

85.48

u/l

0.54

229

864

Arthropathies

5314

21483

1.28

54.03

2.6

2.5

35.95

44.53

u/l

1.79

4561

18479

Other (not insulin) diabetes medications

5284

25400

1.28

54.01

2.7

2.3

38.03

43.81

u/l

1.08

4390

21960

Enlarged lymph nodes

807

4577

1.86

53.79

2.9

2.1

33.75

49.83

u/l

0.87

696

3877

Fissure and fistula of anal and rectal regions

1209

7624

1.65

53.75

2.5

2.4

40.94

59.27

u/l

0.74

1052

6497

Other sexually transmitted chlamydial diseases

407

1827

2.42

53.49

2.4

2.5

27.68

60.43

u/l

0.69

365

1573

COPD related to multimorbidity

1915

11183

1.49

53.25

2.9

2.4

32.96

50.81

u/l

1.62

1592

9569

Atherosclerosis, excluding cerebral and coronary sclerosis

2017

11268

1.48

53.22

3.0

2.4

75.83

38.52

u/l

0.52

1677

9596

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

2284

11138

1.45

53.03

2.5

2.3

44.16

42.35

u/l

0.07

1955

9384

Abnormal involuntary movements

752

4221

1.91

52.90

3.0

2.4

34.16

50.92

u/l

0.81

634

3602

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

1934

13489

1.48

52.60

2.7

2.5

34.64

40.99

u/l

1.10

1634

11637

Attention to artificial openings

258

952

3.09

52.47

2.5

2.3

30.23

37.06

u/l

1.25

233

816

Benign neoplasm: Small intestine

287

1127

2.95

52.40

3.7

2.3

52.69

40.50

u/l

0.48

262

952

Hydronephrosis

604

3172

2.04

52.14

3.0

2.3

37.33

38.00

u/l

0.10

546

2694

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

521

2609

2.17

52.04

3.0

2.3

71.73

56.55

u/l

0.14

460

2234

Use of disulfiram, acamprosate or naltrexone

542

2757

2.14

52.00

3.5

2.8

33.97

56.90

u/l

0.74

457

2414

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

2195

10736

1.45

51.91

2.5

2.2

44.61

42.50

u/l

0.07

1878

9045

Rotator cuff syndrome

3201

17943

1.36

51.90

2.7

2.4

35.65

43.25

u/l

2.08

2718

15406

Personal history of other diseases and conditions

637

3394

1.99

51.79

2.9

2.1

44.34

50.30

u/l

0.11

542

2866

Disorders of lacrimal system

2137

15277

1.45

51.47

2.7

2.4

44.89

42.73

u/l

0.11

1830

12996

Diseases of peritoneum

589

3091

2.06

51.37

4.6

2.4

40.22

53.82

u/l

0.41

514

2654

Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)

512

2550

2.15

51.34

2.9

2.2

61.96

58.06

u/l

0.04

454

2135

Viral infections characterized by skin and mucous membrane lesions

2146

15340

1.44

51.33

3.0

2.5

48.35

41.87

u/l

0.29

1869

13161

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

2228

10923

1.44

51.20

2.5

2.2

44.53

42.62

u/l

0.07

1910

9197

Atopic dermatitis

2948

18853

1.37

51.01

2.5

34.48

43.34

u/l

1.89

2510

16216

Other viral diseases

1529

10251

1.54

50.94

3.3

2.5

45.34

43.43

u/l

0.07

1331

8847

Abnormal spermatozoa

3502

0.20

50.75

2.2

2.6

48.53

59.87

u/l

0.19

3017

Benign neoplasm of other and unspecified endocrine glands

646

3499

1.97

50.69

2.6

2.2

31.69

51.02

u/l

0.79

574

2962

6-mercaptopurine

227

797

3.27

50.68

3.9

2.3

31.06

97.76

u/l

0.59

207

691

Adenocarcinoma of pancreas, excluding all cancers (controls excluding all cancers)

184

572

3.76

50.67

9.0

2.1

46.46

37.24

u/l

0.54

169

464

Congenital malformations of the urinary system

375

1679

2.48

50.41

3.7

2.5

43.70

65.21

u/l

0.34

347

1430

Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)

960

4811

1.74

50.38

2.8

2.2

33.61

39.12

u/l

1.61

842

4038

Other and unspecified injuries of head

380

1711

2.45

50.23

3.1

2.3

33.76

69.10

u/l

0.69

323

1473

Duodenal ulcer

575

3005

2.04

50.14

3.3

2.3

43.81

39.45

u/l

0.20

503

2557

Ocular pain

492

2453

2.19

50.00

3.6

2.3

29.77

58.35

u/l

0.85

430

2101

Eating disorder

505

2523

2.14

49.99

2.7

2.2

31.55

54.75

u/l

0.64

428

2134

Other embolism and thrombosis

718

4043

1.89

49.83

3.0

2.4

44.47

52.56

u/l

0.19

606

3445

Dermatitis

3114

23688

1.35

49.81

2.8

2.5

36.40

45.74

u/l

1.58

2673

20301

Systemic connective tissue disorders

1822

12742

1.48

49.80

2.4

47.99

41.29

u/l

0.23

1545

10814

Abscess of anal and rectal regions

477

2345

2.19

49.69

3.2

2.5

34.14

60.07

u/l

0.70

424

2050

Cardiomyopathies, Primary/intrinsic

655

3587

1.94

49.55

2.4

2.5

38.57

72.99

u/l

0.84

564

3112

Benign neoplasm: Transverse colon

565

2969

2.07

49.47

3.0

2.4

74.98

39.79

u/l

0.47

498

2534

Excessive attrition of teeth

1972

7450

1.48

49.39

2.7

2.4

38.59

41.44

u/l

0.22

1675

6415

Phlebitis and thrombophlebitis (not including DVT)

1202

7747

1.63

49.35

3.1

2.5

36.87

45.49

u/l

0.42

1038

6647

Fibromyalgia

505

2545

2.14

49.29

2.8

2.1

37.13

40.15

u/l

0.17

417

2153

Malignant neoplasm of retroperitoneum and peritoneum, excluding all cancers (controls excluding all cancers)

143

388

4.56

49.19

2.7

1.9

48.98

33.63

u/l

0.44

122

317

Postprocedural disorders of digestive system, not elsewhere classified

236

865

3.17

49.11

4.1

2.3

33.91

32.83

u/l

0.18

209

727

Cardiomyopathy (excluding other)

675

3743

1.92

49.05

2.4

2.5

38.97

71.49

u/l

0.82

581

3245

Crohn's disease of small intestine

421

1992

2.31

49.01

3.2

2.4

43.10

62.50

u/l

0.37

380

1704

Portal vein thrombosis

140

380

4.65

48.45

6.4

2.3

490.78

45.17

u/l

0.48

131

321

Chondrocostal junction syndrome [Tietze]

268

1056

2.91

48.35

3.7

2.3

28.76

38.29

u/l

2.73

234

889

Hyperkinetic disorders

569

2958

2.01

48.18

2.4

2.6

30.03

53.52

u/l

0.83

485

2545

Melanocytic naevi

1355

8986

1.56

48.11

2.8

2.3

34.19

42.51

u/l

0.85

1171

7643

Fungal Sepsis

243

911

3.04

48.03

4.0

2.2

32.63

38.18

u/l

0.94

212

782

Other and unspecified coagulation defects

316

1343

2.63

48.02

3.2

2.4

29.12

37.68

u/l

1.63

275

1133

Carcinoma in situ of skin

389

1799

2.35

47.71

2.7

2.1

31.66

37.98

u/l

1.27

329

1499

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

636

3494

1.93

47.50

2.5

2.2

35.27

51.67

u/l

0.62

547

2949

Disturbance of activity and attention

529

2697

2.05

47.42

2.3

2.5

30.16

56.04

u/l

0.83

449

2314

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

2682

19686

1.37

47.40

2.6

43.21

46.33

u/l

0.14

2315

16938

COPD, hospital admissions 3, with asthma pneumonia sepsis

1300

7264

1.58

47.38

3.1

2.4

32.08

50.70

u/l

1.18

1093

6199

Elevated blood glucose level

481

2424

2.15

47.34

4.5

2.4

32.08

58.66

u/l

0.75

385

2082

Ductal carcinoma of pancreas, excluding all cancers (controls excluding all cancers)

157

8.04

47.19

9.4

2.0

448.62

30.58

u/l

0.57

132

Disorders of skin appendages

2449

18128

1.39

47.18

2.9

2.5

38.55

41.36

u/l

0.35

2090

15592

Obesity due to excess calories

2332

17148

1.40

47.15

2.7

2.5

35.17

43.83

u/l

1.08

1922

14817

Purpura and other haemorrhagic conditions

718

4117

1.85

46.87

2.9

2.5

32.40

49.93

u/l

0.86

631

3511

Epilepsy

1587

10899

1.50

46.68

2.9

2.5

33.26

51.44

u/l

1.59

1370

9333

Volvulus

177

564

3.60

46.57

3.7

2.2

34.16

39.34

u/l

0.50

154

480

Endometriosis

1882

7843

1.47

46.57

2.4

2.3

42.28

37.33

u/l

0.38

1619

6689

Crohn's disease of large intestine

336

1486

2.50

46.40

3.5

2.3

39.00

70.95

u/l

0.50

303

1277

Other obstetric conditions, not elsewhere classified

1565

6895

1.52

46.38

2.4

2.3

34.13

37.21

u/l

0.58

1345

5893

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

423

2052

2.25

46.26

3.3

2.5

40.44

62.49

u/l

0.45

383

1767

Oter anti-inflammatory and antirheumatic agents, non-steroids

1164

4074

1.64

46.21

2.6

37.86

39.25

u/l

0.19

988

3522

Haemorrhage, not elsewhere classified

229

855

3.01

45.32

3.6

2.2

120.02

45.76

u/l

0.41

208

719

Delirium, not induced by alcohol and other psychoactive substances

577

3124

1.97

45.25

3.2

2.4

38.74

53.39

u/l

0.46

494

2679

Cervicocranial syndrome

597

3272

1.94

45.20

2.8

2.2

31.59

54.23

u/l

0.90

516

2797

Other infectious diseases

455

2288

2.16

45.04

3.6

2.4

38.20

59.92

u/l

0.50

396

1949

Implicit fungal Sepsis

225

840

3.06

44.95

3.8

2.3

32.76

38.77

u/l

0.95

195

721

Congenital malformations, deformations and chromosomal abnormalities

3060

22553

1.33

44.73

2.7

2.5

36.04

45.40

u/l

1.49

2676

19352

Recurring oral aphthae, including avohilmo

745

4380

1.81

44.61

2.8

2.4

30.90

49.05

u/l

1.00

625

3734

Superficial injury of wrist and hand

1031

6560

1.64

44.56

2.7

2.5

32.77

46.68

u/l

1.08

887

5632

Open wound of lower leg

766

4533

1.79

44.47

3.1

2.4

31.69

47.69

u/l

0.88

667

3882

Myocardial infarction, strict

2398

12962

1.39

44.45

2.8

2.5

37.14

49.32

u/l

1.57

2052

11127

Eating disorders

581

3167

1.94

44.37

2.8

2.3

31.38

51.93

u/l

0.75

494

2707

Injury of unspecified body region

446

2245

2.16

44.20

2.9

2.4

29.80

60.27

u/l

0.81

392

1917

Benign neoplasm of mouth and pharynx

547

2939

1.98

44.04

2.7

2.2

35.21

52.74

u/l

0.54

456

2503

Fracture of foot, except ankle

1238

8227

1.57

43.94

3.2

2.5

77.02

38.07

u/l

0.51

1062

7074

Pleural effusion

770

4581

1.78

43.86

2.8

2.4

32.03

37.94

u/l

2.44

666

3899

Crohn disease (strict definition, require KELA, min 2 HDR)

391

1880

2.27

43.85

3.3

2.5

41.18

63.74

u/l

0.42

354

1619

Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases

17.82

43.70

2.4

2.5

29.90

27.32

u/l

0.31

Benign neoplasm: Caecum

552

2999

1.99

43.64

3.0

2.4

74.18

38.99

u/l

0.47

494

2555

Benign neoplasm: Duodenum

193

681

3.37

43.61

3.9

2.4

58.12

41.08

u/l

0.46

179

574

Nerve, nerve root and plexus disorders

5712

29550

1.23

43.61

2.8

2.5

48.22

43.43

u/l

0.22

4837

25377

Disorders of vitreous body and globe

2470

18092

1.37

43.60

3.1

2.4

43.04

46.58

u/l

0.23

2068

15431

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

1512

6696

1.51

43.53

2.3

34.36

37.34

u/l

0.53

1295

5733

Sequelae of injuries, of poisoning and of other consequences of external causes

1225

8149

1.57

43.38

2.9

2.6

75.16

41.29

u/l

0.41

1036

7031

Hemiplegia

319

1419

2.47

43.36

3.0

2.4

30.23

41.20

u/l

1.90

279

1208

Maternal care for other conditions predominantly related to pregnancy

1055

6692

1.62

43.34

2.4

2.3

36.01

35.74

u/l

0.03

897

5735

Crohn disease (strict definition, require KELA)

396

1922

2.25

43.32

3.3

2.5

41.02

63.97

u/l

0.44

358

1656

Carcinoma in situ of other and unspecified digestive organs

191

674

3.38

43.23

2.7

2.4

39.09

33.64

u/l

0.50

163

573

Biguanides

5097

25599

1.25

43.03

2.7

2.5

38.33

46.44

u/l

1.23

4228

22053

Injuries to the elbow and forearm

3607

25729

1.29

42.91

2.7

2.5

37.23

45.31

u/l

1.29

3077

22027

Fall on same level involving ice and snow

2878

22122

1.33

42.89

2.7

2.5

34.36

46.19

u/l

2.17

2434

18951

Migraine, single triptan purchase ok & required. ICD-code if available is included

4126

22290

1.28

42.84

2.5

34.02

42.71

u/l

2.57

3525

19124

Triptan medication for migraine, single purchase ok

4126

22290

1.28

42.84

2.5

34.02

42.71

u/l

2.57

3525

19124

Disorders of vitreous body

2402

17639

1.37

42.78

3.2

2.4

43.44

46.89

u/l

0.21

2012

15036

Medical abortion

3379

14248

1.32

42.77

2.4

2.3

33.48

39.59

u/l

2.22

2869

12072

In situ neoplasms

1773

12686

1.45

42.65

2.5

2.4

73.04

38.95

u/l

0.41

1506

10729

Conjunctivitis (acute, non atopic)

1388

9479

1.51

42.19

2.8

2.5

35.05

45.16

u/l

1.05

1201

8088

Other local infections of skin and subcutaneous tissue

558

3069

1.95

42.10

3.4

2.4

33.22

52.16

u/l

0.66

489

2647

Hyperkalaemia

296

1289

2.51

42.09

5.2

2.4

31.69

77.51

u/l

0.65

254

1090

Disorders of other endocrine glands

2200

16050

1.39

42.07

3.0

2.5

39.65

42.55

u/l

0.22

1898

13745

Laparoscopic left hemicolectomy

148

461

3.99

41.80

3.1

2.3

32.41

34.41

u/l

0.24

130

397

Benign neoplasm: Descending colon

337

1555

2.36

41.76

2.8

2.2

34.11

39.39

u/l

0.67

286

1299

Oesophagitis

323

1472

2.41

41.49

4.8

2.2

33.21

41.91

u/l

1.31

278

1252

Other diseases of oesophagus

503

2685

2.00

41.39

3.4

2.3

42.88

40.85

u/l

0.09

436

2287

Other coagulation defects

418

2104

2.15

41.34

3.0

2.4

77.60

60.26

u/l

0.13

369

1786

Other and unspecified drugs and medicaments

479

2529

2.05

41.32

3.1

2.4

74.79

57.45

u/l

0.15

427

2170

Other eating disorders

306

1362

2.44

41.22

2.9

2.2

32.52

33.44

u/l

0.11

262

1138

Disorders of choroid and retina

4082

23835

1.27

41.21

3.3

2.5

41.30

47.03

u/l

0.40

3427

20400

Gonococcal infection

239

964

2.83

41.17

2.2

2.3

29.98

90.22

u/l

0.66

210

832

Propionic acid derivatives

1591

5504

1.49

41.14

2.3

2.6

67.49

38.25

u/l

0.47

1332

4759

Ulcerative enterocolitis

223

867

2.91

41.11

4.2

2.4

38.53

93.74

u/l

0.50

206

742

Primary_lymphoid and hematopoietic malignant neoplasms

1189

7960

1.56

40.98

2.8

2.4

35.70

53.23

u/l

0.97

1026

6770

Poisoning by narcotics and psychodysleptics [hallucinogens]

142

433

3.95

40.93

3.3

2.6

27.48

145.14

u/l

0.55

121

374

Major coronary heart disease event

3576

18836

1.30

40.92

2.8

2.5

57.08

46.60

u/l

0.22

3044

16116

Other disorders of bone

1055

6887

1.60

40.88

3.0

2.5

34.06

46.33

u/l

0.96

896

5921

Sequelae of injuries of lower limb

540

2968

1.95

40.88

2.8

2.5

125.66

39.71

u/l

0.47

453

2572

Urticaria and erythema

1838

13322

1.42

40.77

2.6

2.5

34.93

42.25

u/l

1.10

1560

11443

Idiopathic gout

472

2489

2.04

40.74

2.9

2.5

64.66

36.39

u/l

0.50

411

2112

Non-follicular lymphoma, hilmo, excluding all cancers

446

2301

2.07

40.62

2.4

2.2

36.79

58.01

u/l

0.50

382

1940

Erosion of teeth

131

380

4.12

40.57

5.6

2.4

41.29

51.62

u/l

0.34

118

332

Procreative management

1638

9788

1.46

40.51

2.6

2.7

34.08

44.92

u/l

1.29

1435

8440

Missing teeth due to accident, extraction or parodontitis

594

3368

1.87

40.27

4.0

2.3

36.15

37.95

u/l

0.27

513

2906

Certain disorders involving the immune mechanism

1002

6500

1.62

40.18

2.8

2.5

37.85

44.54

u/l

0.41

872

5578

Other cataract

2195

12641

1.38

39.96

3.1

2.4

48.54

42.90

u/l

0.22

1843

10834

Misadventures to patients during surgical and medical care

726

4368

1.76

39.79

3.5

2.3

91.26

48.22

u/l

0.47

645

3713

Malignant neoplasm of liver and intrahepatic bile ducts

209

802

2.96

39.58

5.1

2.4

29.97

33.51

u/l

0.90

192

673

Malignant melanoma, excluding all cancers (controls excluding all cancers)

762

4645

1.72

39.27

2.8

2.2

33.40

50.01

u/l

0.92

669

3918

Diabetic nephropathy, excluding more controls

761

3861

1.74

39.27

7.2

2.8

50.01

38.93

u/l

0.41

647

3240

Disorders of psychological development

595

3130

1.85

39.22

2.3

2.4

29.01

49.64

u/l

0.74

517

2660

Insulin, fast-acting

1812

13189

1.42

39.07

5.2

2.4

77.70

43.02

u/l

0.38

1401

11407

Stroke, excluding SAH

2919

16829

1.32

39.01

2.7

2.5

41.37

49.05

u/l

0.51

2460

14373

Other and unspecified local infections of skin and subcutaneous tissue

519

2863

1.94

38.85

3.5

2.4

32.46

53.17

u/l

0.67

454

2467

Irregular menses

2389

14686

1.35

38.40

2.5

2.3

36.14

37.29

u/l

0.17

2015

12556

Ductal carcinoma of pancreas

190

6.53

38.34

9.4

2.7

448.62

32.40

u/l

0.57

161

Enthesopathies of lower limb, excluding foot

1116

7471

1.55

38.25

2.6

2.4

30.87

49.51

u/l

2.12

953

6453

Abrasion of teeth

1280

6418

1.52

38.05

2.4

34.49

42.20

u/l

0.77

1095

5526

Valvular heart disease excluding rheumatic fever

2283

12547

1.36

38.03

2.6

2.5

43.90

51.84

u/l

0.43

1960

10721

Benign neoplasm: Adrenal gland

420

2191

2.09

37.87

2.7

2.4

31.95

39.67

u/l

1.93

377

1884

Pacemaker

1499

10331

1.46

37.82

2.5

2.4

36.15

51.05

u/l

1.05

1288

8797

Superficial injury of abdomen, lower back and pelvis

769

4753

1.70

37.70

3.1

2.4

38.56

47.65

u/l

0.39

670

4073

Emotional disorders and disorders of social functioning with onset specific to childhood

290

1290

2.39

37.59

2.5

2.2

27.53

69.63

u/l

0.58

242

1087

Autoimmune hepatitis

194

5.89

37.48

3.5

2.0

37.03

30.50

u/l

1.58

161

Event of undetermined intent

363

1802

2.19

37.36

2.9

2.5

34.10

66.56

u/l

0.66

308

1551

Superficial injury of thorax

764

4734

1.70

37.20

3.0

2.5

32.80

48.49

u/l

0.91

651

4077

Stroke, including SAH

3088

17985

1.30

36.89

2.7

2.5

42.09

48.68

u/l

0.44

2611

15384

Lung transplant status

194

6.01

36.86

2.7

39.74

32.21

u/l

0.91

162

Lung transplantation

194

6.00

36.84

2.7

39.74

32.21

u/l

0.91

162

Ptosis of eyelid

564

3243

1.86

36.81

2.5

2.4

35.35

39.38

u/l

0.71

484

2759

Fentanyl

461

2477

1.96

36.71

3.9

2.1

36.34

39.82

u/l

0.16

411

2098

Zoster [herpes zoster]

881

5667

1.63

36.70

2.9

2.4

43.47

46.47

u/l

0.09

770

4822

Other disorders of glucose regulation and pancreatic internal secretion

465

2523

1.97

36.67

4.7

2.5

28.90

58.60

u/l

0.93

371

2163

Dental caries 2

3998

25496

1.25

36.54

2.7

2.5

38.58

45.64

u/l

0.91

3412

21916

Aortic aneurysm

1046

6851

1.56

36.47

2.6

2.5

37.51

45.09

u/l

0.46

900

5871

Carcinoma in situ of rectum

182

5.99

36.41

1.9

2.0

34.43

31.63

u/l

0.36

153

Other ulcerative colitis

342

1679

2.21

36.32

3.6

2.4

45.11

67.56

u/l

0.36

318

1434

Cyst of kidney

383

1967

2.12

36.11

2.9

2.4

66.60

37.25

u/l

0.41

342

1679

Iron deficiency anaemia secondary to blood loss (chronic)

789

4965

1.67

36.01

3.3

2.3

33.01

47.60

u/l

0.85

677

4219

ILD, hospital admission 2, with pulmonary infections

463

2519

1.96

35.99

3.0

2.3

36.56

58.74

u/l

0.61

426

2156

Anti-inflammatory and antirheumatic products, non-steroids

1557

5505

1.45

35.93

2.4

2.6

66.90

38.25

u/l

0.45

1311

4759

Malignant neoplasm of stomach

290

1343

2.36

35.83

4.7

2.4

37.62

38.71

u/l

0.09

263

1139

All influenza (not pneumonia)

752

4676

1.68

35.83

3.2

2.4

29.51

51.17

u/l

1.47

647

4070

Candidiasis

696

4259

1.72

35.83

3.1

2.3

35.13

48.49

u/l

0.61

600

3646

Other and unspecified visual disturbances

512

2887

1.90

35.77

3.1

2.3

31.35

56.76

u/l

0.90

448

2477

Disorders of the thyroid gland

5053

27422

1.22

35.76

2.5

36.07

45.74

u/l

1.95

4256

23526

Carcinoma in situ of skin of other and unspecified parts of face

406

2131

2.06

35.71

2.8

2.3

30.86

37.24

u/l

2.08

350

1774

Other metabolic disorders

661

3991

1.74

35.64

2.7

2.2

43.38

49.90

u/l

0.20

582

3404

Other inflammation of vagina/vulva

230

970

2.63

35.53

2.2

2.1

29.50

35.67

u/l

1.60

187

810

Other systemic involvement of connective tissue (FG)

1313

9147

1.48

35.45

2.4

53.11

42.96

u/l

0.26

1107

7755

Decubitus ulcer and pressure area

311

1486

2.28

35.42

3.3

2.3

32.88

39.44

u/l

0.74

238

1261

Non-rheumatic valve diseases

2253

12481

1.35

35.30

2.6

2.5

43.99

51.98

u/l

0.43

1935

10661

Other shoulder lesions

503

2826

1.89

35.28

3.0

2.3

31.83

40.45

u/l

2.39

422

2434

Special screening examination for neoplasms

253

1112

2.48

35.23

3.3

2.3

37.04

46.43

u/l

0.61

217

951

Non-small cell lung cancer, adenocarcinoma, helper endpoint

342

1700

2.19

35.20

2.8

2.4

32.44

38.18

u/l

0.85

299

1446

Non-small cell lung cancer, adenocarcinoma

342

1700

2.19

35.20

2.8

2.4

32.44

38.18

u/l

0.85

299

1446

Radiculopathy

817

5208

1.64

35.16

2.7

2.3

33.84

49.44

u/l

1.01

682

4465

Adenocarcinoma of pancreas

184

707

2.99

35.10

9.0

2.2

46.46

32.52

u/l

1.02

169

586

Peripheral arterial reconstruction

787

4981

1.65

35.06

2.6

2.4

124.34

37.99

u/l

0.46

653

4228

malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)

843

5327

1.63

34.94

2.2

34.06

35.39

u/l

0.26

710

4453

Dental caries 2 and operation codes

3904

25235

1.25

34.92

2.7

2.5

38.09

45.84

u/l

1.03

3333

21681

Diseases of salivary glands

922

6047

1.58

34.81

2.7

2.3

50.31

37.23

u/l

0.43

787

5211

Other interventions on the root canals of the tooth

143

483

3.49

34.80

4.7

2.5

36.40

32.10

u/l

0.55

122

411

Other acute viral hepatitis

112

328

4.22

34.72

4.0

2.5

25.57

175.17

u/l

0.52

100

280

Angina pectoris

2973

15828

1.30

34.65

2.7

2.5

36.05

48.47

u/l

2.07

2526

13557

Mixed disorders of conduct and emotions, excluding more controls

135

434

3.43

34.50

2.3

23.00

33.57

u/l

4.78

109

366

Other disorders of eyelid

2099

15390

1.35

34.43

2.5

2.4

37.73

47.32

u/l

0.72

1786

13074

Diabetic nephropathy

770

4822

1.66

34.38

7.3

2.8

49.98

53.88

u/l

0.07

653

3998

Insulin, fast-acting or short human

1826

13581

1.38

34.36

5.2

2.4

77.51

42.68

u/l

0.38

1412

11714

Other viral diseases, not elsewhere classified

933

6142

1.58

34.34

3.2

2.5

53.14

44.36

u/l

0.21

801

5284

Toxic effect of other and unspecified substances

110

320

4.14

34.09

4.5

2.4

23.66

178.63

u/l

0.52

271

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

373

1926

2.07

33.99

2.6

2.2

38.44

37.76

u/l

0.05

310

1608

Other specified/unspecified arthritis

1337

9480

1.46

33.90

2.9

2.5

36.19

45.61

u/l

1.00

1122

8115

Unspecified/other endometriosis

469

2605

1.90

33.85

2.3

2.2

33.28

37.11

u/l

0.71

407

2229

Urticaria

1475

10644

1.43

33.77

2.7

2.4

34.09

41.69

u/l

0.95

1251

9141

Triptan medication for migraine, min. 3 purchases

2794

17345

1.30

33.71

2.3

2.5

36.02

41.47

u/l

0.64

2384

14928

Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)

632

3833

1.73

33.35

3.0

2.2

34.53

50.14

u/l

0.65

559

3235

Ischaemic Stroke, excluding all haemorrhages

2678

15869

1.30

33.22

2.7

2.5

41.78

49.85

u/l

0.49

2259

13564

Other systemic involvement of connective tissue

1352

9653

1.45

33.14

2.4

52.42

42.30

u/l

0.26

1140

8189

Amputation

482

2724

1.88

33.07

4.0

2.4

32.43

37.52

u/l

0.98

389

2322

Other disorders involving the immune mechanism, not elsewhere classified

206

859

2.71

33.04

3.3

2.6

37.50

95.32

u/l

0.53

193

743

Schizoaffective disorder

427

2335

1.96

32.93

2.5

27.53

60.64

u/l

0.99

360

2031

DVT of lower extremities

939

6269

1.56

32.91

3.0

2.5

69.86

47.38

u/l

0.39

818

5358

Dentofacial anomalies [including malocclusion]

1283

8964

1.46

32.91

2.7

2.3

35.20

40.67

u/l

0.91

1123

7773

Laparoscopic right hemicolectomy

317

1580

2.21

32.83

2.6

2.3

35.90

39.31

u/l

0.36

278

1337

Acute pharyngitis

734

4601

1.65

32.78

2.7

2.6

31.28

41.62

u/l

1.79

628

3990

Unspecified acute lower respiratory infection

741

4701

1.65

32.68

3.1

2.7

78.54

53.80

u/l

0.22

627

4072

Other and unspecified disorders of vitreous body

1941

14629

1.36

32.61

2.5

2.4

44.56

48.55

u/l

0.20

1623

12456

Injuries to the neck

1116

7716

1.50

32.61

3.1

2.5

35.17

43.39

u/l

0.62

949

6635

Other retinal disorders

3040

19501

1.28

32.52

3.6

2.5

42.37

48.14

u/l

0.29

2535

16675

Extrapyramidal and movement disorders

1728

12872

1.38

32.49

2.4

2.5

33.15

49.65

u/l

1.63

1446

10977

Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)

196

799

2.71

32.47

2.6

2.2

388.60

41.52

u/l

0.48

169

662

Carcinoma in situ of rectum

200

5.41

32.47

1.9

2.6

34.43

u/l

0.00

167

Hypoglycaemia, other or unspecified

371

1948

2.05

32.47

4.6

2.5

29.44

64.13

u/l

0.80

294

1672

Other disorders starting during childhood or adolecense, excluding more controls

218

887

2.52

32.45

2.3

26.43

33.23

u/l

3.17

185

750

Cytomegalovirus infection, IBD co-morbidity

157

580

3.14

32.44

5.9

2.4

35.99

116.17

u/l

0.48

146

494

Filling of root of tooth

203

848

2.70

32.42

4.6

2.5

34.27

95.25

u/l

0.55

175

725

Failure and rejection of transplanted organs and tissues

108

322

4.07

32.41

8.3

2.3

48.53

175.41

u/l

0.42

282

Follow-up examination after treatment for malignant neoplasms

508

2929

1.83

32.41

2.7

2.2

38.49

42.39

u/l

0.38

425

2497

Sleep disorders, other/unspecified

216

926

2.60

32.34

2.7

2.3

33.05

93.82

u/l

0.60

181

775

Other pleural conditions

500

2886

1.83

32.01

3.0

2.4

38.12

38.79

u/l

0.05

433

2456

Toxic liver disease

122

396

3.69

31.94

4.7

2.1

49.09

33.64

u/l

0.51

109

334

Peripheral artery operations in Hilmo

598

3623

1.73

31.68

3.6

2.4

155.46

50.25

u/l

0.40

489

3094

Unstable angina pectoris

1824

11357

1.37

31.60

2.7

2.5

33.45

44.43

u/l

1.73

1548

9718

Conduction disorders

1352

8045

1.44

31.55

2.6

2.4

34.69

52.91

u/l

1.05

1154

6893

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

191

787

2.74

31.46

3.3

2.6

38.13

100.45

u/l

0.53

180

687

Acute and transient psychotic disorders

625

3847

1.71

31.44

2.9

2.5

29.39

51.57

u/l

1.13

536

3331

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

811

5123

1.60

31.44

3.1

2.5

43.89

46.03

u/l

0.08

727

4406

Acidosis

135

467

3.35

31.35

4.8

2.5

42.85

43.18

u/l

0.01

122

401

Other extrapyramidal and movement disorders in other diseases

1084

7530

1.50

31.18

2.5

2.4

31.42

44.71

u/l

1.37

905

6428

Cytomegaloviral disease

160

609

3.02

31.17

5.8

2.3

35.87

110.42

u/l

0.47

149

525

Intestinal malabsorption

268

1275

2.30

31.17

5.8

2.3

35.91

37.83

u/l

0.17

222

1087

Cluster headache, strict

221

971

2.51

31.14

2.9

2.6

31.21

41.38

u/l

1.14

192

845

Other neurological diseases

3522

23088

1.25

31.13

2.8

2.5

35.77

47.19

u/l

1.99

2972

19720

Toxic effects of substances chiefly nonmedicinal as to source

588

3576

1.73

31.04

3.3

2.5

39.90

51.30

u/l

0.32

502

3088

Melanocytic naevi of trunk

538

3193

1.77

30.93

2.8

2.2

35.57

51.77

u/l

0.53

471

2695

Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

236

1067

2.41

30.88

2.5

2.1

32.86

34.34

u/l

0.24

194

881

Other diseases of lip and oral mucosa

752

4849

1.62

30.85

3.2

2.3

44.85

37.51

u/l

0.43

622

4190

Bulimia nervosa (incl. atypical)

209

898

2.55

30.83

2.5

2.2

34.48

34.81

u/l

0.03

177

744

Striking against or struck by other objects

1568

11588

1.39

30.82

2.7

2.6

36.38

42.96

u/l

0.65

1359

10021

Emotional disorders starting during childhood or adolescence

264

1235

2.27

30.76

2.5

2.2

27.43

71.95

u/l

0.59

218

1038

Non-small cell lung cancer

729

4673

1.63

30.76

2.8

2.3

33.11

38.00

u/l

1.38

643

3945

Stomatitis and related lesions

421

2336

1.91

30.73

2.9

2.3

32.19

39.40

u/l

1.67

362

2044

Suppurative and necrotic conditions of lower respiratory tract

295

1465

2.19

30.50

3.4

2.5

38.26

38.66

u/l

0.02

261

1257

Presence of cardiac and vascular implants and grafts

2164

12637

1.33

30.46

2.6

2.4

41.81

43.45

u/l

0.10

1848

10783

Osteonecrosis

326

1684

2.11

30.32

2.6

2.3

31.95

41.23

u/l

1.49

271

1462

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

1621

12094

1.38

30.24

2.7

2.5

38.68

42.98

u/l

0.38

1392

10319

Thrombocytopenia, unspecified

370

1991

2.00

30.19

3.1

2.4

31.42

62.72

u/l

0.71

318

1696

Amputation of toe

356

1892

2.02

30.14

4.0

2.5

31.21

37.89

u/l

1.06

293

1608

Intentional self-harm by unspecified means

103

312

3.97

30.11

3.5

2.5

30.46

30.39

u/l

0.01

257

Other infective otitis externa

332

1727

2.08

30.06

2.6

2.4

28.50

67.77

u/l

0.81

274

1476

Rheumatism, unspecified

708

4537

1.63

30.04

3.0

2.2

29.45

38.80

u/l

6.63

585

3845

Mycoses

1264

9077

1.44

30.03

3.0

2.5

33.43

44.84

u/l

1.28

1093

7767

Primary biliary cholangitis (PBC)

155

593

3.01

29.92

3.7

2.1

41.74

36.17

u/l

0.55

146

494

Other benign neoplasms of skin

1562

11367

1.38

29.81

2.5

2.3

38.39

42.65

u/l

0.38

1279

9596

Endocarditis

204

883

2.55

29.77

3.0

2.6

31.79

93.46

u/l

0.60

179

758

Excessive, frequent and irregular menstruation

1998

8449

1.34

29.56

2.5

2.3

33.07

36.76

u/l

1.12

1654

7200

Other/unspecified cytomegaloviral diseases

138

502

3.22

29.53

6.3

2.3

37.17

129.28

u/l

0.48

127

427

ILD, hospital admissions 3, with pneumonia sepsis

386

2114

1.94

29.53

2.8

2.3

35.49

39.81

u/l

0.76

354

1815

Speech and linguistic disorders

435

2362

1.86

29.44

2.4

2.3

28.12

53.02

u/l

0.66

384

1998

Symptoms and signs involving emotional state

187

785

2.65

29.32

3.3

2.4

30.93

97.15

u/l

0.56

167

667

Cervicobrachial syndrome

1068

7471

1.48

29.29

2.7

2.4

47.20

48.47

u/l

0.03

912

6452

Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)

484

2826

1.78

29.04

2.7

2.2

38.28

37.91

u/l

0.04

415

2344

Pregnancy examination and test

796

3230

1.59

28.99

2.2

2.5

34.67

36.35

u/l

0.23

670

2743

Disorders of lens

3430

17669

1.25

28.89

3.1

2.5

58.90

44.82

u/l

0.30

2918

15144

Other and unspecified paralytic syndromes

109

351

3.68

28.82

3.6

2.4

28.53

46.66

u/l

0.76

288

Reimbursement for rheumatic diseases

2867

23094

1.26

28.67

2.9

2.4

50.55

44.78

u/l

0.19

2501

19696

Other symptoms and signs involving general sensations and perceptions

222

1017

2.39

28.36

3.5

2.3

29.71

85.66

u/l

0.63

196

862

Other general symptoms and signs

256

1219

2.22

28.33

3.2

2.0

29.58

80.95

u/l

0.71

209

1029

Thoracic aortic aneurysm

642

4084

1.65

28.32

2.5

39.48

51.31

u/l

0.43

549

3527

Transient ischemic attack

2432

15958

1.29

28.27

2.7

2.4

37.49

47.98

u/l

1.10

2037

13609

AV-block

759

4521

1.58

28.22

2.5

2.4

33.96

64.59

u/l

0.98

642

3890

L01XE Protein kinase inhibitors

317

1665

2.07

28.22

3.0

2.4

72.76

39.96

u/l

0.39

290

1432

Postprocedural endocrine and metabolic disorders, not elsewhere classified

591

3684

1.68

28.21

2.7

2.2

45.33

51.79

u/l

0.18

523

3137

Clear cell adenocarcinoma of kidney, excluding all cancers (controls excluding all cancers)

224

1031

2.37

28.20

3.3

2.2

37.20

40.63

u/l

0.25

201

867

Emphysema

348

1873

1.98

28.18

3.0

2.4

32.06

39.11

u/l

1.30

306

1589

Pericarditis

205

911

2.46

28.09

3.9

2.5

32.30

95.57

u/l

0.64

173

781

Benign neoplasm of other and unspecified endocrine glands

646

4128

1.65

28.06

2.6

2.4

31.69

49.96

u/l

0.92

574

3512

IgA nephropathy (IgA glomerulonephritis)

162

654

2.82

28.01

3.0

2.5

39.62

107.51

u/l

0.47

152

574

Disorders of breast

2367

17364

1.29

28.00

2.3

35.38

39.00

u/l

0.96

2035

14716

Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)

471

2766

1.78

27.94

2.5

2.1

33.10

36.97

u/l

0.81

400

2289

Heart failure and coronary heart disease

1470

8103

1.39

27.92

2.7

2.4

34.83

40.01

u/l

1.20

1238

6922

Noninflammatory disorders of female genital tract

2211

8621

1.32

27.84

2.3

36.67

36.69

u/l

0.00

1857

7345

Other and unspecified diseases of blood and blood-forming organs

162

656

2.80

27.76

2.8

2.3

35.33

33.87

u/l

0.12

143

550

Other specified/unspecified bacterial intestinal infections

348

1889

1.98

27.71

2.9

2.3

32.50

64.57

u/l

0.69

290

1626

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

488

2920

1.77

27.68

2.9

2.4

215.34

55.36

u/l

0.56

417

2503

Sequelae of other external causes

288

1468

2.12

27.64

2.9

2.4

136.18

73.65

u/l

0.25

250

1252

Postmenopausal bleeding

1396

5594

1.41

27.55

2.3

2.4

53.51

38.87

u/l

0.44

1156

4771

Other arthritis (FG)

1521

11399

1.37

27.49

2.8

2.5

35.62

45.27

u/l

1.32

1274

9750

Diplopia

634

4049

1.64

27.47

2.8

2.4

33.11

50.52

u/l

0.81

541

3456

COPD, hospital admissions 1, only main diagnosis

1564

9993

1.37

27.45

2.8

2.4

32.90

51.94

u/l

1.49

1308

8502

Covid-19 suspected case

1007

7063

1.47

27.29

2.8

2.4

31.85

43.92

u/l

1.08

895

6062

Superficial injury of ankle and foot

586

3675

1.67

27.26

2.9

2.4

53.85

37.40

u/l

0.32

495

3168

Cluster headache, wide

229

1079

2.31

27.24

2.9

2.5

30.97

40.81

u/l

1.23

198

935

Traumatic subdural haemorrhage

582

3577

1.67

27.21

2.9

2.4

42.56

58.45

u/l

0.35

486

3100

Other and unspecified abdominal hernia

227

1068

2.33

27.20

3.8

2.2

39.50

36.40

u/l

0.12

205

906

Otitis externa

1052

7451

1.46

27.13

2.8

2.5

31.79

43.15

u/l

1.06

876

6374

Malignant neoplasm of head and neck, excluding all cancers (controls excluding all cancers)

433

2511

1.81

27.07

2.8

2.2

40.62

38.02

u/l

0.20

366

2121

Hypothyroidism, strict autoimmune

3775

20748

1.22

26.96

2.5

2.3

36.40

44.72

u/l

1.17

3170

17788

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

1353

9995

1.39

26.86

2.5

36.26

43.93

u/l

0.75

1175

8598

Manic episode

183

792

2.54

26.74

2.5

28.59

39.15

u/l

1.14

153

681

Other respiratory diseases principally affecting the interstitium

802

5416

1.54

26.70

2.9

2.4

36.24

46.44

u/l

0.58

716

4602

Biomechanical lesions, not elsewhere classified

269

1362

2.15

26.55

2.7

2.3

36.41

41.05

u/l

0.28

233

1158

Maternal care for known or suspected fetal abnormality and damage

762

4515

1.56

26.53

2.4

35.59

38.62

u/l

0.37

633

3881

Diseases of external ear

1577

11953

1.36

26.43

2.7

2.5

33.98

49.72

u/l

1.46

1327

10248

Other enthesopathies

1422

10624

1.37

26.19

2.7

2.4

38.24

42.14

u/l

0.45

1196

9122

Type 1 diabetes

1236

9025

1.41

26.15

5.7

2.4

45.35

45.52

u/l

0.01

955

7862

Nephrotic syndrome

193

867

2.47

26.12

4.2

2.4

46.86

88.46

u/l

0.35

173

740

Carcinoma in situ of skin of trunk

149

593

2.78

26.09

2.9

2.1

34.62

33.08

u/l

0.21

123

473

Other aneurysm

276

1415

2.10

26.03

2.6

2.3

89.75

69.34

u/l

0.14

237

1195

Chronic hepatitis NAS

105

353

3.54

25.99

3.4

2.3

32.72

32.27

u/l

0.05

299

Hypothyroidism, other/unspecified

4598

25740

1.20

25.92

2.5

35.93

44.94

u/l

1.73

3865

22098

Pruritus

537

3343

1.69

25.91

3.1

2.2

32.32

38.95

u/l

1.98

463

2835

Atypical facial pain

293

1541

2.06

25.90

2.9

2.3

29.30

39.71

u/l

1.83

258

1314

Campylobacter enteritis

170

729

2.60

25.65

3.0

2.4

113.00

34.33

u/l

0.54

155

626

Diseases of spleen

121

442

3.17

25.63

4.9

2.4

37.39

43.20

u/l

0.22

106

371

Algoneurodystrophy

194

880

2.42

25.49

2.6

2.3

34.57

41.16

u/l

0.45

164

747

Superficial injury of hip and thigh

679

4471

1.58

25.42

2.8

2.4

31.53

49.36

u/l

1.00

561

3814

Myocarditis

244

1202

2.16

25.41

2.8

2.4

37.61

44.30

u/l

0.64

213

1057

Barrett oesophagus

255

1287

2.15

25.36

3.9

2.3

31.03

41.33

u/l

1.37

214

1116

Pyothorax

229

1112

2.25

25.33

3.4

2.4

41.56

38.08

u/l

0.15

202

958

Specific development disorders of scholastic skills

233

1119

2.21

25.32

2.3

2.4

30.73

77.35

u/l

0.55

205

942

Senile cataract

3095

15729

1.24

25.25

3.0

2.4

61.45

45.57

u/l

0.31

2627

13455

Glomerulonephritis

498

3066

1.71

25.24

3.7

2.5

82.04

53.06

u/l

0.40

447

2636

Superficial injury of forearm

476

2893

1.73

25.23

2.7

2.4

33.71

54.27

u/l

0.67

411

2487

Gastrointestinal stromal tumor and sarcoma, excluding all cancers (controls excluding all cancers)

246

4.08

25.20

3.0

1.9

37.81

36.41

u/l

0.06

205

Malignant neoplasm of small intestine

141

562

2.87

25.18

3.2

2.5

32.15

32.83

u/l

0.08

128

476

Viral and other specified intestinal infections

944

6474

1.46

25.05

3.5

2.3

37.04

45.26

u/l

0.52

808

5564

Temporomandibular joint disorders, including avohilmo

1987

15607

1.30

24.98

2.6

2.4

35.68

40.52

u/l

0.71

1712

13370

Malignant neoplasm of skin

2872

17660

1.25

24.94

2.5

2.4

41.93

46.12

u/l

0.20

2473

14981

Other diseases of arteries and capillaries

436

2600

1.77

24.93

3.8

2.4

29.20

56.89

u/l

0.88

380

2223

Carcinoma in situ of skin

389

2257

1.84

24.89

2.7

2.3

31.66

39.68

u/l

2.08

329

1906

Acute gastritis

373

2131

1.85

24.84

3.4

2.3

33.01

38.82

u/l

0.99

311

1810

Diseases of the myoneural junction and muscle

571

3646

1.64

24.82

3.2

2.4

76.14

50.86

u/l

0.27

469

3119

Benign neoplasm of mouth and pharynx

547

3461

1.66

24.82

2.7

2.4

35.21

51.98

u/l

0.64

456

2981

Congenital malformations of gallbladder, bile ducts and liver

240

4.16

24.80

5.8

2.2

45.65

28.92

u/l

1.68

199

Persons encountering health services in other circumstances

1673

12865

1.33

24.79

3.3

2.3

41.83

46.28

u/l

0.20

1435

11002

Neuromuscular dysfunction of bladder

426

2529

1.77

24.72

2.8

2.4

32.48

59.03

u/l

0.78

366

2176

Fracture at wrist and hand level

1613

12370

1.33

24.64

2.8

2.6

79.62

45.56

u/l

0.36

1396

10635

Degeneration of macula and posterior pole

2086

13603

1.29

24.60

2.5

2.4

45.02

48.46

u/l

0.11

1763

11517

Open wound of ankle and foot

496

3073

1.69

24.43

3.8

2.4

35.13

38.88

u/l

0.44

410

2636

Poisoning by medicine, drug-induced

106

371

3.36

24.40

2.8

2.6

30.09

33.94

u/l

0.25

314

COPD-related respiratory insufficiency

531

3347

1.66

24.33

3.0

2.4

28.51

38.58

u/l

4.28

453

2849

Osteoporosis

1158

8096

1.41

24.27

3.1

2.3

34.85

46.03

u/l

1.00

1011

6846

Symptoms and signs involving the nervous and musculoskeletal systems

2734

22358

1.24

24.20

2.8

2.5

46.90

44.96

u/l

0.08

2327

19134

Sacrococcygeal disorders, not elsewhere classified

180

808

2.44

24.20

2.6

2.1

150.04

42.49

u/l

0.43

151

698

Malignant neoplasm of other connective and soft tissue, excluding all cancers (controls excluding all cancers)

208

989

2.28

24.13

2.7

2.1

47.17

89.00

u/l

0.38

183

818

Weight loss

467

2864

1.72

24.11

2.9

2.3

33.27

54.13

u/l

0.67

397

2446

Immunodeficiencies

263

1368

2.08

23.99

2.9

2.5

32.77

73.94

u/l

0.62

232

1162

Oxicams

1116

4554

1.43

23.96

2.4

2.7

77.99

38.71

u/l

0.43

928

3940

Arthrosis

3757

17285

1.21

23.96

2.6

2.5

55.45

44.69

u/l

0.24

3216

14868

Agranulocytosis

543

3461

1.65

23.91

3.4

2.4

32.26

51.91

u/l

0.80

482

2956

Hypertensive Renal Disease

175

777

2.43

23.86

3.5

2.3

37.46

40.26

u/l

0.18

156

671

Other surgical follow-up care

188

865

2.37

23.82

3.5

2.2

34.51

38.23

u/l

0.29

164

738

Hypothyreosis and Thyroxine purchase for inclusion criteria

4737

26775

1.18

23.74

2.5

36.15

44.74

u/l

1.69

3982

22974

Benign neoplasm: Liver/bile ducts

141

574

2.73

23.72

3.4

2.1

31.15

35.92

u/l

0.66

117

477

Benign neoplasm of ovary

760

5199

1.52

23.71

2.5

2.2

33.06

36.08

u/l

0.98

652

4370

Carcinoma in situ of skin of ear and external auricular canal

223

3.96

23.70

2.3

2.2

27.35

29.89

u/l

0.66

171

Traumatic subarachnoid haemorrhage

191

886

2.34

23.64

2.6

2.3

29.49

43.82

u/l

1.73

160

768

Carcinoma in situ of skin of scalp and neck

119

446

2.99

23.64

2.7

2.1

31.36

33.46

u/l

0.33

106

351

Abnormal findings in nipple discharge synovial fluid wound secretions

111

405

3.18

23.62

4.5

2.3

35.34

33.51

u/l

0.17

340

Abnormal findings on diagnostic imaging of other body structures

619

4077

1.59

23.52

3.2

2.3

52.81

49.43

u/l

0.07

531

3470

Alcoholic gastritis

107

383

3.22

23.49

5.6

2.3

26.23

43.99

u/l

0.93

335

Other and unspecified tonsillitis

1611

10515

1.33

23.46

2.7

2.6

41.05

41.03

u/l

0.00

1387

9125

Infection of intervertebral disc (pyogenic)

315

3.53

23.39

2.9

2.1

28.57

183.21

u/l

0.51

266

Benign neoplasm: Rectosigmoid junction

196

923

2.31

23.36

2.8

2.0

32.61

39.52

u/l

0.68

169

767

ILD, hospital admissions

664

4442

1.56

23.33

2.7

2.4

36.22

48.36

u/l

0.57

603

3774

Crushed, pushed or stepped on by crowd or human stampede

365

2112

1.82

23.30

2.3

2.7

29.78

61.53

u/l

0.80

317

1827

Late syphilis

337

3.42

23.30

4.4

2.5

32.46

179.93

u/l

0.52

285

Other orthopaedic follow-up care

292

1584

1.97

23.27

2.8

2.3

30.36

71.67

u/l

0.77

238

1362

Adenocarcinoma and papillary adenocarcinoma of stomach, excluding all cancers (controls excluding all cancers)

141

576

2.67

23.26

5.0

2.1

37.23

32.86

u/l

0.61

130

465

Dementia in Alzheimer disease

277

4308

0.53

23.24

2.2

2.4

28.34

36.45

u/l

4.44

216

3620

Deforming dorsopathies

1288

9657

1.37

23.23

2.5

2.4

35.67

47.02

u/l

1.27

1091

8290

Cramp and spasm

253

1315

2.08

23.18

3.5

2.4

32.03

76.64

u/l

0.65

218

1121

Fitting and adjustment of other devices

795

10558

0.69

23.07

2.6

2.2

52.70

45.20

u/l

0.16

646

8946

Meniscus derangement

2856

16055

1.24

23.07

2.5

42.72

45.45

u/l

0.17

2403

13797

Dissociative [conversion] disorders

202

965

2.25

23.05

3.5

2.1

36.91

37.14

u/l

0.01

183

796

Opening and dilatation of root channel of tooth

334

1895

1.88

23.02

3.8

2.4

32.55

64.26

u/l

0.69

289

1639

Benign neoplasm: Descending colon

337

1922

1.88

23.00

2.8

2.4

34.11

38.90

u/l

0.68

286

1648

Benign neoplasm: Skin of eyelid, including canthus

634

4205

1.57

23.00

2.3

2.2

37.38

48.67

u/l

0.47

506

3552

Disorders of parathyroid gland

961

6814

1.44

22.99

3.2

2.4

46.85

44.47

u/l

0.07

837

5766

Exposure to other and unspecified inanimate mechanical forces

350

2013

1.85

22.97

3.2

2.5

31.35

64.01

u/l

0.77

312

1731

Vitamin B12 deficiency anaemia

497

3125

1.66

22.95

3.6

2.3

36.14

53.55

u/l

0.56

428

2642

Other protozoal intestinal diseases

101

355

3.29

22.93

1.9

2.3

29.56

34.91

u/l

0.71

308

Haemolytic anaemias

194

920

2.31

22.92

3.7

2.4

40.48

90.39

u/l

0.47

174

783

Open wound of forearm

448

2751

1.71

22.91

2.8

2.5

34.63

55.12

u/l

0.61

387

2366

Other necrotizing vasculopathies (FG)

307

1702

1.93

22.89

2.4

2.3

33.40

70.32

u/l

0.72

267

1456

Neuroendocrine tumor and carcinoma of pancreas, excluding all cancers (controls excluding all cancers)

145

5.23

22.85

3.9

2.0

126.57

31.88

u/l

0.94

119

Fracture of femur

1146

7713

1.39

22.85

2.6

2.4

36.17

43.01

u/l

0.52

948

6567

Diffuse large B-cell lymphoma, helper endpoint

204

984

2.24

22.80

2.2

2.3

33.76

38.88

u/l

0.43

178

813

Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)

204

984

2.24

22.80

2.2

2.3

33.76

38.88

u/l

0.43

178

813

Other and/or unspecified nontoxic goitre

427

2601

1.74

22.77

2.6

2.3

39.18

37.11

u/l

0.10

352

2193

Salpingitis and oophoritis

864

6108

1.47

22.74

2.6

2.3

33.33

36.72

u/l

1.04

726

5185

Diagnoses used for exclusion with ILD

1169

8684

1.38

22.57

2.9

2.5

35.76

43.20

u/l

0.67

993

7417

Otalgia

404

2431

1.76

22.57

2.8

2.3

30.02

58.40

u/l

0.82

350

2066

Colonic or urogenital fistula

1281

9651

1.36

22.56

2.5

40.45

45.18

u/l

0.23

1117

8274

Ulcerative rectosigmoiditis

412

2487

1.74

22.56

3.1

2.4

37.31

57.23

u/l

0.52

355

2146

Protozoal diseases

166

748

2.48

22.49

3.5

2.4

36.52

33.38

u/l

0.40

145

644

Vitreous haemorrhage

479

3008

1.67

22.48

6.1

2.4

43.06

54.59

u/l

0.31

401

2593

General examination and investigation of persons without complaint and reported diagnosis

3144

13837

1.22

22.47

3.0

2.3

56.58

45.78

u/l

0.30

2687

11927

Haemorrhoids and perianal venous thrombosis

1182

8781

1.38

22.41

2.7

2.3

33.43

55.22

u/l

1.51

988

7433

Other necrotizing vasculopathies

355

2068

1.83

22.40

2.4

35.11

63.00

u/l

0.63

307

1748

Other interstitial pulmonary diseases

667

4507

1.54

22.32

2.7

2.4

36.17

48.12

u/l

0.57

605

3836

Viral pneumonia (known virus, not influenza)

146

625

2.62

22.28

2.7

2.4

27.63

39.53

u/l

0.96

132

525

Hyperparathyroidism

847

5918

1.46

22.20

3.2

2.3

48.69

45.64

u/l

0.08

733

5023

Other diseases of jaws

333

1903

1.85

22.20

3.0

2.3

30.88

39.19

u/l

1.62

267

1671

Disorders of synovium and tendon

2499

18385

1.24

22.10

2.6

2.4

35.94

42.66

u/l

1.76

2098

15787

Interstitial lung disease endpoints

667

4517

1.54

22.08

2.7

2.4

36.17

48.08

u/l

0.57

605

3840

Interstitial lung disease

667

4517

1.54

22.08

2.7

2.4

36.17

48.08

u/l

0.57

605

3840

ILD, hospital admissions 1, main diag only

595

3939

1.58

22.05

2.8

2.4

35.70

38.45

u/l

0.62

539

3346

Basal cell carcinoma, including avohilmo

2577

16621

1.24

22.00

2.4

42.90

46.42

u/l

0.14

2212

14092

Other symptoms and signs involving the urinary system

467

2927

1.67

21.95

2.8

2.4

34.31

56.80

u/l

0.74

411

2513

Left hemicolectomy

145

623

2.61

21.94

3.8

2.4

42.66

33.46

u/l

0.39

128

520

Pneumonitis due to solids and liquids

363

2132

1.79

21.93

3.3

2.4

31.00

60.08

u/l

0.71

312

1820

Dissocial personality disorder

113

432

2.98

21.88

3.0

2.9

27.51

152.69

u/l

0.62

384

Pneumocystosis

111

424

3.05

21.81

4.0

2.4

38.13

33.54

u/l

0.46

100

361

Basal cell carcinoma

2511

16362

1.25

21.80

2.4

43.10

46.53

u/l

0.14

2153

13868

Psoriasis

1342

10229

1.35

21.78

3.0

2.5

34.65

45.09

u/l

1.22

1171

8792

Other/unspecified enthesopathies of lower limb, excluding foot

359

2110

1.80

21.74

2.8

2.3

29.52

62.85

u/l

0.87

309

1840

D07AA Corticosteroids, weak (group I)

728

5017

1.50

21.72

2.9

2.4

35.01

46.77

u/l

0.61

622

4298

Psychotic depression

277

1503

1.94

21.71

2.7

2.2

43.76

35.25

u/l

0.42

240

1322

Amenorrhoea

330

1890

1.83

21.66

2.8

2.1

29.84

35.26

u/l

1.92

273

1627

Melanocytic naevi

1355

10349

1.34

21.63

2.8

2.5

34.19

42.63

u/l

1.04

1171

8850

Malignant neoplasm of oral cavity, excluding all cancers (controls excluding all cancers)

216

1085

2.14

21.61

2.9

2.2

36.75

39.55

u/l

0.18

181

910

Localized swelling, mass and lump of skin and subcutaneous tissue

1436

11058

1.33

21.55

2.7

2.4

40.25

44.52

u/l

0.23

1231

9425

Schizophrenia

782

5487

1.47

21.40

2.4

2.6

27.20

51.22

u/l

2.01

650

4769

Non-follicular lymphoma

446

2788

1.68

21.39

2.4

36.79

55.71

u/l

0.56

382

2375

Valvular operations

619

4149

1.55

21.35

2.6

2.5

42.55

68.96

u/l

0.69

537

3602

Toxic effect of ethanol

225

1154

2.10

21.33

3.9

2.6

29.63

80.96

u/l

0.68

185

997

Immunodeficiency with predominantly antibody defects

157

706

2.46

21.28

2.9

2.5

32.92

108.94

u/l

0.57

133

590

Benign neoplasm of meninges

425

2626

1.70

21.18

2.4

2.2

30.06

37.23

u/l

2.15

366

2218

Artrosis, including avohilmo

4463

21019

1.18

21.16

2.5

2.6

41.36

44.14

u/l

0.21

3814

18104

Carcinoma in situ of skin of lower limb, including hip

109

416

2.96

21.08

2.3

2.0

29.63

31.47

u/l

0.37

334

Other diseases of blood and blood-forming organs

340

1991

1.81

21.07

2.5

2.4

33.91

62.37

u/l

0.63

300

1709

Osteomyelitis

309

1760

1.87

21.05

4.6

2.4

33.62

62.75

u/l

0.55

261

1522

Hepatocellular carcinoma

121

488

2.79

20.97

4.1

2.5

29.93

34.50

u/l

0.81

113

420

Benign neoplasm of urinary organs

211

1065

2.12

20.83

2.6

2.1

49.90

39.66

u/l

0.39

189

879

Carcinoma in situ of colon

287

3.43

20.74

2.8

2.1

36.44

33.63

u/l

0.33

238

Intentional self-harm by sharp object

150

667

2.47

20.72

3.6

2.3

25.97

106.11

u/l

0.57

128

561

Malignant neoplasm of other and ill-defined digestive organs, excluding all cancers (controls excluding all cancers)

340

3.15

20.66

3.2

2.0

43.95

34.00

u/l

0.44

275

Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers

190

926

2.20

20.66

2.7

2.1

36.11

38.94

u/l

0.19

166

770

Inguinal or femoral hernia, bilateral

467

2972

1.64

20.58

2.5

41.26

55.49

u/l

0.38

414

2552

Dental pulpitis 3

585

2778

1.56

20.55

2.8

2.1

29.80

60.82

u/l

0.89

498

2363

Benign neoplasm: Other and unspecified parts of small intestine

100

371

3.07

20.50

3.3

1.9

40.99

33.45

u/l

0.50

297

Abnormal weight loss

416

2585

1.70

20.49

2.9

2.3

32.45

56.56

u/l

0.71

355

2206

Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)

305

1744

1.86

20.49

2.1

31.47

34.80

u/l

0.85

263

1473

Dental pulpitis 3, only avohilmo

544

2584

1.59

20.42

2.7

2.1

29.52

43.98

u/l

0.65

465

2191

Other degenerative diseases of the nervous system

1223

6993

1.36

20.42

2.5

2.3

33.11

48.43

u/l

0.88

1001

6023

Hepatomegaly and splenomegaly, not elsewhere classified

182

4.08

20.38

3.2

1.8

30.29

59.01

u/l

0.62

153

Malignant neoplasm of rectosigmoid junction, excluding all cancers (controls excluding all cancers)

140

607

2.51

20.38

2.1

31.30

33.06

u/l

0.38

129

496

Leiomyoma of uterus

2123

9620

1.27

20.34

2.3

2.2

38.23

36.40

u/l

0.26

1835

8125

Somnolence, stupor and coma

222

1151

2.06

20.33

4.1

2.4

31.07

82.02

u/l

0.65

187

976

Neuroendocrine tumor and carcinoma of small intestine, excluding all cancers (controls excluding all cancers)

307

3.32

20.32

2.9

2.1

33.44

33.99

u/l

0.04

251

Other predominantly sexually transmitted diseases, not elsewhere classified

790

5601

1.45

20.31

2.6

2.5

41.79

45.74

u/l

0.15

688

4842

Lymphoid leukaemia

237

1254

2.01

20.31

3.3

2.2

31.09

39.23

u/l

1.22

213

1038

Charcot foot

112

443

2.87

20.30

9.2

2.4

36.96

138.13

u/l

0.48

388

Sleep apnoea

4607

27059

1.17

20.21

2.4

2.6

43.46

44.46

u/l

0.05

3882

23260

Fibroblastic disorders

1038

7700

1.38

20.21

2.7

2.4

39.65

42.32

u/l

0.16

879

6581

Malignant neoplasm of anus and anal canal, excluding all cancers (controls excluding all cancers)

270

3.48

20.20

2.5

2.0

30.12

35.21

u/l

0.58

229

Abnormal blood-pressure reading, without diagnosis

221

1146

2.06

20.19

3.1

2.1

35.74

83.92

u/l

0.61

178

984

Other congenital malformations of the digestive system

227

1182

2.05

20.18

4.2

2.4

40.96

74.92

u/l

0.38

204

982

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

597

4021

1.54

20.17

2.6

2.3

33.96

50.00

u/l

0.73

517

3409

Follicular cysts of skin and subcutaneous tissue

851

6128

1.43

20.16

2.8

2.5

41.17

45.06

u/l

0.18

723

5271

Disorders of vestibular function (Vertigo)

2148

17371

1.25

20.15

2.6

2.5

42.27

46.94

u/l

0.24

1820

14806

Cluster headache, strict, including avohilmo

256

1399

1.96

20.08

2.9

2.5

33.76

40.79

u/l

0.82

222

1204

Other specified/unspecified dorsopathies

193

959

2.17

20.04

2.4

2.1

29.91

41.43

u/l

1.39

159

835

Gingival hyperplasia

168

792

2.30

20.04

4.1

2.2

42.48

42.46

u/l

0.00

145

691

Benign neoplasm: Liver/bile ducts

141

623

2.50

19.91

3.4

2.3

31.15

35.87

u/l

0.69

117

530

Other disorders of bladder

514

3368

1.59

19.89

2.5

2.4

31.40

53.06

u/l

0.89

435

2904

Benign neoplasm: Cerebral meninges

386

2367

1.71

19.89

2.5

2.2

30.32

37.94

u/l

2.03

335

1995

Benign neoplasm: Kidney

165

776

2.31

19.83

2.6

2.1

55.07

35.83

u/l

0.71

149

638

Arterial embolism and thrombosis

270

1500

1.90

19.83

2.7

2.4

32.13

39.63

u/l

1.03

239

1273

Deviated nasal septum

1546

12140

1.30

19.82

2.6

36.63

51.06

u/l

1.32

1330

10478

Gastrointestinal stromal tumor and sarcoma

287

3.45

19.76

3.0

2.3

37.81

36.06

u/l

0.08

242

severe traumatic brain injury, does not include concussion

951

6989

1.40

19.75

2.7

2.5

90.72

37.80

u/l

0.52

792

5978

Neuroendocrine tumor and carcinoma of pancreas

162

4.64

19.74

3.9

2.6

126.57

30.93

u/l

0.95

135

Disorders of tooth development and eruption

235

1214

1.99

19.73

3.1

2.3

43.51

39.65

u/l

0.16

213

1057

Biological medication for rheuma

735

5180

1.47

19.71

3.0

2.5

40.13

46.51

u/l

0.30

646

4466

Premature rupture of membranes

494

5513

0.64

19.67

2.2

2.4

48.94

38.08

u/l

0.39

419

4741

Gangrene, not elsewhere classified

150

4.47

19.63

2.2

38.24

30.93

u/l

0.29

123

Chondropathies

738

5215

1.46

19.53

3.1

2.5

33.94

46.32

u/l

0.72

630

4503

Suggestive for eosinophilic asthma

435

2764

1.65

19.48

2.5

2.4

32.02

56.81

u/l

0.82

369

2379

Disorders of muscles

468

3019

1.62

19.46

2.8

2.4

87.08

40.53

u/l

0.50

394

2602

Non-invasive ventilation

392

5856

0.62

19.45

3.0

2.2

35.59

49.88

u/l

1.32

348

5127

Oral leukoplakia and related diseases, including avohilmo

427

2707

1.66

19.43

2.8

2.4

39.12

57.28

u/l

0.48

351

2335

Retinal detachments and breaks

1567

12378

1.29

19.34

2.8

2.5

37.34

49.40

u/l

1.00

1331

10601

Disorders of sclera, cornea, iris and ciliary body

2548

21181

1.22

19.33

3.0

2.5

55.57

45.31

u/l

0.30

2164

18188

Gonarthrosis

3279

15875

1.20

19.32

2.4

2.5

63.18

45.66

u/l

0.36

2753

13624

Sleep apnoea, including avohilmo

4897

27729

1.16

19.19

2.4

2.6

43.03

44.08

u/l

0.06

4126

23856

Ulcerative proctitis

305

1778

1.81

19.16

2.8

2.3

38.71

65.31

u/l

0.49

266

1520

Other noninflammatory disorders of vulva and perineum

430

2732

1.64

19.12

2.5

2.2

38.94

36.86

u/l

0.15

372

2314

Injury of intra-abdominal organs

148

679

2.40

19.10

3.3

2.5

501.46

112.86

u/l

0.38

128

579

Other and unspecified myopathies

392

2442

1.69

19.09

3.2

2.5

93.88

58.06

u/l

0.26

316

2089

Chronic nephritic syndrome

211

1103

2.06

19.08

3.4

2.5

99.38

40.17

u/l

0.47

186

955

Complications of internal orthopaedic prosthetic devices, implants and grafts

965

7153

1.39

19.06

2.7

2.3

50.45

44.60

u/l

0.14

775

6053

Other diseases of pericardium

216

1136

2.04

19.05

3.1

2.4

27.65

84.82

u/l

0.77

176

977

Inguinal hernia, bilateral

452

2908

1.62

19.04

2.6

2.5

41.52

55.82

u/l

0.37

401

2503

Benign neoplasm: Liver

120

504

2.63

18.94

3.1

2.1

31.39

35.64

u/l

0.49

422

Reactive arthropathies

426

2709

1.64

18.92

2.7

2.4

36.45

55.81

u/l

0.56

366

2331

1748

13186

1.27

18.81

2.5

2.4

33.75

45.69

u/l

1.39

1490

11170

Scar conditions and fibrosis of skin

213

1123

2.04

18.75

2.5

2.1

31.67

38.72

u/l

1.23

190

949

Acute posthaemorrhagic anaemia

177

874

2.18

18.70

5.3

2.4

29.59

34.79

u/l

1.46

148

735

Personal history of risk-factors, not elsewhere classified

338

3.08

18.70

3.7

2.1

31.82

33.77

u/l

0.09

280

Papulosquamous disorders

1812

14615

1.27

18.64

2.8

2.5

37.40

47.96

u/l

0.91

1564

12509

Tinnitus

1114

8469

1.35

18.64

2.5

35.30

44.66

u/l

0.92

938

7262

Cluster headache, wide,, including avohilmo

264

1491

1.88

18.60

2.9

2.5

33.48

40.42

u/l

0.86

228

1285

Enteropathic arthropathies

136

609

2.46

18.59

2.7

2.3

47.50

118.48

u/l

0.43

121

518

Benign neoplasm: Endocrine pancreas

149

4.59

18.56

2.7

1.8

304.65

30.58

u/l

0.55

122

Pneumothorax

329

1975

1.75

18.52

2.8

2.5

43.90

64.06

u/l

0.34

288

1688

UC patients in KELA-register (code 208), prior to 1994

237

1300

1.96

18.52

3.5

2.5

36.01

42.31

u/l

0.68

215

1122

Benign neoplasm of middle ear and respiratory system

327

1957

1.75

18.46

2.5

2.3

33.99

62.95

u/l

0.61

267

1652

Sequelae of cerebrovascular disease

1486

10269

1.30

18.44

2.7

2.4

38.27

49.39

u/l

0.65

1223

8762

Congenital malformation of biliary tract

7.70

18.42

6.3

3.5

59.64

29.90

u/l

1.05

Malignant neoplasm of mesothelium and soft tissue

222

1195

2.00

18.41

2.5

2.4

45.19

36.65

u/l

0.37

201

1019

Anosmia

100

381

2.77

18.35

3.6

1.6

31.18

49.98

u/l

0.90

324

Macular pucker

647

4525

1.49

18.34

2.5

2.4

36.18

38.52

u/l

0.29

549

3866

Benign neoplasm of major salivary glands

397

2500

1.66

18.31

2.6

2.2

36.40

55.55

u/l

0.49

342

2112

Carcinoma in situ of skin of upper limb, including shoulder

110

451

2.70

18.30

3.1

2.1

32.25

32.78

u/l

0.06

363

Other problems related to primary support group, including family circumstances

520

3385

1.55

18.30

3.1

2.4

34.70

50.59

u/l

0.55

421

2908

Other disorders of the musculoskeletal system and connective tissue

668

4699

1.47

18.26

2.7

2.4

36.46

48.62

u/l

0.58

573

4016

Unspecified event, undetermined intent

148

693

2.35

18.21

3.4

2.4

31.19

110.79

u/l

0.60

130

587

Dislocation, sprain and strain of joints and ligaments of knee

2890

22667

1.20

18.18

2.6

2.5

37.20

47.51

u/l

1.46

2491

19520

Dislocation, sprain and strain of joints and ligaments at neck level

698

4946

1.46

18.16

3.0

2.4

36.80

46.26

u/l

0.42

599

4270

Restless leg syndrome

562

3835

1.53

18.12

2.4

31.49

50.82

u/l

0.91

460

3284

Hypermobility syndrome

269

1539

1.85

18.08

2.4

2.2

29.70

36.84

u/l

2.07

210

1287

Oesophageal obstruction

178

893

2.15

18.07

3.1

2.3

38.31

43.67

u/l

0.29

151

749

Inflammatory diseases of the central nervous system

393

2486

1.66

17.96

2.6

2.5

68.00

58.25

u/l

0.10

346

2143

Crohn disease (strict definition, all UC cases excluded)

259

1470

1.87

17.96

3.2

2.4

33.28

69.91

u/l

0.58

237

1251

Personal history of allergy to drugs, medicaments and biological substances

279

3.28

17.91

2.9

1.9

26.94

32.66

u/l

0.82

235

Other salmonella infections

190

978

2.08

17.89

3.6

2.2

35.47

85.46

u/l

0.52

165

837

Abnormal results of function studies

406

2592

1.64

17.88

3.6

2.4

36.04

56.57

u/l

0.57

351

2231

Other and unspecified iridocyclitis

224

1223

1.97

17.76

2.4

37.21

74.48

u/l

0.46

194

1047

Polycystic ovarian syndrome, consortium definition

3511

18126

1.18

17.76

2.5

2.3

36.16

38.86

u/l

0.57

2918

15453

Benign lipomatous neoplasm

1173

9027

1.33

17.68

2.6

2.3

51.38

45.35

u/l

0.13

1004

7667

Benign neoplasm: Tongue

143

667

2.34

17.67

2.6

2.1

32.70

42.05

u/l

0.69

120

559

Malignant neoplasm, without specification of site, excluding all cancers (controls excluding all cancers)

193

998

2.04

17.63

3.1

2.2

36.96

89.25

u/l

0.52

166

813

Unspecified lump in breast

738

5317

1.44

17.60

2.3

33.39

37.51

u/l

1.15

623

4482

Unspecified misadventure during surgical and medical care

269

1556

1.84

17.60

3.6

2.4

188.92

69.94

u/l

0.50

246

1318

Fracture of forearm

2581

20289

1.21

17.51

2.7

2.4

36.18

43.92

u/l

1.47

2181

17333

Anorexia (incl.atypical)

289

1700

1.78

17.42

2.4

2.3

31.77

66.12

u/l

0.63

257

1426

Magnesium deficiency

6.64

17.41

5.6

2.1

28.24

28.69

u/l

0.04

Maternal care for (suspected) damage to fetus from alcohol

5.95

17.40

3.1

2.4

37.23

28.74

u/l

0.45

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

1923

10204

1.25

17.39

2.1

2.2

41.13

36.86

u/l

0.82

1643

8580

Skin changes due to chronic exposure to nonionizing radiation

1629

12378

1.27

17.35

2.5

2.4

33.30

46.49

u/l

1.48

1395

10492

Herpesviral [herpes simplex] infections

538

3671

1.52

17.29

3.0

2.4

35.21

51.58

u/l

0.67

467

3149

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

1922

10205

1.25

17.28

2.1

2.2

41.12

36.86

u/l

0.81

1642

8580

Mixed disorders of conduct and emotions

135

619

2.36

17.28

2.3

2.2

23.00

35.59

u/l

3.66

109

515

Behavioural disorders, excluding more controls

103

417

2.66

17.26

3.1

2.2

25.13

36.73

u/l

3.01

364

Metatarsalgia

436

2848

1.60

17.25

2.7

2.2

29.45

39.71

u/l

4.19

357

2429

Viral agents as the cause of diseases classified to other chapters

128

579

2.44

17.21

3.2

2.3

32.94

34.57

u/l

0.17

109

496

Gestational diabetes (for exclusion)

1594

8999

1.28

17.14

2.3

35.60

37.71

u/l

0.23

1355

7706

Alcohol induced polyneuropathy

254

3.38

17.12

5.0

2.7

26.40

36.24

u/l

1.52

220

Pneumonia due to other infectious organisms, not elsewhere classified

160

788

2.19

17.10

3.9

2.1

37.41

97.26

u/l

0.50

143

686

Small fibre neuropathy

149

719

2.28

17.06

3.5

2.5

38.37

39.40

u/l

0.05

131

608

Lung diseases due to external agents

578

4005

1.49

16.98

3.2

2.4

32.35

50.18

u/l

0.85

497

3403

Maltreatment syndromes

254

1456

1.84

16.93

2.8

2.5

31.39

71.10

u/l

0.65

211

1256

Benign neoplasm: Parotid gland

322

1966

1.71

16.93

2.6

2.2

37.12

61.70

u/l

0.49

279

1660

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

728

5258

1.43

16.92

2.6

2.2

34.69

36.02

u/l

0.19

626

4447

Cervical disc disorders

1648

13295

1.26

16.89

2.8

2.4

43.87

50.51

u/l

0.27

1403

11428

Open wound of wrist and hand

1986

16175

1.24

16.83

2.9

2.6

42.31

44.89

u/l

0.13

1708

13945

Female infertility, cervigal, vaginal, other or unspecified origin

1246

6468

1.32

16.75

2.2

2.3

33.54

36.21

u/l

0.59

1067

5522

Other and unspecified immunodeficiencies with predominantly antibody defects

330

3.00

16.74

2.7

2.6

28.88

33.76

u/l

0.45

279

Diseases of the ear and mastoid process

6337

28618

1.13

16.72

2.6

2.5

42.48

44.84

u/l

0.11

5386

24561

Entropion and trichiasis of eyelid

363

2293

1.66

16.67

2.5

2.4

32.72

36.58

u/l

1.04

307

1929

Hypertension, portal

6.70

16.58

4.7

2.6

36.71

31.66

u/l

0.22

Dental caries 2, only avohilmo

3697

25257

1.17

16.57

2.5

38.58

45.79

u/l

0.90

3154

21701

Other bursitis of hip

115

505

2.51

16.55

2.7

2.0

39.07

39.44

u/l

0.02

442

Melanocytic naevi of trunk

538

3706

1.51

16.50

2.8

2.4

35.57

50.64

u/l

0.59

471

3181

Benign neoplasm: Anus and anal canal

134

625

2.32

16.49

2.4

2.0

35.20

34.40

u/l

0.06

111

519

Other enthesopathy of foot (+metatarsalgia)

462

3087

1.56

16.44

2.7

2.2

29.46

38.94

u/l

4.10

381

2634

Inguinal hernia

2755

15704

1.20

16.41

2.6

62.18

47.42

u/l

0.25

2387

13483

Other arterial embolism and thrombosis

143

686

2.25

16.39

2.7

2.3

34.62

34.49

u/l

0.01

124

579

Gonarthrosis [arthrosis of knee](FG)

3830

19536

1.17

16.38

2.4

2.5

59.59

42.97

u/l

0.41

3221

16757

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

180

937

2.05

16.38

2.9

2.1

33.53

39.11

u/l

0.46

150

778

Diabetic neuropathy

500

3388

1.53

16.38

5.1

3.1

33.30

58.32

u/l

0.61

395

2821

Benign paroxysmal vertigo

1271

10002

1.30

16.36

2.7

2.4

45.36

45.00

u/l

0.01

1074

8527

Actinic keratosis

1572

12023

1.27

16.35

2.5

2.4

33.20

46.91

u/l

1.50

1347

10177

Other symptoms and signs involving the digestive system and abdomen

571

3965

1.48

16.34

2.7

1.8

32.39

38.64

u/l

1.99

484

3278

Prurigo nodularis

134

631

2.33

16.30

3.2

2.2

29.96

33.97

u/l

0.75

114

529

Tubulo-interstitial nephritis, not specified as acute or chronic

315

1932

1.71

16.29

3.6

2.2

37.68

38.51

u/l

0.06

259

1614

Type 1 diabetes, wide definition, subgroup 1

933

7033

1.36

16.28

5.8

2.1

26.82

33.20

u/l

5.09

703

6123

Benign neoplasm: Endocrine pancreas

164

4.13

16.20

2.7

2.5

304.65

33.48

u/l

0.55

136

Oral leukoplakia and related diseases

276

1647

1.78

16.18

3.0

2.3

42.08

40.96

u/l

0.04

220

1410

Discitis, unspecified

406

2.71

16.17

2.5

2.2

28.21

143.37

u/l

0.51

358

Other and unspecified urticaria

884

6634

1.37

16.16

2.7

2.4

34.22

44.88

u/l

0.79

756

5665

Disorders of mineral metabolism

356

2257

1.65

16.14

4.2

2.4

34.85

60.75

u/l

0.65

301

1940

Reactive arthropathies, FINNGEN

345

2173

1.66

16.11

2.7

2.5

36.78

63.51

u/l

0.64

298

1884

Diseases of male genital organs

2515

10641

1.21

16.09

2.9

2.8

34.50

60.24

u/l

2.23

2200

9261

Other malignant neoplasms of skin (=non-melanoma skin cancer)

2404

15928

1.21

16.08

2.4

43.50

43.90

u/l

0.01

2058

13487

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

249

1416

1.81

16.07

2.4

26.16

67.89

u/l

0.66

216

1193

Exposure to other and unspecified animate mechanical forces

158

795

2.15

16.05

2.6

2.4

28.84

101.84

u/l

0.64

136

669

Malignant neoplasm of urinary organs

430

2851

1.57

16.00

3.1

2.4

66.18

39.59

u/l

0.43

390

2428

Diseases of inner ear

2468

20389

1.20

15.97

2.6

2.5

41.53

46.59

u/l

0.31

2101

17373

Contact with sharp object, undetermined intent

123

564

2.39

15.96

2.4

2.6

39.53

124.52

u/l

0.52

494

Other and unspecified glaucoma

321

1996

1.69

15.91

3.2

2.3

43.70

59.69

u/l

0.26

264

1687

Chronic lymphocytic leukaemia, helper endpoint

125

575

2.35

15.90

2.1

34.19

33.84

u/l

0.04

115

460

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)

125

575

2.35

15.90

2.1

34.19

33.84

u/l

0.04

115

460

Pedestrian injured in transport accident

331

2073

1.68

15.88

3.3

2.4

45.37

62.60

u/l

0.30

293

1780

Acquired haemolytic anaemia

129

605

2.34

15.86

3.9

2.4

41.84

115.58

u/l

0.45

118

512

Internal derangement of knee

1777

14509

1.24

15.85

2.5

84.65

45.97

u/l

0.46

1508

12464

Neuralgia and neuritis, unspecified

248

1444

1.82

15.76

2.8

2.2

52.53

43.29

u/l

0.17

203

1244

Clear cell adenocarcinoma of kidney

224

1272

1.89

15.76

3.3

2.4

37.20

40.41

u/l

0.28

201

1091

Malignant neoplasm of kidney, except renal pelvis

399

2617

1.59

15.65

3.1

2.4

68.78

38.34

u/l

0.47

360

2228

Thyrotoxicosis

1130

8812

1.31

15.64

2.5

2.4

39.89

42.46

u/l

0.16

975

7487

Nonischemic cardiomyopathy

267

1591

1.77

15.63

2.2

2.6

41.40

69.81

u/l

0.46

230

1376

Previous suicide attempt

244

3.26

15.62

3.9

2.2

35.00

30.52

u/l

0.19

200

Use of pramipexole

962

7351

1.34

15.61

3.0

2.4

33.71

44.16

u/l

0.89

818

6277

Carcinoma in situ of skin of ear and external auricular canal

288

3.02

15.60

2.3

2.4

27.35

33.21

u/l

1.24

239

Benign neoplasm: Appendix

233

3.30

15.59

2.8

2.0

32.05

36.11

u/l

0.34

189

Carcinoma in situ of skin of trunk

149

746

2.17

15.43

2.9

2.4

34.62

35.30

u/l

0.06

123

621

Allergic urticaria

384

2508

1.60

15.31

3.0

2.4

33.81

57.68

u/l

0.68

325

2152

Open wound of abdomen, lower back and pelvis

159

815

2.10

15.29

3.9

2.6

29.39

98.35

u/l

0.63

133

708

Neuroendocrine tumor and carcinoma of small intestine

358

2.81

15.29

2.9

2.4

33.44

31.87

u/l

0.15

301

Cardiac arrest

269

1378

1.75

15.19

3.0

2.3

68.50

43.10

u/l

0.34

230

1191

Other spirochaetal diseases

1146

8993

1.31

15.17

2.3

2.5

33.64

43.93

u/l

1.20

979

7683

Childhood asthma (age<16), excluding more controls

559

3090

1.47

15.17

2.4

2.3

29.89

62.03

u/l

1.12

470

2681

Dental caries 1 and operation codes, only avohilmo

1376

5472

1.29

15.16

2.5

2.7

34.47

44.06

u/l

0.84

1154

4753

Excessive vomiting in pregnancy

378

2469

1.59

15.03

2.2

34.59

35.54

u/l

0.06

324

2091

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

1176

5599

1.31

14.93

2.4

35.18

51.74

u/l

1.09

981

4775

Vulvovaginal ulceration/inflammation in other diseases

270

1631

1.74

14.92

2.7

2.1

30.02

35.83

u/l

1.55

235

1375

Idiopathic urticaria

117

541

2.37

14.91

2.4

2.2

31.58

32.32

u/l

0.09

456

Spondyloarthritis

804

6023

1.37

14.83

2.7

2.4

78.28

45.73

u/l

0.34

679

5139

Calcific aortic valvular stenosis, including rheumatic fever

1194

9221

1.29

14.82

2.5

2.4

43.85

52.85

u/l

0.33

1013

7824

Adalimumab

415

2777

1.56

14.80

3.4

2.6

39.06

56.28

u/l

0.50

365

2412

Hordeolum and other deep inflammation of eyelid

269

1631

1.74

14.79

2.5

2.4

30.40

67.66

u/l

0.70

229

1408

Calcific aortic valvular stenosis

1189

9192

1.29

14.74

2.5

2.4

43.67

53.01

u/l

0.34

1010

7802

Calcific aortic valvular stenosis, operated

1189

9192

1.29

14.74

2.5

2.4

43.67

53.01

u/l

0.34

1010

7802

Malignant neoplasm of other and unspecified female genital organs

397

2.71

14.74

2.4

2.2

31.48

33.18

u/l

0.15

331

Calcific aortic valvular stenosis, diagnosis (helper)

1188

9184

1.29

14.73

2.5

2.4

43.67

52.97

u/l

0.34

1010

7795

Operations 2 for CAVS

1188

9184

1.29

14.73

2.5

2.4

43.67

52.97

u/l

0.34

1010

7795

Hallux valgus (acquired)

1603

9438

1.25

14.69

2.3

2.4

34.98

37.85

u/l

0.90

1368

8039

Childhood asthma (age<16)

559

3111

1.46

14.68

2.4

2.3

29.89

61.75

u/l

1.12

470

2701

Other disorders of white blood cells

260

1568

1.75

14.62

2.8

2.4

32.76

71.69

u/l

0.69

232

1329

Atopic dermatitis, strict definition with reimbursement

1349

10485

1.27

14.60

2.7

2.4

33.61

44.11

u/l

1.37

1163

9023

Benign neoplasm: Liver

120

566

2.32

14.58

3.1

2.3

31.39

36.11

u/l

0.58

480

Malignant melanoma

627

4543

1.43

14.55

2.8

2.4

32.98

38.36

u/l

1.32

551

3881

Pedestrian injured in collision with pedal cycle

164

865

2.04

14.54

3.1

2.3

56.13

90.03

u/l

0.24

145

731

Other disorders of breast

578

4132

1.45

14.54

2.2

31.96

37.43

u/l

1.68

508

3474

Abnormal findings on antenatal screening of mother

110

2293

0.46

14.53

2.1

36.73

35.39

u/l

0.12

1950

Heart failure and hypertrophic cardiomyopathy

102

453

2.52

14.51

2.5

2.4

32.92

32.30

u/l

0.08

385

Benign neoplasm: Other and unspecified parts of small intestine

100

441

2.55

14.49

3.3

2.3

40.99

32.42

u/l

0.62

365

Assault by blunt object

359

2.70

14.46

3.2

2.6

26.59

179.16

u/l

0.61

311

Carcinoma in situ of skin of scalp and neck

119

563

2.33

14.43

2.7

2.3

31.36

35.78

u/l

0.58

106

474

Anaemia in chronic diseases classified elsewhere

129

629

2.24

14.41

6.1

2.5

112.46

108.81

u/l

0.01

111

537

Tumor necrosis factor alpha inhibitors

636

4623

1.42

14.41

3.1

2.5

40.07

48.01

u/l

0.34

558

3983

Polyp of the female genital tract

1478

6924

1.27

14.40

2.3

33.22

37.77

u/l

1.61

1239

5913

Female infertility

1356

6680

1.28

14.37

2.2

2.3

33.30

36.07

u/l

0.69

1158

5697

Lyme disease

1126

8880

1.30

14.35

2.3

2.5

33.73

43.99

u/l

1.17

959

7591

Benign neoplasm of breast

502

3506

1.48

14.31

2.2

33.21

36.50

u/l

0.56

433

2955

Other diseases of the respiratory system

834

6322

1.35

14.26

2.8

2.4

31.09

45.97

u/l

1.25

712

5364

Other respiratory disorders and diseases

834

6322

1.35

14.26

2.8

2.4

31.09

45.97

u/l

1.25

712

5364

Lactose intolerance

158

828

2.04

14.23

2.6

2.3

38.44

95.82

u/l

0.48

131

695

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

101

449

2.49

14.22

4.9

2.2

44.77

32.89

u/l

0.66

377

Carcinoma in situ of skin of lower limb, including hip

109

503

2.41

14.16

2.3

2.2

29.63

29.14

u/l

0.10

413

Benign neoplasm: Ill-defined sites within the digestive system

136

4.06

14.15

3.1

2.1

34.48

30.04

u/l

0.46

110

Chronic conjunctivitis

154

804

2.06

14.10

2.7

2.2

122.77

38.58

u/l

0.47

138

673

Disorders of oesophagus in diseases classified elsewhere

106

482

2.41

14.08

3.8

2.2

33.42

31.52

u/l

0.23

403

Assault by unspecified means

118

561

2.30

14.05

3.3

2.6

36.42

126.17

u/l

0.55

102

487

Psoriasis vulgaris

841

6403

1.35

14.05

3.2

2.5

35.27

45.13

u/l

0.65

748

5504

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

111

514

2.34

14.03

2.6

2.2

31.56

41.58

u/l

0.98

425

Postmenopausal atrophic vaginitis

1178

5587

1.30

14.02

2.3

2.4

41.10

38.97

u/l

0.22

993

4761

Adenocarcinoma and papillary adenocarcinoma of stomach

141

715

2.12

14.01

5.0

2.4

37.23

33.20

u/l

0.56

130

606

Other congenital malformations

386

2571

1.56

14.00

2.8

2.4

29.14

56.58

u/l

0.85

342

2198

Dissection of aorta

153

802

2.04

13.80

2.6

2.3

56.21

94.68

u/l

0.25

135

667

Amputation of foot

128

633

2.20

13.78

4.5

2.4

26.64

34.70

u/l

1.60

107

543

Contact with and exposure to communicable diseases

867

11206

0.76

13.72

2.4

2.5

31.40

42.39

u/l

1.70

756

9658

Secondary and unspecified malignant neoplasm of lymph nodes

367

2436

1.57

13.69

2.5

2.4

34.89

39.02

u/l

0.65

313

2086

Intracranial and intraspinal abscess and granuloma

280

2.93

13.68

3.5

2.5

218.89

32.99

u/l

0.50

240

Malignant neoplasm of respiratory system and intrathoracic organs

863

6075

1.34

13.66

2.7

2.4

32.94

38.15

u/l

1.80

762

5113

Dysplasia of cervi uteri

1030

6216

1.31

13.62

2.4

2.3

36.88

36.79

u/l

0.01

863

5301

Other menopausal disorders

1263

5797

1.28

13.62

2.3

2.4

37.71

39.06

u/l

0.20

1056

4949

Burns and corrosions

608

4430

1.41

13.60

2.7

2.6

36.54

47.70

u/l

0.49

513

3837

Contusion of other and unspecified parts of foot

236

1413

1.76

13.59

3.1

2.4

28.51

37.83

u/l

3.31

203

1202

Other specified/unspecified hearing loss

371

2472

1.57

13.59

2.6

2.4

33.54

38.12

u/l

0.85

315

2107

Presence of other devices

548

7573

0.71

13.57

2.5

2.3

60.84

43.66

u/l

0.29

450

6420

Carbimazole or st.post thyroidectomy, condition for graves disease

915

7080

1.32

13.56

2.5

2.4

41.52

43.58

u/l

0.09

792

6033

Other puerperal infections

334

2172

1.60

13.56

2.2

39.00

35.63

u/l

0.17

285

1840

Thyrotoxicosis, other and/or unspecified

878

6762

1.33

13.46

2.6

2.4

41.79

44.89

u/l

0.15

764

5782

Other disorders of penis

417

2850

1.52

13.40

3.0

2.8

32.83

57.38

u/l

0.86

356

2503

Bicipital tendinitis

224

1329

1.78

13.38

2.5

2.3

32.28

42.23

u/l

1.57

190

1164

Carcinoma in situ of colon

363

2.66

13.37

2.8

2.4

36.44

33.11

u/l

0.39

310

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

1327

8690

1.26

13.36

2.2

48.81

36.33

u/l

0.98

1134

7293

Benign neoplasm: Rectosigmoid junction

196

1126

1.86

13.31

2.8

2.3

32.61

36.80

u/l

0.73

169

961

Abdominal aortic aneurysm (AAA)

385

2563

1.53

13.30

2.4

35.13

35.41

u/l

0.03

335

2144

Pyoderma gangrenosum

195

3.41

13.29

3.5

2.6

44.98

29.33

u/l

0.77

159

Recurrent dislocation and subluxation of joint

325

2117

1.60

13.13

2.5

31.31

60.79

u/l

0.74

281

1856

Sensorineural hearing loss

2789

22546

0.86

13.13

2.5

40.83

47.23

u/l

0.33

2366

19226

Other/unspecified soft tissue disorders related to use, overuse and pressure

150

797

2.02

13.04

2.4

2.2

34.76

44.57

u/l

0.74

129

688

Later onset COPD

1121

6989

1.29

13.04

2.6

2.3

33.59

49.99

u/l

0.91

934

5923

Blood alcohol or alcohol intoxication level

132

674

2.11

12.95

4.2

2.6

26.93

112.63

u/l

0.65

107

577

Other and unspecified psoriasis

299

1923

1.63

12.94

3.1

2.4

33.79

64.12

u/l

0.66

260

1661

Atopic dermatitis, strict definition

1301

10329

1.26

12.93

2.6

2.5

33.70

40.76

u/l

0.82

1120

8887

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

190

1088

1.85

12.91

9.0

2.2

32.05

32.16

u/l

0.01

147

960

Dependence on enabling machines and devices, not elsewhere classified

305

2.77

12.89

5.2

2.2

44.68

29.19

u/l

0.98

256

Blepharochalasis

1240

10015

1.26

12.88

2.5

2.4

33.90

52.60

u/l

1.41

1046

8483

Rare circulating lymphoid malignancy, excluding all cancers (controls excluding all cancers)

130

659

2.10

12.85

4.4

2.1

31.02

41.99

u/l

0.78

110

533

Vitamin deficiency, wide

223

1337

1.76

12.84

3.5

2.4

31.92

37.64

u/l

0.74

194

1154

Vitamin deficiency

223

1337

1.76

12.84

3.5

2.4

31.92

37.64

u/l

0.74

194

1154

Dislocation, sprain and strain of joints and ligaments of thorax

159

866

1.96

12.81

2.7

2.4

29.43

94.65

u/l

0.62

144

738

Secondary uncertain malignant neoplasm

528

3799

1.43

12.81

2.7

2.4

33.48

50.50

u/l

0.74

456

3243

Other and unspecified medical devices associated with adverse incidents

142

3.96

12.80

3.4

2.6

29.14

29.56

u/l

0.03

114

Arthropathy in ulcerative colitis

338

2.65

12.76

2.4

2.3

56.48

33.88

u/l

1.16

285

Hypothyroidism, strict autoimmune, 3 medication purchases required

4142

25076

1.14

12.75

2.4

35.83

45.28

u/l

1.79

3454

21502

Keratitis

1559

12901

1.23

12.68

2.9

2.5

43.12

43.36

u/l

0.01

1311

11089

Ill-defined and unknown causes of mortality

1812

0.44

12.67

2.2

2.4

34.15

38.83

u/l

0.43

1526

Malignant neoplasm of tongue, excluding all cancers (controls excluding all cancers)

122

610

2.15

12.64

3.0

2.1

41.48

43.29

u/l

0.06

104

502

Car occupant injured in noncollision transport accident

184

1052

1.86

12.64

3.3

2.4

29.28

81.48

u/l

0.61

161

906

Bacterial, viral and other infectious agents

395

2705

1.52

12.63

3.4

2.7

46.06

56.65

u/l

0.22

340

2367

Multiple myeloma, excluding all cancers (controls excluding all cancers)

180

1019

1.86

12.63

2.7

2.2

47.11

38.39

u/l

0.39

150

837

L04AC Interleukin inhibitors

235

1437

1.72

12.59

3.2

2.5

39.15

72.53

u/l

0.51

206

1248

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

347

2320

1.56

12.58

3.4

2.3

34.25

59.04

u/l

0.63

300

1980

Disorders of calcium metabolism

263

1652

1.67

12.55

3.8

2.4

37.17

69.20

u/l

0.57

228

1418

Drug-induced acute pancreatitis

7.89

12.51

6.5

2.3

93.74

28.61

u/l

2.54

Arthropathies in other diseases classified elsewhere

178

1012

1.87

12.48

6.8

2.4

33.15

87.37

u/l

0.61

142

868

Benign neoplasm: Other and unspecified parts of mouth

150

808

1.97

12.46

2.4

2.1

36.34

40.56

u/l

0.23

128

671

Panniculitis affecting regions of neck and back

181

1033

1.85

12.43

3.3

2.2

37.13

84.52

u/l

0.53

160

908

Other disorders of gingiva or/and edentulous alveolar ridge

219

1317

1.75

12.42

4.0

2.2

39.12

41.24

u/l

0.13

190

1152

Other encephalitis

136

712

2.05

12.42

2.3

2.4

39.75

36.45

u/l

0.11

122

598

Benign neoplasm: Tongue

143

763

2.02

12.41

2.6

2.4

32.70

40.35

u/l

0.63

120

644

Other follicular disorders

319

2100

1.58

12.39

3.1

2.4

38.93

61.45

u/l

0.48

273

1807

Benign neoplasm: Kidney

165

921

1.92

12.37

2.6

2.3

55.07

37.73

u/l

0.61

149

781

Injury of eye and orbit

609

4505

1.39

12.37

3.3

2.5

39.12

49.27

u/l

0.44

527

3909

Respiratory insufficiency

298

1923

1.60

12.35

2.6

2.3

30.63

65.22

u/l

0.77

251

1620

Adhesive capsulitis of shoulder

728

5541

1.35

12.22

2.8

2.4

33.75

40.19

u/l

2.13

609

4758

Plantar fascial fibromatosis

423

2952

1.48

12.21

2.7

2.2

52.71

41.66

u/l

0.34

357

2524

Other or ill-defined heart diseases

228

1389

1.71

12.21

3.0

2.5

35.00

74.07

u/l

0.60

202

1205

Osteoporosis with pathological fracture (FG)

299

1951

1.61

12.19

2.9

2.2

34.78

40.90

u/l

1.01

265

1659

Contact with heat and hot substances

245

1525

1.69

12.19

2.6

2.5

33.93

70.45

u/l

0.61

207

1309

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

366

2484

1.53

12.19

2.4

2.5

31.23

57.93

u/l

0.79

313

2162

Procedures for purposes other than remedying health state

131

682

2.07

12.18

2.4

2.1

32.38

36.88

u/l

0.56

115

581

221

3.08

12.17

3.9

2.2

33.00

33.51

u/l

0.04

188

Melanocytic naevi of other and unspecified parts of face

249

1555

1.67

12.15

2.4

2.2

33.55

68.00

u/l

0.57

207

1309

Otitis externa, unspecified

469

3340

1.45

12.12

2.7

2.4

31.45

51.14

u/l

0.77

394

2881

Exclusions for E4_PCOS_BROAD

736

5616

1.34

12.10

3.0

2.5

34.68

45.51

u/l

0.64

628

4815

Malignant melanoma of skin

475

3395

1.45

12.07

3.1

2.4

34.20

39.47

u/l

0.86

421

2892

Other disorders starting during childhood or adolescence

219

1313

1.72

12.06

2.3

2.4

26.31

69.66

u/l

0.61

186

1094

Dipeptidyl peptidase 4 (DPP-4) inhibitors

501

3615

1.43

12.05

3.0

2.4

34.04

53.81

u/l

0.82

406

3133

Psoriatic and enteropathic arthropathies

534

3893

1.41

12.01

2.8

2.5

39.64

50.84

u/l

0.42

468

3350

Cauda equina syndrome

342

2.59

11.99

3.2

2.4

30.53

30.79

u/l

0.03

287

Acute appendicitis, with complications

877

6860

1.31

11.98

2.6

33.68

47.85

u/l

1.16

764

5886

Other neurotic disorders

229

1408

1.71

11.98

3.4

2.4

31.87

41.56

u/l

1.44

194

1212

Thyrotoxicosis with toxic multinodular goitre

269

1722

1.64

11.97

2.2

2.3

31.39

37.31

u/l

1.32

227

1463

Foreign body entering into or through eye or natural orifice

358

2432

1.53

11.96

2.3

2.6

43.79

57.90

u/l

0.28

305

2109

Caught, crushed, jammed or pinched in or between objects

228

1402

1.71

11.95

2.7

2.6

32.49

74.33

u/l

0.67

202

1217

Hallux rigidus

615

4588

1.38

11.92

2.2

2.4

39.50

49.34

u/l

0.42

518

3912

Lactose intolerance, other/unspecified

137

728

2.01

11.92

2.7

2.3

39.87

101.91

u/l

0.45

114

611

Other/unspecified reactive arthropathies

301

1976

1.59

11.91

2.7

2.4

33.07

62.91

u/l

0.67

257

1706

Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)

1100

5252

1.28

11.89

2.3

2.4

35.37

43.74

u/l

1.20

921

4463

Asthma and opportunity respiratory infection

214

1300

1.74

11.85

2.4

2.2

28.13

38.45

u/l

3.83

182

1117

Sequelae of intentional self-harm, assault and events of undetermined intent

152

3.50

11.79

4.7

2.5

35.14

32.23

u/l

0.24

128

Spondylolisthesis/Spondylolysis

774

5972

1.33

11.76

2.6

2.4

33.44

51.32

u/l

1.38

652

5149

Acute myeloid leukaemia and myelodysplastic syndromes, excluding all cancers (controls excluding all cancers)

139

743

1.97

11.74

2.4

2.1

43.61

32.00

u/l

0.49

119

604

Dental caries 3 and operation codes, only avohilmo

1564

6490

1.23

11.72

2.5

2.6

35.85

42.70

u/l

0.64

1318

5639

Spirochaetal infections, other/unspecified

370

2545

1.51

11.71

2.0

2.5

32.69

57.21

u/l

0.72

314

2184

Assault by other specified means

248

2.87

11.71

3.0

2.4

34.51

28.50

u/l

1.27

211

Ehlers-Danlos syndrome

248

2.87

11.69

3.3

2.5

31.02

32.70

u/l

0.11

206

Other/unspecified synovitis and tenosynovitis

501

3628

1.42

11.69

2.7

2.3

34.19

40.54

u/l

1.43

418

3105

Other/unspecified enthesopathies, not elsewhere classified

379

2613

1.50

11.69

2.9

2.3

36.43

40.95

u/l

0.42

324

2254

Vasomotor and allergic rhinitis

1703

14099

1.21

11.68

2.3

2.5

36.97

40.43

u/l

0.56

1444

12139

Recurring oral aphthae

219

1345

1.72

11.61

3.0

2.3

31.21

73.65

u/l

0.63

188

1136

Specific development disorders of speech and language

248

1504

1.65

11.57

2.4

2.3

27.11

65.15

u/l

0.62

221

1252

Pain associated with micturition

487

3522

1.43

11.51

2.9

2.3

35.70

52.76

u/l

0.65

424

2993

Other and unspecified disorders of white blood cells

190

1128

1.78

11.48

2.9

2.4

33.59

82.22

u/l

0.59

169

949

Senility

151

3.28

11.47

2.7

1.9

34.45

31.18

u/l

0.41

121

Hyperaldosteronism

142

777

1.97

11.46

2.7

2.6

31.53

41.93

u/l

1.00

120

669

Hypotension due to drugs

323

2.57

11.45

2.7

2.5

25.15

32.70

u/l

1.83

266

Thyroiditis, ILD-related definition

505

3678

1.42

11.44

2.7

2.2

32.62

50.14

u/l

0.72

428

3109

Benign neoplasm: Oesophagus

262

2.76

11.41

2.6

2.0

33.96

34.41

u/l

0.03

213

Sequelae of injuries of head

235

1473

1.67

11.39

3.1

2.5

34.78

41.94

u/l

0.75

202

1274

Chronic diseases of tonsils and adenoids

3917

22081

1.13

11.33

2.6

2.5

50.32

46.16

u/l

0.12

3378

18997

Diffuse large B-cell lymphoma

204

1240

1.74

11.32

2.2

2.4

33.76

38.90

u/l

0.53

178

1052

Other and unspecified types of non-Hodgkin lymphoma, hilmo

190

1133

1.78

11.30

2.7

2.3

36.11

34.84

u/l

0.14

166

963

Dislocation, sprain and strain of joint and ligaments of hip

169

976

1.84

11.29

2.4

2.3

60.37

33.67

u/l

0.48

136

828

Olecranon bursitis

265

1713

1.61

11.23

3.0

2.5

68.46

41.47

u/l

0.35

218

1493

Single delivery by forceps and vacuum extractor

413

3545

0.69

11.23

2.1

2.6

44.33

38.38

u/l

0.23

361

3010

Malignant neoplasm of head and neck

343

2343

1.52

11.19

2.8

2.5

42.95

38.84

u/l

0.28

291

2003

Endometriosis of pelvic peritoneum

667

5007

1.34

11.17

2.4

55.64

36.34

u/l

0.65

569

4288

Somnolence

333

2.52

11.17

3.3

2.4

29.76

32.89

u/l

0.30

277

Other noninfective disorders of lymphatic vessels and lymph nodes

167

964

1.84

11.16

2.7

2.3

34.12

45.31

u/l

0.87

144

825

Other and unspecified injuries of lower leg

319

2150

1.54

11.09

2.8

2.3

29.44

58.76

u/l

0.73

271

1849

Malignant neoplasm of other and ill-defined sites, excluding all cancers (controls excluding all cancers)

333

2.48

11.03

3.5

2.0

43.72

29.88

u/l

0.63

268

Burns and corrosions of external body surface, specified by site

464

3356

1.43

10.99

2.4

2.5

33.37

52.30

u/l

0.74

391

2903

Other disorders of the genitourinary system

556

4145

1.38

10.98

2.7

2.3

32.80

38.63

u/l

1.85

483

3502

Drug-induced polyneuropathy

234

2.92

10.98

3.4

2.2

27.71

28.45

u/l

0.09

196

Vasculitis limited to skin, not elsewhere classified

126

672

2.01

10.97

2.4

2.3

44.64

35.33

u/l

0.46

114

570

Atrophic disorders of skin

630

4781

1.36

10.96

2.4

2.3

30.92

48.58

u/l

1.08

532

4077

Scoliosis

355

2451

1.49

10.86

2.3

2.1

35.94

58.60

u/l

0.59

303

2086

Wide developmental disorders, excluding more controls

110

550

2.07

10.85

2.0

2.5

25.41

35.14

u/l

3.52

472

Coxarthrosis

2297

13454

1.17

10.78

2.6

2.5

74.95

46.83

u/l

0.42

1938

11501

Superficial injury of shoulder and upper arm

477

3478

1.41

10.76

2.6

2.5

31.86

52.51

u/l

0.87

413

2998

Nasal polyp

817

6425

1.30

10.75

2.5

2.6

36.45

39.22

u/l

0.40

692

5530

Benign neoplasm of urinary organs

211

1310

1.70

10.74

2.6

2.3

49.90

36.82

u/l

0.58

189

1110

Other ill-defined and unspecified causes of mortality

1594

0.45

10.74

2.2

2.4

34.57

38.80

u/l

0.35

1342

Assault by sharp object

456

2.24

10.73

4.5

2.7

32.42

148.00

u/l

0.59

402

Injuries involving multiple body regions

176

1043

1.78

10.70

3.2

2.4

38.64

82.63

u/l

0.47

146

889

LSIL lesion of the cervix uteri, vagina or vulva

587

4423

1.36

10.67

2.3

42.11

35.43

u/l

0.45

504

3761

Benign neoplasm of ovary

760

5937

1.31

10.66

2.5

2.3

33.06

36.90

u/l

1.51

652

5020

Other obstructive and reflux uropathy

192

1163

1.73

10.65

2.9

2.3

34.50

38.04

u/l

0.32

169

974

Conductive and sensorineural hearing loss

3032

23762

0.87

10.63

2.5

40.78

47.21

u/l

0.37

2574

20276

Postpartum care and examination

308

2895

0.66

10.63

2.7

2.4

34.09

36.98

u/l

0.38

281

2459

Superficial injuries involving multiple body regions

130

707

1.96

10.62

3.3

2.5

41.03

100.81

u/l

0.42

111

602

Panniculitis, unspecified

254

2.73

10.60

3.8

2.0

30.15

32.16

u/l

0.25

222

Carcinoma in situ of skin of upper limb, including shoulder

110

569

2.10

10.59

3.1

2.3

32.25

35.28

u/l

0.30

477

Multiple myeloma and malignant plasma cell neoplasms

172

1013

1.78

10.58

2.8

2.2

47.65

38.46

u/l

0.39

142

832

Pregnancy with abortive outcome

3131

14426

1.15

10.57

2.3

33.99

39.52

u/l

1.78

2668

12227

Nail disorders

366

2562

1.48

10.54

3.6

2.5

32.95

57.12

u/l

0.72

313

2217

Benign neoplasm: Ill-defined sites within the digestive system

164

3.32

10.54

3.1

2.5

34.48

28.50

u/l

0.70

137

Disorder of the sleep-wake schedule

481

2.19

10.47

2.5

2.3

24.49

34.89

u/l

2.79

405

Congenital malformations of the musculoskeletal system, not elsewhere classified

368

2.38

10.46

2.9

2.5

32.74

32.49

u/l

0.02

310

Benign neoplasm: Appendix

288

2.63

10.45

2.8

2.3

32.05

32.28

u/l

0.02

238

Deficiency of other B group vitamins

101

507

2.14

10.44

3.2

2.3

34.68

32.71

u/l

0.16

424

Unspecified visual impairment (binocular)

382

2.36

10.44

2.9

2.2

29.77

30.26

u/l

0.03

317

Essential (haemorrhagic) thrombocythaemia

153

877

1.84

10.43

2.2

2.1

32.47

36.11

u/l

0.58

134

732

Hyperkinetic disorders (excl. ADHD)

456

2.20

10.38

2.6

26.54

141.17

u/l

0.57

393

Urethritis and urethral syndrome

108

556

2.08

10.38

3.6

2.4

30.29

46.65

u/l

1.16

466

Hypertrophic cardiomyopathy

187

1140

1.74

10.30

2.9

2.4

35.27

37.91

u/l

0.21

161

978

Malignant neoplasm of bronchus and lung

719

5226

1.31

10.29

2.8

2.3

33.17

37.97

u/l

1.35

636

4393

Diseases of tongue

263

1732

1.58

10.27

2.7

2.3

31.84

40.34

u/l

1.69

218

1501

Other and unspecified injuries of wrist and hand

171

1017

1.77

10.24

3.0

2.2

30.31

82.25

u/l

0.55

153

845

Focal epilepsy

882

7039

1.28

10.23

2.6

2.5

36.53

44.17

u/l

0.53

754

6013

Other and unspecified disorders of adult personality and behaviour

144

3.37

10.18

2.9

2.3

25.89

35.59

u/l

0.76

118

Squamous cell neoplasms and carcinomas of the skin

471

3461

1.40

10.13

2.5

2.4

33.09

38.75

u/l

1.37

400

2919

Early complications of trauma

191

1174

1.71

10.13

3.3

2.5

29.81

78.78

u/l

0.65

164

1013

!Aliquae complicationes praecoces traumatis

191

1174

1.71

10.13

3.3

2.5

29.81

78.78

u/l

0.65

164

1013

Disorders of optic nerve and visual pathways

409

2942

1.44

10.10

3.5

2.4

32.65

54.83

u/l

0.76

346

2532

Other/unspecified disorders of vestibular function

177

1070

1.75

10.06

2.3

2.2

30.44

37.35

u/l

1.43

156

908

Alzheimer’s disease, wide definition, excluding more controls

625

3231

1.34

10.02

2.0

2.3

33.27

40.46

u/l

1.88

505

2783

Other and unspecified haemorrhagic conditions

408

2.27

10.02

3.0

2.3

30.04

31.98

u/l

0.38

339

Injury of other and unspecified intrathoracic organs

272

1816

1.56

10.01

3.3

2.5

41.80

66.15

u/l

0.41

230

1566

Cardiomyopathy in other diseases

114

3.72

10.00

2.1

2.3

647.79

30.48

u/l

0.48

Vascular dementia (subcortical)

125

684

1.94

9.98

2.7

2.3

29.14

34.04

u/l

0.76

106

576

Abnormal findings on examination of urine, without diagnosis

197

1225

1.69

9.98

3.5

2.4

80.33

78.09

u/l

0.01

176

1054

Mouth breathing

1782

15244

1.18

9.96

2.6

49.99

47.57

u/l

0.07

1491

13126

Generalized epilepsy

199

1240

1.68

9.95

2.7

2.4

34.23

77.64

u/l

0.57

180

1047

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

1247

10354

1.22

9.93

2.7

2.6

36.70

44.58

u/l

0.84

1058

8949

Encephalitis

137

774

1.88

9.92

2.3

2.4

39.61

36.00

u/l

0.12

123

657

Hypoplasia of dental enamel, including avohilmo

179

3.01

9.91

3.7

2.5

42.91

29.58

u/l

0.49

153

Seborrhoeic keratosis

916

7378

1.27

9.91

2.7

2.4

33.15

38.93

u/l

2.85

785

6277

Coronary artery bypass grafting

1142

7134

1.24

9.90

2.4

2.5

36.65

41.43

u/l

0.87

953

6138

Temporal arteritis

166

992

1.78

9.90

2.4

2.3

29.33

36.01

u/l

1.56

139

825

Perineal laceration during delivery

385

4767

0.71

9.89

2.0

2.3

43.30

36.04

u/l

0.27

337

4050

Social disorders starting during childhood or adolecense, excluding more controls

134

3.28

9.84

2.9

2.3

29.00

32.51

u/l

0.37

116

Medial epicondylitis

178

1083

1.73

9.82

2.8

2.3

54.03

45.02

u/l

0.19

151

951

Trigeminal neuralgia

264

1762

1.56

9.78

2.9

2.3

37.87

37.77

u/l

0.01

223

1503

Conduct disorder

106

554

2.03

9.74

3.1

2.3

25.24

37.79

u/l

2.54

468

Myositis

120

655

1.95

9.70

2.4

2.2

65.74

42.25

u/l

0.40

100

566

Other hammer toe(s) (acquired)

750

5543

1.30

9.70

2.5

2.4

35.40

38.55

u/l

0.46

639

4713

Benign neoplasm: Anus and anal canal

134

758

1.88

9.70

2.4

2.3

35.20

36.87

u/l

0.12

111

645

Diabetes mellitus in pregnancy

1352

7308

1.22

9.68

2.6

2.3

32.33

37.28

u/l

1.03

1152

6259

Menorrhagia

1597

7460

1.20

9.64

2.6

2.3

33.68

37.78

u/l

1.32

1322

6362

Carcinoma in situ of other and unspecified sites

126

698

1.90

9.63

2.6

2.1

31.54

39.58

u/l

0.60

110

575

Melanocytic naevi of lower limb, including hip

179

1096

1.71

9.60

2.8

2.1

34.66

38.96

u/l

0.42

159

915

Orchitis and epididymitis

372

2653

1.44

9.60

2.8

2.6

47.43

58.79

u/l

0.25

319

2317

Single spontaneous delivery

1489

9383

0.83

9.58

2.2

2.4

37.05

36.84

u/l

0.03

1274

7907

Anankastic personality disorder

177

1083

1.72

9.57

2.9

2.4

38.47

85.17

u/l

0.53

152

929

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

180

1107

1.71

9.57

2.9

2.4

33.53

38.39

u/l

0.45

150

943

Isolated proteinuria

140

807

1.85

9.53

3.5

2.4

96.98

92.67

u/l

0.02

126

694

Tic and related disorders

240

2.60

9.52

2.1

2.0

185.15

36.20

u/l

0.45

201

Arthropathy in Crohn disease

268

2.58

9.51

3.0

2.4

33.68

29.68

u/l

0.59

219

Viral encephalitis, not elsewhere classified/unspecified

101

526

2.07

9.51

2.8

2.4

29.99

32.35

u/l

0.28

453

Persistent delusional disorders

327

2287

1.48

9.51

2.9

2.4

28.24

60.79

u/l

0.94

293

1987

Marginal zone B-cell lymphoma, excluding all cancers (controls excluding all cancers)

350

2.33

9.48

2.2

2.1

29.36

45.88

u/l

0.68

289

Drug-induced osteoporosis with pathological fracture

392

2.27

9.44

4.0

2.3

35.99

30.79

u/l

0.47

319

Fall involving bed

132

749

1.87

9.44

3.0

2.3

24.96

35.25

u/l

2.50

113

632

Benign leiomyoma with endometriosis

608

4687

1.33

9.43

2.2

2.1

44.13

36.16

u/l

0.41

515

3923

Lymphoid leukaemia

237

1560

1.59

9.40

3.3

2.4

31.09

39.00

u/l

1.44

213

1309

Giant cell arteritis

183

1137

1.70

9.40

2.4

2.3

29.12

37.42

u/l

2.36

153

957

Post-traumatic wound infection, not elsewhere classified

125

700

1.91

9.39

3.8

2.5

29.81

39.89

u/l

0.86

108

594

Osteonecrosis due to drugs

335

2.40

9.36

2.4

2.5

28.30

32.16

u/l

0.62

282

Other disorders of adrenal gland

196

1239

1.66

9.30

3.5

2.3

36.00

79.53

u/l

0.57

170

1044

Autonomic disorders

108

580

2.00

9.27

2.7

2.3

30.08

39.90

u/l

0.61

491

Postzoster neuralgia

388

2.26

9.27

2.6

2.5

28.43

30.41

u/l

0.36

324

Parodontitis, under 40 years

382

2753

1.42

9.23

3.9

2.5

38.86

52.87

u/l

0.36

338

2361

Malignant neoplasm of larynx, excluding all cancers (controls excluding all cancers)

405

2.18

9.22

2.3

2.2

56.79

44.64

u/l

0.21

327

Alzheimer’s disease (Late onset), excluding more controls

579

2941

1.34

9.21

2.1

2.3

33.67

39.38

u/l

1.40

469

2529

Wet age-related macular degeneration

654

5016

1.31

9.15

2.3

33.14

36.75

u/l

0.87

537

4257

FESS (DNB20)

289

4140

0.68

9.12

2.5

35.08

49.20

u/l

0.63

242

3582

Giant cell arteritis with polymyalgia rheumatica

166

1015

1.73

9.12

2.4

2.3

29.33

36.37

u/l

1.74

139

848

Monoplegia

383

2.25

9.12

3.0

2.2

33.35

34.95

u/l

0.12

327

Coronary revascularization (ANGIO or CABG)

2000

12095

1.17

9.10

2.6

2.5

37.10

48.35

u/l

1.40

1683

10388

Parodontitis, under 40 years, or operation codes

382

2761

1.42

9.08

3.9

2.5

38.86

52.81

u/l

0.36

338

2366

Type 1 diabetes, wide definition

958

7817

1.24

9.02

5.8

2.4

27.36

46.71

u/l

2.48

719

6828

Other congenital malformations of circulatory system

123

695

1.89

9.00

2.2

2.4

32.34

41.61

u/l

0.68

106

595

Myelodysplastic syndrome, excluding all cancers (controls excluding all cancers)

105

561

1.97

9.00

2.4

2.1

47.99

30.69

u/l

0.58

446

Infarction of spleen

150

3.21

8.99

6.5

2.6

36.03

34.12

u/l

0.08

121

Antenatal screening

989

4526

1.25

8.99

2.2

2.4

36.23

37.45

u/l

0.18

865

3852

Abnormal findings in secretions and smears from cervix uteri vagina vulva

2111

14461

1.16

8.98

2.4

2.3

34.24

37.94

u/l

0.97

1812

12311

Degeneration of the brain due to alcohol

108

587

1.98

8.98

4.7

2.5

31.51

43.77

u/l

0.86

515

Other and unspecified vasculitis limited to skin

111

608

1.95

8.98

2.5

2.3

47.41

33.88

u/l

0.65

100

513

Malignant neoplasm of hypopharynx, excluding all cancers (controls excluding all cancers)

126

3.29

8.97

3.0

1.9

33.74

72.94

u/l

0.53

102

Polymyalgia rheumatica

517

3930

1.35

8.97

2.6

2.3

35.33

38.51

u/l

0.65

445

3314

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

213

2.73

8.96

2.8

2.0

30.39

31.15

u/l

0.06

173

Shock, not elsewhere classified

200

2.75

8.96

3.2

1.9

29.18

30.65

u/l

0.13

168

Trigger finger

589

4556

1.32

8.94

2.8

2.3

37.67

39.81

u/l

0.20

488

3903

Retinal detachment with retinal break

525

4002

1.35

8.94

2.9

2.4

34.94

51.38

u/l

0.76

444

3450

Complications predominantly related to the puerperium

1084

8978

1.23

8.93

2.3

33.99

36.51

u/l

0.44

917

7642

SLE (Finngen)

159

965

1.73

8.91

2.8

2.2

39.83

40.65

u/l

0.05

137

813

Focal brain injury

264

1792

1.52

8.89

2.7

2.5

37.10

41.62

u/l

0.26

221

1571

Benign neoplasm of meninges

425

3148

1.39

8.87

2.4

2.3

30.06

37.23

u/l

4.14

366

2679

Hypertrophy of breast in women and men

818

6590

1.27

8.86

2.4

2.3

33.02

37.74

u/l

0.94

701

5587

Synovial cyst of popliteal space [Baker]

306

2144

1.48

8.83

2.5

2.2

42.49

41.12

u/l

0.05

258

1822

Pyogenic arthritis

274

1879

1.51

8.82

3.1

2.5

283.89

64.24

u/l

0.41

237

1610

Other renal tubulo-interstitial diseases

108

588

1.95

8.82

2.6

2.3

31.07

34.11

u/l

0.43

490

Other specified/unspecified soft tissue disorders

210

1364

1.60

8.81

3.1

2.1

33.17

39.42

u/l

0.93

174

1169

Generalized epilepsy, strict definition

113

625

1.92

8.81

2.7

2.5

27.40

37.92

u/l

1.85

101

522

Molar incisor enamel hypoplasia, with caries

155

3.02

8.78

3.5

2.2

45.22

29.98

u/l

0.46

131

Disorders of continuity of bone

405

2981

1.40

8.76

3.9

2.4

38.36

54.95

u/l

0.51

324

2577

Bursitis of shoulder

117

656

1.89

8.73

2.7

2.1

40.61

46.21

u/l

0.18

574

Renal tubulo-interstitial disorders in diseases classified elsewhere

247

2.57

8.72

4.6

2.5

35.88

33.38

u/l

0.22

209

Contusion of toe(s) without damage to nail

113

627

1.91

8.71

3.0

2.2

35.40

35.03

u/l

0.02

530

Benign neoplasm of eye and adnexa

359

2591

1.43

8.70

2.6

2.2

76.03

54.45

u/l

0.21

305

2185

Familial hypercholesterolemia

597

4643

1.31

8.68

3.1

2.4

37.75

64.36

u/l

0.83

494

3975

Degeneration of nervous system due to alcohol

108

594

1.95

8.67

4.7

2.4

31.51

43.41

u/l

0.82

515

Left bundle-branch block

279

1928

1.50

8.65

2.4

2.3

37.45

39.19

u/l

0.16

230

1658

Focal epilepsy, strict definition

796

6409

1.27

8.65

2.6

2.5

35.78

44.10

u/l

0.54

675

5485

Other keratitis

469

3537

1.36

8.62

2.9

2.5

64.49

52.05

u/l

0.15

379

3069

Sarcoidosis

568

4400

1.32

8.61

2.6

2.5

40.03

48.74

u/l

0.35

477

3792

Congenital malformations of the circulatory system

586

4410

1.32

8.60

2.5

35.80

47.58

u/l

0.53

512

3794

Melanoma in situ

149

897

1.74

8.59

2.3

2.1

30.67

36.02

u/l

1.11

127

737

Ganglion

882

7188

1.25

8.54

2.4

33.60

41.13

u/l

1.45

728

6163

Macular cyst

121

693

1.87

8.53

3.0

2.4

31.32

37.01

u/l

0.89

102

589

Achilles tendinitis

431

3215

1.38

8.52

2.7

2.3

33.32

53.92

u/l

0.78

370

2793

L02BA Anti-estrogens

693

5509

1.29

8.52

2.2

2.3

52.67

37.37

u/l

0.60

601

4658

Viral conjunctivitis

105

576

1.95

8.47

2.9

2.4

32.11

33.50

u/l

0.17

493

Contusion of ankle

170

1063

1.67

8.45

2.7

2.4

31.71

35.23

u/l

0.53

138

913

Injury of nerves at wrist and hand level

165

1025

1.69

8.44

2.8

2.4

45.59

80.10

u/l

0.34

145

886

Benign neoplasm: Skin of eyelid, including canthus

634

4995

1.30

8.42

2.3

2.4

37.38

46.72

u/l

0.46

506

4249

Malignant cancer of tonsil and base of tongue, excluding all cancers (controls excluding all cancers)

101

548

1.96

8.38

3.5

2.4

43.62

43.74

u/l

0.00

459

Car occupant injured in other and unspecified transport accidents

793

6407

1.26

8.38

3.0

2.5

119.43

45.36

u/l

0.41

696

5514

Bronchiectasis

320

2285

1.45

8.36

2.4

29.49

40.86

u/l

4.19

270

1944

Ingrowing nail

235

1584

1.54

8.36

3.7

2.5

32.53

69.57

u/l

0.66

201

1358

Peroneal tendinitis

403

2.14

8.32

2.6

2.1

31.67

154.53

u/l

0.54

352

Benign neoplasm: Cerebral meninges

386

2848

1.40

8.31

2.5

2.3

30.32

37.22

u/l

3.42

335

2426

Benign mammary dysplasia

612

4811

1.30

8.31

2.4

2.3

41.35

37.54

u/l

0.36

527

4044

Astigmatism

258

1771

1.51

8.30

2.6

2.4

33.63

65.78

u/l

0.62

230

1507

Glaucoma suspect

1090

13011

0.83

8.30

2.7

2.4

42.64

48.06

u/l

0.33

904

11083

Pure hyperglyceridaemia

101

551

1.95

8.26

3.1

2.6

40.95

32.94

u/l

0.34

474

Lesion of ulnar nerve

594

4653

1.31

8.26

3.1

2.6

42.40

38.55

u/l

0.17

488

4035

Palmar fascial fibromatosis [Dupuytren]

596

4664

1.30

8.26

2.8

2.4

32.09

41.74

u/l

3.60

503

3977

malignant neoplasm of female genital organs

622

4905

1.30

8.25

2.2

2.3

33.00

37.70

u/l

1.40

531

4152

Disorders of speech understanding and production

170

1048

1.66

8.24

2.3

27.67

32.01

u/l

1.49

152

874

Motor disorders, excluding more controls

256

2.37

8.21

2.1

2.7

22.98

37.80

u/l

3.51

213

Carcinoma in situ, bladder

116

660

1.85

8.20

2.6

2.2

32.17

33.03

u/l

0.11

103

541

Nonhereditary hypogammaglobulinemia

287

2.39

8.16

2.6

2.4

31.46

29.02

u/l

0.21

242

ILD-related respiratory insufficiency

137

821

1.77

8.15

3.0

2.4

37.73

33.99

u/l

0.62

125

684

Benign neoplasm of middle ear and respiratory system

327

2354

1.43

8.15

2.5

33.99

59.26

u/l

0.67

267

2026

Malignant neoplasm of other and unspecified parts of tongue, excluding all cancers (controls excluding all cancers)

482

2.01

8.14

2.7

2.1

41.63

35.94

u/l

0.24

396

Acute laryngitis and tracheitis

485

3642

1.34

8.09

2.7

2.4

42.10

38.12

u/l

0.23

427

3132

Evidence of alcohol involvement determined by blood alcohol level

415

2.11

8.09

3.3

2.6

27.20

147.73

u/l

0.54

356

Hypertrophy of breast

710

5695

1.27

8.07

2.3

33.63

36.66

u/l

0.44

606

4804

Other symptoms and signs involving the circulatory and respiratory systems

249

1706

1.51

8.06

3.2

2.2

32.67

70.37

u/l

0.75

219

1463

Other specified disorders of kidney and ureter

147

900

1.72

8.05

2.6

2.4

38.11

95.76

u/l

0.55

132

765

Gluteal tendinitis

158

984

1.68

8.03

2.5

2.1

27.43

44.27

u/l

2.60

129

865

Pneumonia derived septicemia

147

900

1.72

8.01

3.3

2.3

33.03

87.13

u/l

0.50

120

761

All dysplastic lesions of the cervix uteri, vagina or vulva

1170

9798

1.20

8.00

2.4

2.3

37.76

36.55

u/l

0.12

985

8371

Malignant neoplasm of breast, ER-negative, excluding all cancers (controls excluding all cancers)

881

6945

1.24

7.99

2.1

2.2

36.53

36.02

u/l

0.05

739

5812

Mental retardation, excluding more controls

143

851

1.72

7.98

2.3

2.4

26.60

42.82

u/l

2.22

115

725

Other disorders of patella

760

6146

1.26

7.98

2.5

36.03

48.81

u/l

0.84

654

5300

LSIL lesion of the cervix uteri

453

3438

1.35

7.98

2.3

2.2

41.51

34.96

u/l

0.35

388

2922

Dementia in other diseases classified elsewhere

184

1190

1.61

7.97

2.7

2.4

38.33

36.71

u/l

0.11

147

1010

Lichen simplex chronicus and prurigo

268

1872

1.48

7.96

3.2

2.2

31.39

65.36

u/l

0.74

231

1617

Defect, injury or illness of neck

131

3.15

7.92

3.4

2.7

29.71

27.32

u/l

0.34

108

Sub-endpoint used in defining T1D endpoints

1266

10569

1.19

7.91

5.6

2.4

44.39

43.56

u/l

0.03

968

9117

Chronic lymphocytic leukaemia

125

738

1.80

7.89

2.1

2.4

34.19

32.80

u/l

0.23

115

617

Disorders of ocular muscles, binocular movement, accommodation and refraction

2038

17777

1.15

7.88

2.5

34.79

41.06

u/l

1.15

1712

15286

Benign neoplasm: Parotid gland

322

2328

1.43

7.86

2.6

2.4

37.12

59.19

u/l

0.55

279

2010

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

132

791

1.76

7.84

2.4

31.16

101.96

u/l

0.62

105

680

Benign neoplasm: Oesophagus

312

2.28

7.80

2.6

2.4

33.96

31.37

u/l

0.30

264

Benign neoplasm of major salivary glands

397

2971

1.37

7.78

2.6

2.4

36.40

53.86

u/l

0.55

342

2555

Haemangioma, any site

308

2212

1.43

7.75

2.9

2.2

36.44

60.62

u/l

0.56

272

1855

Sulfasalazine

1233

10470

1.19

7.74

2.5

2.4

63.61

45.35

u/l

0.29

1068

8933

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

255

1770

1.48

7.67

2.4

33.44

38.76

u/l

0.76

224

1493

Gout due to impairment of renal function

262

2.41

7.67

4.7

2.5

44.85

36.49

u/l

0.70

222

Malignant neoplasm of oral cavity

149

928

1.69

7.67

2.9

2.4

40.50

39.27

u/l

0.05

126

791

Other disorders of prostate

141

863

1.71

7.66

2.4

2.6

49.78

47.39

u/l

0.06

114

747

Allergic rhinitis

1309

11068

1.19

7.66

2.2

2.5

37.30

42.32

u/l

0.47

1119

9531

Frontotemporal dementia

146

3.03

7.65

2.5

35.15

37.32

u/l

0.10

117

Abscess of lung

375

2.13

7.63

3.5

2.5

29.03

34.23

u/l

0.72

320

Hyperhidrosis

121

711

1.78

7.63

2.1

1.9

74.15

37.10

u/l

0.44

105

587

Hidradenitis suppurativa

159

1005

1.66

7.63

3.2

2.4

39.21

89.88

u/l

0.54

141

860

Myocardial infarction, with ST-elevation

668

5354

1.27

7.62

2.7

2.4

41.51

46.52

u/l

0.22

585

4562

Acquired absence of organs, not elsewhere classified

308

2.27

7.61

3.6

2.0

29.12

30.02

u/l

0.12

257

Ectopic pregnancy

718

5805

1.26

7.61

2.5

2.3

32.30

37.37

u/l

1.69

615

4937

443

2.00

7.58

2.8

2.2

27.47

29.68

u/l

0.61

362

Generalized epilepsy, mode (most common among epilepsy diagnosis)

144

890

1.70

7.57

2.6

2.4

34.32

41.30

u/l

0.47

133

748

Burns classified according to extent of body surface involved

250

2.43

7.57

3.8

2.5

32.38

32.84

u/l

0.03

212

Visual impairment including blindness (binocular or monocular)

264

1859

1.47

7.48

3.9

2.3

29.93

64.89

u/l

0.73

220

1555

Adrenocortical insufficiency

153

964

1.67

7.48

3.7

2.3

37.45

92.98

u/l

0.57

134

816

Use of antiglaucoma preparations and miotics

322

2347

1.41

7.48

3.3

2.3

36.78

56.31

u/l

0.45

271

1975

Other bursopathies

521

4066

1.31

7.47

2.5

2.4

41.79

41.27

u/l

0.03

437

3476

Glaucoma-related operations

230

1584

1.51

7.45

2.3

40.43

35.79

u/l

0.26

196

1345

Malignant neoplasm of heart, mediastinum and pleura, excluding all cancers (controls excluding all cancers)

356

2.12

7.43

2.4

2.0

32.02

30.73

u/l

0.14

284

Other abnormalities of plasma proteins

401

2.09

7.42

3.4

2.2

29.66

30.91

u/l

0.18

337

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

314

2283

1.42

7.41

3.3

2.3

31.15

37.25

u/l

1.63

271

1932

Behavioural disorders

103

585

1.86

7.41

3.1

2.4

25.13

36.63

u/l

2.34

493

Rheumatoid arthritis

1394

10898

1.18

7.39

2.4

36.25

44.05

u/l

0.92

1192

9309

Benign lipomatous neoplasm of other sites/unspecified

311

2255

1.42

7.39

2.6

2.2

106.94

57.88

u/l

0.31

265

1906

Family history of malignant neoplasm

434

3314

1.34

7.38

2.6

2.2

47.10

52.37

u/l

0.13

390

2807

Dependent personality disorder

101

573

1.88

7.37

3.1

2.3

28.64

36.65

u/l

1.47

484

Nonsuppurative otitis media

967

6965

1.22

7.37

2.8

2.4

80.13

40.84

u/l

0.37

819

5994

Haemangioma and lymphangioma, any site

327

2393

1.40

7.36

2.8

2.2

36.08

58.35

u/l

0.56

288

2010

Eosinophilic disease (BM)

331

2.16

7.33

2.7

2.0

29.95

175.56

u/l

0.51

284

Dystonia

236

1638

1.50

7.32

2.2

2.3

29.66

70.53

u/l

0.79

197

1404

Retinal vascular occlusion

447

3431

1.33

7.31

2.8

2.4

33.84

39.23

u/l

1.20

369

2923

Calculus of lower urinary tract

205

1383

1.54

7.31

2.7

2.5

30.74

71.96

u/l

0.63

178

1175

Melanocytic naevi of other and unspecified parts of face

249

1745

1.48

7.31

2.4

2.3

33.55

65.65

u/l

0.61

207

1486

Redundant prepuce, phimosis and paraphimosis

814

6663

1.24

7.29

3.1

2.9

39.33

66.79

u/l

1.29

712

5842

Malignant neoplasm of endocrine gland, excluding all cancers (controls excluding all cancers)

312

2271

1.41

7.28

2.6

2.2

35.97

57.98

u/l

0.49

267

1918

Amyloidosis, other/unspecified

395

2.06

7.28

2.6

46.34

31.74

u/l

1.15

340

Benign neoplasm: Other and unspecified parts of mouth

150

949

1.66

7.24

2.4

2.3

36.34

35.69

u/l

0.04

128

795

Drug-induced hypoglycaemia without coma

410

2.04

7.24

5.1

2.3

28.21

33.64

u/l

0.72

342

Muscle strain

140

870

1.69

7.22

2.7

2.2

30.42

45.34

u/l

1.78

122

758

Other specified/unspecified systemic involvement of connective tissue

252

1775

1.47

7.22

2.4

2.3

38.90

37.26

u/l

0.09

217

1508

Malignant neoplasm of floor of mouth, excluding all cancers (controls excluding all cancers)

191

2.60

7.22

2.9

2.1

54.75

31.81

u/l

0.59

162

Parodontitis, under 40 years and operation codes

349

2586

1.38

7.21

4.0

2.5

35.36

54.94

u/l

0.53

313

2219

Secondary parkinsonism, excluding more controls

101

574

1.85

7.21

2.0

2.2

26.85

40.70

u/l

2.72

502

Foreign body in alimentary tract

228

1577

1.50

7.19

2.7

2.4

84.04

68.35

u/l

0.12

191

1342

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

157

1005

1.64

7.19

2.9

2.4

34.25

89.87

u/l

0.61

136

857

Suppurative and unspecified otitis media

1557

11989

1.16

7.17

2.7

2.5

61.88

40.94

u/l

0.31

1332

10351

Retinal vascular disorders

453

3493

1.33

7.16

2.8

2.4

33.80

39.05

u/l

1.18

375

2973

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

344

2552

1.38

7.14

2.5

2.2

35.34

35.74

u/l

0.04

312

2184

Other disorders of optic [2nd] nerve and visual pathways

258

1828

1.46

7.14

3.6

2.3

31.78

65.22

u/l

0.69

222

1557

Injury of muscle and tendon at hip and thigh level

388

2933

1.36

7.14

2.4

43.51

54.35

u/l

0.24

332

2529

Parodontitis, operation under 40 years and operation codes

349

2591

1.38

7.13

4.0

2.5

35.36

54.87

u/l

0.53

313

2224

Delivery

1544

9409

0.86

7.13

2.2

2.4

36.54

36.81

u/l

0.04

1326

7926

Open wound of hip and thigh

142

889

1.67

7.12

3.0

2.6

30.05

85.95

u/l

0.54

125

768

Malignant neoplasm of oesophagus

109

639

1.81

7.11

2.1

2.5

32.12

40.79

u/l

0.60

550

Contracture of joint

309

2.20

7.10

3.3

2.2

37.86

39.43

u/l

0.07

256

Other benign neoplasms of skin

1562

13608

1.16

7.09

2.5

2.4

38.39

48.05

u/l

0.79

1279

11615

Complications of other internal prosthetic devices, implants and grafts

161

1040

1.62

7.08

2.6

2.2

30.95

39.72

u/l

1.56

141

889

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

271

1936

1.44

7.07

2.5

2.2

35.70

35.62

u/l

0.01

244

1663

Benign neoplasm: salivary glands, exclude unknown (D119)

352

2630

1.38

7.03

2.6

2.4

36.74

56.44

u/l

0.55

306

2265

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

1000

8422

1.21

7.03

2.6

2.5

32.09

55.29

u/l

1.62

822

7330

Systemic lupus erythematosus

159

1027

1.62

7.02

2.8

2.2

39.83

41.18

u/l

0.08

137

858

Disorder of external ear, unspecified

137

855

1.68

7.01

2.7

2.4

33.25

38.39

u/l

0.67

118

729

Other noninflammatory disorders of uterus, except cervix

958

5462

1.22

7.00

2.6

2.3

59.97

38.70

u/l

0.46

811

4642

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

478

3722

1.31

7.00

2.4

2.2

31.33

51.35

u/l

0.90

403

3165

Diffuse brain injury

155

993

1.62

6.99

3.1

2.4

33.24

42.34

u/l

1.02

130

874

Rare circulating lymphoid malignancy

130

801

1.71

6.98

4.4

2.4

31.02

41.21

u/l

0.94

110

678

Hodgkin lymphoma

117

701

1.75

6.97

3.1

2.3

38.46

35.15

u/l

0.25

100

600

Special screening examination for other diseases and disorders

317

2326

1.39

6.96

3.7

2.1

36.20

42.50

u/l

0.70

268

1980

Habit and impulse disorders

437

1.98

6.95

2.6

2.8

35.65

154.84

u/l

0.56

373

Disorders of refraction and accommodation

1087

9190

1.19

6.94

2.5

34.12

44.19

u/l

1.00

925

7881

Brain meningioma, excluding all cancers (controls excluding all cancers)

190

1276

1.54

6.93

2.5

2.1

32.16

35.14

u/l

0.64

165

1065

Gonarthrosis,primary

4183

24155

1.10

6.91

2.4

2.5

40.72

47.27

u/l

0.63

3510

20705

Diabetic retinopathy, excluding more controls

1074

5103

1.21

6.91

5.1

2.8

38.56

39.96

u/l

0.11

853

4258

Other sleep disorders

445

3442

1.32

6.90

2.8

2.5

59.27

51.62

u/l

0.09

381

2979

Ankylosing spondylitis

366

2756

1.36

6.88

2.7

2.5

130.88

55.56

u/l

0.37

313

2411

Female genital prolapse

1299

6422

1.18

6.88

2.4

38.09

38.34

u/l

0.02

1113

5479

Other disorders of pigmentation

183

1224

1.56

6.88

2.9

2.3

35.81

41.04

u/l

0.50

153

1043

Prophylactic surgery

177

2.63

6.87

2.5

2.3

32.29

32.95

u/l

0.04

155

Benign neoplasm: Tonsil

273

2.26

6.86

2.8

2.1

30.84

35.07

u/l

0.46

227

Viral infections of the central nervous system

302

2212

1.41

6.86

2.8

2.4

33.62

59.65

u/l

0.64

259

1914

Toxic effect of alcohol

100

578

1.83

6.84

4.9

2.5

82.86

123.88

u/l

0.17

497

Other and unspecified erythematous conditions

136

853

1.68

6.83

2.4

2.2

36.38

34.55

u/l

0.11

122

720

Embolic stroke with flimmer

561

1.83

6.82

2.5

2.4

40.08

38.63

u/l

0.06

462

Paranoid personality disorder

498

1.90

6.81

2.4

2.5

27.55

130.59

u/l

0.55

424

Other otitis externa (chronic)

262

1878

1.44

6.80

2.6

2.4

28.04

63.61

u/l

0.79

218

1613

Helminthiases

477

1.92

6.79

2.5

36.58

33.62

u/l

0.14

392

Meralgia paraesthetica

149

957

1.63

6.78

3.1

2.3

51.29

42.34

u/l

0.18

133

821

Drug-induced neutropenia

292

2135

1.41

6.77

3.4

2.3

29.92

60.02

u/l

0.76

263

1847

Myeloproliferative diseases

331

2467

1.38

6.75

2.4

2.5

32.63

57.80

u/l

0.71

288

2116

Collapsed vertebra, not elsewhere classified

185

2.57

6.75

2.6

2.0

32.94

29.36

u/l

0.37

154

Psoriatic arthropathies

419

3226

1.33

6.75

2.9

2.5

36.53

53.77

u/l

0.59

367

2771

Recurrent dislocation of patella

213

1470

1.49

6.74

2.9

2.3

28.48

69.06

u/l

0.67

185

1249

Malignant neoplasm of bladder

254

1811

1.44

6.72

2.6

2.3

39.47

37.00

u/l

0.26

215

1520

Thyroiditis

302

2222

1.40

6.71

2.2

2.3

44.84

39.52

u/l

0.18

254

1893

Other noninflammatory disorders of vagina

321

2383

1.38

6.67

2.3

2.2

66.60

37.10

u/l

0.83

272

2023

Other and unspecified injuries of ankle and foot

176

1174

1.56

6.67

2.6

2.3

36.46

35.82

u/l

0.04

148

991

Dermatitis due to substances taken internally

228

1600

1.47

6.67

3.1

2.2

35.74

68.62

u/l

0.56

195

1362

Nontoxic goitre/thyroid nodule

1254

10810

1.18

6.66

2.4

37.90

44.18

u/l

0.49

1037

9145

Complications of the puerperium, not elsewhere classified

169

1118

1.57

6.66

2.3

2.2

31.87

38.37

u/l

0.84

144

934

Contact with other sharp object(s)

264

1901

1.43

6.65

2.8

2.5

32.54

63.84

u/l

0.68

233

1645

Lesion of lateral popliteal nerve

206

1421

1.50

6.64

3.6

2.4

39.02

41.18

u/l

0.13

184

1226

Carrier of infectious disease

107

636

1.78

6.64

3.1

2.3

26.84

110.07

u/l

0.56

531

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

245

2.35

6.64

2.8

2.2

30.39

32.96

u/l

0.20

198

Torsion of ovary, ovarian pedicle and fallopian tube

101

590

1.80

6.62

2.3

2.2

32.81

39.95

u/l

0.67

513

Ethmoidectomy

324

4314

0.74

6.62

2.5

35.24

49.04

u/l

0.64

274

3725

Other localized connective tissue disorders

503

1.88

6.61

3.1

2.2

27.79

37.28

u/l

1.67

421

Other and unspecified disorders of skin and subcutaneous tissue

120

1913

0.61

6.60

2.7

2.3

36.60

40.38

u/l

0.26

103

1642

Other and unspecified acquired haemolytic anaemias

239

2.35

6.58

4.1

2.4

41.09

34.23

u/l

0.39

198

Mixed hyperlipidaemia

159

1041

1.59

6.58

2.5

33.22

38.77

u/l

0.55

134

903

Persons encountering health services in circumstances related to reproduction

2615

15958

1.12

6.57

2.4

2.7

36.90

43.04

u/l

0.97

2269

13765

Allergic purpura

132

830

1.66

6.55

2.4

34.38

94.23

u/l

0.52

120

699

Superficial injury of neck

526

1.85

6.55

2.5

2.4

32.39

129.68

u/l

0.54

443

Oligomenorrhoea

150

970

1.61

6.54

2.7

2.1

36.20

38.22

u/l

0.09

116

840

Frontotemporal dementia, wide, incl. Pick's disease

170

2.66

6.53

2.4

35.03

35.22

u/l

0.01

138

Coxarthrosis [arthrosis of hip](FG)

2438

15835

1.12

6.52

2.6

2.5

72.41

43.14

u/l

0.48

2057

13537

Malignant neoplasm of other connective and soft tissue

102

602

1.79

6.51

2.3

61.80

32.19

u/l

0.64

512

Endometriosis of ovary

682

5564

1.24

6.51

2.3

2.4

35.18

37.09

u/l

0.24

579

4757

Other bursitis of elbow

195

2.49

6.47

2.7

2.0

30.21

36.04

u/l

0.72

167

Malignant neoplasm of gum, excluding all cancers (controls excluding all cancers)

228

2.35

6.40

2.5

2.0

35.62

32.44

u/l

0.21

179

Nonalcoholic steatohepatitis

223

2.41

6.40

3.2

2.1

29.33

28.98

u/l

0.02

187

Melanoma in situ of other and unspecified parts of face

235

2.31

6.35

2.1

27.51

32.15

u/l

0.92

193

Other and unspecified vaccines and biological substances

172

2.60

6.34

2.5

2.2

30.52

29.52

u/l

0.09

137

SLE, strict definition

151

989

1.60

6.32

2.7

2.2

38.56

37.52

u/l

0.10

128

823

SLE, ICD10

151

989

1.60

6.32

2.7

2.2

38.56

37.52

u/l

0.10

128

823

Cardiomyopathy, Hypertrophic obstructive

458

1.90

6.32

2.8

2.4

44.04

32.82

u/l

0.59

390

Benign neoplasm: Skin of ear and external auricular canal

135

859

1.63

6.30

2.4

2.0

30.80

38.71

u/l

0.74

103

698

Organic, including symptomatic, mental disorders

1993

12802

1.14

6.30

2.6

2.4

36.33

49.69

u/l

1.12

1652

10918

Undefined dementia

213

2772

0.69

6.29

2.4

2.3

29.31

35.71

u/l

1.93

175

2306

Acute nasopharyngitis (common cold)

494

3894

1.29

6.29

3.5

2.8

140.95

43.37

u/l

0.52

433

3388

Acute suppurative otitis media

1087

8678

1.18

6.29

2.7

2.5

75.95

40.24

u/l

0.38

931

7542

Wegener granulomatosis

424

1.95

6.29

2.0

2.4

36.23

31.76

u/l

0.66

358

Mixed connective tissue disease

271

1983

1.41

6.28

2.5

2.3

38.16

36.59

u/l

0.09

233

1691

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

289

2134

1.39

6.25

2.6

2.2

31.48

59.49

u/l

0.66

245

1805

Follicular lymphoma

155

1022

1.58

6.24

2.6

2.1

30.34

38.38

u/l

0.98

131

845

Insulin, fast-acting (human)

600

4868

1.25

6.24

7.3

2.4

33.32

48.19

u/l

0.83

447

4261

Retinal breaks without detachment

636

5199

1.25

6.23

2.5

2.4

42.91

48.64

u/l

0.23

548

4451

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

144

937

1.61

6.22

2.5

2.4

30.44

34.76

u/l

0.92

131

797

Rosacea

454

3574

1.30

6.21

2.6

2.3

45.99

37.96

u/l

0.42

389

3043

Arterial embolism and thrombosis of lower extremity artery

137

879

1.62

6.21

2.7

2.3

30.98

33.84

u/l

0.45

124

741

Melanocytic naevi of scalp and neck

100

594

1.77

6.21

2.9

2.2

26.92

35.56

u/l

1.96

486

1105

8395

1.18

6.19

2.3

2.4

53.97

37.48

u/l

0.40

929

7101

Autoimmune hyperthyroidism

253

1833

1.42

6.19

2.9

2.1

39.75

35.76

u/l

0.25

215

1563

Unspecified dementia

209

2666

0.69

6.16

2.4

2.3

29.22

35.91

u/l

1.97

171

2235

TMD muscular pain linked with fibromyalgia

239

2.29

6.14

4.3

2.1

33.61

33.02

u/l

0.03

200

Acne

383

2947

1.32

6.14

3.6

2.5

34.09

52.55

u/l

0.59

335

2527

Malignant neoplasm of base of tongue, excluding all cancers (controls excluding all cancers)

180

2.49

6.13

4.0

2.1

65.26

42.41

u/l

0.47

145

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

121

758

1.67

6.11

2.3

2.2

32.04

39.70

u/l

1.10

101

658

Molar incisor enamel hypoplasia

113

681

1.69

6.09

2.9

2.3

35.56

28.82

u/l

0.58

556

Contact with other hot fluids

134

862

1.63

6.09

2.5

2.4

31.56

91.66

u/l

0.56

116

736

Embolic stroke

174

1179

1.52

6.08

2.6

2.4

37.47

36.56

u/l

0.07

144

988

Alzheimer disease, excluding more controls

656

3575

1.24

6.08

2.1

2.3

32.68

59.20

u/l

0.75

526

3078

Erythema nodosum

130

832

1.64

6.04

2.3

35.35

37.85

u/l

0.12

107

697

Malignant neoplasm of palate, excluding all cancers (controls excluding all cancers)

151

2.67

6.03

3.3

2.0

31.81

33.54

u/l

0.16

121

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

232

1664

1.43

6.01

3.1

2.2

32.96

66.71

u/l

0.61

196

1413

Speech disturbances, not elsewhere classified

323

2443

1.36

5.98

3.0

2.4

34.96

38.27

u/l

0.47

278

2089

Melanocytic naevi of upper limb, including shoulder

540

1.79

5.98

2.2

2.0

34.22

34.60

u/l

0.03

447

Striae atrophicae

282

2.15

5.97

2.3

2.2

29.30

32.34

u/l

0.29

235

Fibrosis of liver

184

2.51

5.97

4.0

2.3

41.89

32.99

u/l

0.35

155

Other misadventures during surgical and medical care

557

1.79

5.97

3.9

2.3

30.54

31.57

u/l

0.15

469

Benign neoplasm: Pituitary gland, craniopharyngeal duct

190

1317

1.49

5.97

2.1

2.3

29.87

39.82

u/l

1.76

165

1095

Use of donepezil

451

5462

0.78

5.95

2.0

2.3

33.12

36.99

u/l

1.16

363

4596

Nontoxic multinodular goitre

815

6855

1.21

5.92

2.2

2.3

36.37

41.23

u/l

0.43

684

5819

Benign neoplasm: Other parts of oropharynx

229

2.29

5.92

2.3

1.9

30.97

32.84

u/l

0.23

189

Carcinoid syndrome

250

2.24

5.92

2.3

2.6

31.09

32.04

u/l

0.05

214

Sicca syndrome [Sjögren]

362

2790

1.33

5.92

2.2

2.3

43.22

38.93

u/l

0.33

298

2376

Polypectomy (DHB20)

271

2002

1.39

5.92

2.3

2.5

37.32

63.85

u/l

0.57

231

1729

Emergency coronary revascularization (for ACS)

2273

14697

1.12

5.91

2.6

2.5

36.44

51.20

u/l

1.60

1907

12588

Malignant immunoproliferative diseases

209

2.34

5.91

3.8

2.1

26.62

34.08

u/l

1.35

174

Other abnormal products of conception

1272

7348

1.17

5.90

2.2

2.3

37.77

37.32

u/l

0.04

1079

6281

Ovarian dysfunction

286

2130

1.38

5.86

2.5

2.2

37.70

34.97

u/l

0.14

237

1799

Other and unspecified injuries of abdomen, lower back and pelvis

368

1.97

5.84

4.1

2.4

27.90

29.54

u/l

0.37

309

Other and unspecified acute skin changes due to ultraviolet radiation

112

698

1.69

5.84

2.5

2.3

42.76

32.15

u/l

0.85

586

Aortic valve malfunction, age under 60 years

377

2926

1.32

5.83

2.9

2.7

44.75

55.16

u/l

0.24

322

2568

Other acquired deformities of musculoskeletal system and connective tissue

194

1359

1.48

5.83

2.3

2.5

41.49

72.91

u/l

0.42

169

1171

Hydrocele

438

3457

1.29

5.82

3.3

2.7

44.80

78.33

u/l

0.73

371

2999

Ulcer of oesophagus

260

1912

1.40

5.81

2.9

2.3

36.29

39.66

u/l

0.25

224

1621

Adenocarcinoma of small intestine

3.75

5.81

5.9

3.3

24.43

32.07

u/l

0.95

Graves ophthalmopathy, strict

600

1.74

5.79

2.2

2.3

28.31

38.11

u/l

1.73

507

Peritonsillar abscess

857

7247

1.20

5.79

2.6

37.93

38.14

u/l

0.02

733

6283

Erectile dysfunction

298

2241

1.37

5.78

2.9

2.6

33.65

38.97

u/l

0.75

261

1928

L02BB Anti-androgens

307

2316

1.36

5.78

2.3

2.5

31.66

38.86

u/l

1.36

254

1968

Other congenital malformations of skin

166

1130

1.52

5.78

2.7

2.3

29.18

81.19

u/l

0.64

146

944

Injury of nerves and spinal cord at neck level

101

616

1.73

5.78

2.7

2.5

29.76

39.64

u/l

0.74

537

Dermatographic urticaria

271

2010

1.39

5.77

2.5

2.3

31.26

59.95

u/l

0.64

222

1718

Melanocytic naevi of lower limb, including hip

179

1238

1.50

5.77

2.8

2.3

34.66

36.68

u/l

0.29

159

1052

Bell's palsy

478

3822

1.28

5.76

2.5

2.4

130.26

38.81

u/l

0.46

419

3279

Other erythematous conditions

147

978

1.57

5.76

2.4

2.2

35.70

34.77

u/l

0.06

129

827

Personal history of medical treatment

239

2.24

5.74

3.0

2.2

30.75

30.55

u/l

0.02

193

Nail dystrophy

174

2.50

5.73

2.4

2.3

36.75

30.79

u/l

0.44

144

Other maternal disorders predominantly related to pregnancy

2518

14335

1.11

5.71

2.5

2.3

38.17

37.54

u/l

0.08

2144

12183

Foreign body in respiratory tract

208

1481

1.45

5.69

2.3

34.51

72.40

u/l

0.59

188

1256

Supervision of high-risk pregnancy

834

4235

1.21

5.69

2.3

2.4

40.62

37.76

u/l

0.19

707

3604

Iridocyclitis

924

7881

1.19

5.69

3.4

2.5

79.40

44.59

u/l

0.45

790

6764

Other acute skin changes due to ultraviolet radiation

146

972

1.56

5.69

2.9

2.3

39.38

36.86

u/l

0.17

119

819

Myeloproliferative diseases (CML excluded)

297

2240

1.36

5.68

2.3

2.4

32.89

39.12

u/l

1.40

257

1922

Other mental disorders due to brain damage and dysfunction and to physical disease

420

3314

1.30

5.68

2.7

2.4

33.04

53.33

u/l

0.78

348

2835

Hypothyroidism due to medicaments and other exogenous substances

281

2.12

5.68

2.5

2.2

28.38

29.27

u/l

0.15

233

Urethral stricture

204

1446

1.45

5.68

2.5

33.13

72.50

u/l

0.63

174

1237

Sequelae of injuries of neck and trunk

126

813

1.62

5.67

3.3

2.5

27.81

42.91

u/l

1.78

104

702

Congenital malformations and deformations of the musculoskeletal system

341

2604

1.33

5.67

2.3

2.4

40.43

54.86

u/l

0.31

286

2213

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

542

1.77

5.67

2.7

2.3

48.49

31.03

u/l

0.87

444

Cardiomyopathies, Secondary/extrinsic

149

2.60

5.67

3.3

2.5

32.73

30.04

u/l

0.20

127

Complications following infusion, transfusion and therapeutic injection

387

1.93

5.66

2.5

2.3

38.60

34.40

u/l

0.18

333

Myeloid leukaemia

571

1.74

5.66

2.7

2.1

29.35

123.83

u/l

0.56

469

Malignant neoplasm of eye, brain and central nervous system, excluding all cancers (controls excluding all cancers)

244

1782

1.40

5.66

2.1

2.3

34.88

65.12

u/l

0.58

203

1513

Unknown and unspecified causes of morbidity

129

1959

0.64

5.65

3.2

2.1

33.38

67.37

u/l

0.77

118

1663

Amyloidosis

482

1.82

5.64

2.6

2.5

45.03

31.61

u/l

1.18

406

Chronic tubulo-interstitial nephritis

153

1029

1.54

5.63

3.4

2.2

41.32

38.88

u/l

0.21

133

860

Malignant neoplasm of testis, excluding all cancers (controls excluding all cancers)

445

1.84

5.62

3.4

2.4

31.22

143.34

u/l

0.55

389

Fracture of neck

224

1620

1.43

5.61

3.4

2.5

29.85

68.74

u/l

0.73

188

1387

Systemic lupus erythematosus, unspecified

130

848

1.60

5.60

2.8

2.3

39.22

38.38

u/l

0.07

112

700

Polyarthritis, unspecified

154

1040

1.54

5.60

2.8

2.4

33.42

42.17

u/l

1.48

120

890

Impetigo

172

1186

1.50

5.58

2.9

2.2

29.16

74.36

u/l

0.58

146

1009

Acute generalized exanthematous pustulosis

182

1271

1.48

5.58

2.8

2.3

37.07

39.30

u/l

0.12

158

1070

Serous carcinoma of ovary, excluding all cancers (controls excluding all cancers)

134

881

1.59

5.56

2.3

2.0

34.00

35.29

u/l

0.13

120

742

Fistulae involving female genital tract

441

1.86

5.55

3.0

2.3

35.89

43.43

u/l

0.50

387

Acne varioliformis

3.62

5.55

2.0

3.1

22.47

28.27

u/l

0.84

Effects of foreign body entering through natural orifice

984

8452

1.18

5.54

2.5

2.7

48.20

46.35

u/l

0.06

845

7337

Varicella [chickenpox]

188

1321

1.47

5.54

2.9

2.7

35.01

76.65

u/l

0.62

171

1162

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

332

1.99

5.53

3.4

2.4

28.25

33.05

u/l

0.71

276

Drug-induced cataract

104

647

1.69

5.52

5.7

2.4

41.04

35.17

u/l

0.42

558

Dronedarone medication

121

780

1.63

5.51

2.6

2.3

41.08

40.77

u/l

0.02

669

Ectropion of eyelid

141

937

1.56

5.50

2.4

2.3

39.87

36.84

u/l

0.18

122

774

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

344

2659

1.32

5.49

2.5

2.2

35.34

36.36

u/l

0.11

312

2264

Vascular dementia

286

2077

1.36

5.47

2.3

2.4

28.86

35.59

u/l

2.80

236

1738

Papillary adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)

236

1728

1.40

5.46

2.6

2.2

31.08

38.05

u/l

1.45

199

1453

Malignant neoplasm, without specification of site

115

732

1.63

5.45

3.3

2.4

31.84

31.28

u/l

0.06

618

Other pulmonary heart/vessel disease

177

1235

1.48

5.45

2.4

55.58

33.74

u/l

0.78

153

1044

Arthropathic psoriasis

454

3636

1.28

5.44

2.9

2.4

38.30

51.80

u/l

0.50

400

3141

Benign neoplasm of breast

502

4069

1.26

5.42

2.2

2.3

33.21

37.61

u/l

0.91

433

3418

Mantle cell lymphoma, excluding all cancers (controls excluding all cancers)

306

2.02

5.39

2.8

2.1

32.95

35.29

u/l

0.23

255

Other and unspecified injuries of shoulder and upper arm

122

791

1.61

5.38

2.9

2.4

27.05

35.87

u/l

2.08

103

672

Operations for atrial fibrillation

417

1.88

5.38

3.0

2.5

37.97

34.36

u/l

0.35

357

Kela reimbursement Agammaglobulinemia (D80-84)

232

2.22

5.38

2.9

2.4

32.12

27.14

u/l

0.38

195

Exposure to other and unspecified forces of nature

154

2.55

5.36

3.8

2.4

47.79

33.55

u/l

0.43

130

Tongue abnormality

243

1797

1.40

5.35

2.6

2.3

32.06

40.21

u/l

1.63

203

1541

Anorexia

409

1.87

5.34

2.7

2.4

46.79

31.44

u/l

0.65

343

Certolizumab pegol

461

1.82

5.34

2.6

2.1

36.91

31.90

u/l

0.53

385

Malignant neoplasm of gallbladder

117

2.82

5.34

7.3

2.6

31.21

30.46

u/l

0.08

Burn and corrosion of wrist and hand

155

1059

1.52

5.34

2.2

2.5

28.67

83.60

u/l

0.66

129

916

Nonspecific lymphadenitis

247

1830

1.39

5.33

2.8

2.5

36.06

65.98

u/l

0.60

212

1582

Pulmonary oedema

393

1.87

5.32

3.2

2.5

34.67

32.35

u/l

0.24

327

Adenocarcinoma of small intestine, excluding all cancers (controls excluding all cancers)

3.53

5.32

5.9

2.0

24.43

34.09

u/l

1.51

Otitis media, unspecified

431

3159

1.28

5.31

2.6

2.3

28.02

35.49

u/l

3.70

365

2695

Methotrexate

594

4905

1.23

5.30

2.9

2.3

38.35

47.62

u/l

0.43

511

4166

Other specified/unspecified spondylopathies

102

637

1.67

5.28

2.4

2.1

32.02

33.15

u/l

0.10

543

Vitamin D deficiency

455

1.81

5.26

4.1

2.5

26.13

32.77

u/l

1.54

392

Hypoplasia of dental enamel , including avohilmo

104

644

1.66

5.26

3.1

2.3

36.93

28.86

u/l

0.67

530

Other and unspecified disorders of binocular movement

142

2.58

5.25

2.0

2.4

37.92

28.15

u/l

0.70

120

Benign neoplasm: Conjunctiva

117

755

1.61

5.25

2.4

2.2

161.11

40.90

u/l

0.46

631

Spondylopathies (FG)

570

4692

1.24

5.25

2.6

2.5

97.86

48.56

u/l

0.37

484

4054

Mental and behabioural disorders of puerperum, not classified elsewhere, excluding more controls

246

2.12

5.24

2.5

2.0

36.66

34.69

u/l

0.09

210

Chalazion

449

3607

1.27

5.23

2.3

2.4

42.55

52.06

u/l

0.28

372

3097

Evidence of alcohol involvement determined by level of intoxication

289

2.04

5.23

6.2

2.6

26.72

35.11

u/l

1.03

241

Dental caries 2 and operation codes, only avohilmo

3328

19029

1.09

5.23

2.5

2.6

38.41

39.94

u/l

0.16

2840

16296

Primary open-angle glaucoma

946

10685

0.85

5.22

2.3

2.4

38.02

45.92

u/l

0.51

793

9056

Pneumococcal septicemia

135

902

1.56

5.22

3.0

2.4

34.46

86.49

u/l

0.48

108

764

Other hereditary haemolytic anaemias

169

2.43

5.18

3.5

2.3

28.94

32.40

u/l

0.42

138

Other retinal artery occlusion

579

1.70

5.18

2.9

2.4

35.59

32.74

u/l

0.31

492

Parkinson's disease, strict definition, excluding more controls

440

3458

1.27

5.17

2.3

2.4

40.56

60.68

u/l

0.45

365

3010

Other specified and unspecified retinal disorders

140

945

1.54

5.16

3.4

2.4

44.06

38.85

u/l

0.21

125

807

Supervision of normal pregnancy

899

4380

1.19

5.16

2.2

2.4

33.58

37.71

u/l

1.05

777

3726

Disorders of magnesium metabolism

169

2.42

5.15

4.6

2.8

28.97

31.10

u/l

0.16

144

All dysplastic lesions of the vulva

177

1250

1.47

5.15

2.5

2.2

30.80

35.58

u/l

1.08

149

1065

Other female pelvic inflammatory diseases

654

5469

1.22

5.14

2.5

2.3

32.16

36.15

u/l

1.06

573

4639

Secondary right heart disease

161

1118

1.49

5.12

2.4

2.3

58.26

34.31

u/l

0.77

139

943

Benign neoplasm of other and unspecified sites

122

800

1.58

5.12

2.9

2.0

37.28

41.23

u/l

0.20

671

Open wound of thorax

422

1.83

5.12

2.2

2.4

34.57

157.51

u/l

0.57

366

Disorders of orbit

175

1234

1.47

5.11

2.4

2.3

30.47

40.29

u/l

1.55

145

1053

Pollen allergy

732

6115

1.20

5.10

2.2

2.4

35.23

44.69

u/l

0.59

620

5289

Osteopathy in diseases classified elsewhere

197

2.31

5.10

5.4

2.4

37.94

32.58

u/l

0.31

171

Autism spe, excluding more controls

427

1.80

5.07

2.0

2.3

26.32

36.52

u/l

2.53

369

Pervasive developmental disorders excl. Autism + Asperger

283

2.02

5.07

2.1

2.5

24.54

33.66

u/l

2.08

234

Use of biperiden

209

1522

1.42

5.06

2.5

2.4

29.59

72.98

u/l

0.79

179

1318

All dysplastic lesions of the cervix uteri

986

8514

1.17

5.06

2.4

2.3

37.31

35.81

u/l

0.13

830

7278

Open wound of shoulder and upper arm

537

1.73

5.05

3.4

2.4

38.55

35.35

u/l

0.20

453

Mucinous and mucinous cystic tumor of rectum, excluding all cancers (controls excluding all cancers)

102

2.88

5.04

2.7

1.9

27.15

32.53

u/l

0.78

Personal history of allergy to analgesic agent

158

2.46

5.04

2.0

2.3

25.27

28.60

u/l

0.95

131

Bullous disorders

222

1635

1.40

5.03

2.7

2.4

31.79

37.70

u/l

1.37

189

1385

Hypothermia

477

1.77

5.03

2.7

2.4

927.84

33.81

u/l

0.49

408

Intercostal neuropathy

218

2.21

5.02

2.6

27.78

29.17

u/l

0.16

189

Left ventricular outflow tract obstruction (LVOTO), broad definition

399

3182

1.28

5.01

2.9

2.7

43.62

53.35

u/l

0.25

343

2793

Bilateral sagittal split ramus osteotomy operation

966

0.53

5.01

2.6

2.4

30.84

90.98

u/l

0.64

820

Injury of muscle and tendon at shoulder and upper arm level

1442

12816

1.14

5.00

2.7

2.6

45.05

52.96

u/l

0.37

1231

11061

Diseases of middle ear and mastoid

2532

18947

1.10

4.99

2.8

2.5

52.07

40.55

u/l

0.26

2152

16302

conjunctival haemorrhage

274

2084

1.35

4.99

3.0

2.4

86.70

39.46

u/l

0.48

239

1774

Mandibular retrognathia AND surgery (BSSRO)

700

0.45

4.98

3.0

2.4

34.11

114.13

u/l

0.60

586

Idiopathic pulmonary fibrosis

267

2023

1.35

4.98

2.5

2.4

33.88

40.98

u/l

1.27

242

1712

593

1.68

4.98

2.3

2.4

26.98

31.90

u/l

1.89

495

Benign neoplasm: Tonsil

309

1.98

4.97

2.8

2.4

30.84

34.49

u/l

0.38

261

Myasthenia gravis

442

1.80

4.94

2.4

2.3

47.02

31.70

u/l

0.84

372

L02BX Other hormone antagonists and related agents

188

1353

1.44

4.93

2.4

2.5

29.52

41.34

u/l

1.64

162

1161

Tobacco use

204

1488

1.41

4.92

3.2

2.4

31.35

40.37

u/l

1.41

173

1279

Parkinson's disease, excluding more controls

474

3755

1.25

4.91

2.3

38.51

58.56

u/l

0.50

392

3261

Burns and corrosions of multiple and unspecified body regions

603

1.67

4.91

3.0

2.5

29.34

118.92

u/l

0.60

524

Disorders in reading

412

1.82

4.90

2.5

25.90

155.40

u/l

0.56

344

Complications of genitourinary prosthetic devices, implants and grafts

611

1.66

4.88

4.1

2.2

29.57

34.75

u/l

0.90

520

Other injuries of spine and trunk, level unspecified

220

2.18

4.88

3.6

2.4

30.76

33.71

u/l

0.24

183

Malignant neoplasm of anus and anal canal

129

2.64

4.88

2.7

2.2

31.64

28.65

u/l

0.27

104

Intracerebral haemorrhage

445

3599

1.26

4.87

2.7

2.4

37.63

51.35

u/l

0.48

376

3052

Optic neuritis

172

1221

1.46

4.86

3.5

2.3

35.27

40.65

u/l

0.52

142

1028

Pyoderma

504

1.73

4.86

3.2

2.4

30.03

34.37

u/l

0.66

431

Radial styloid tenosynovitis [de Quervain]

220

1626

1.39

4.85

2.7

2.1

35.25

41.41

u/l

0.65

173

1400

Intrahepatic Cholestasis of Pregnancy (ICP)

271

2065

1.34

4.85

2.5

2.2

35.70

36.48

u/l

0.06

244

1759

Other appendicitis

342

2689

1.30

4.84

2.5

32.00

56.94

u/l

0.80

296

2340

Malignant neoplasm of ovary

188

1359

1.43

4.84

2.1

2.2

30.72

37.40

u/l

1.21

162

1153

Pediculosis, acariasis and other infestations

226

1679

1.38

4.84

3.3

2.6

30.98

65.76

u/l

0.67

194

1470

Congenital malformations of ovaries, fallopian tubes and broad ligaments

224

1662

1.39

4.83

2.4

2.2

32.18

37.73

u/l

1.13

191

1407

Benign neoplasm of brain and other parts of central nervous system

221

1635

1.39

4.83

2.6

2.2

30.95

67.09

u/l

0.64

184

1367

Status epilepticus

145

999

1.50

4.82

3.4

2.5

33.30

39.31

u/l

0.52

119

855

Noise effects on inner ear

1193

0.58

4.81

2.6

35.73

79.89

u/l

0.58

1049

Other symptoms and signs involving the nervous and musculoskeletal systems

1399

15710

0.88

4.80

2.9

2.5

49.53

47.02

u/l

0.06

1217

13462

Retrobulbar neuritis in diseases classified elsewhere

2.93

4.79

3.5

2.2

28.89

28.21

u/l

0.05

Primary open-angle glaucoma, strict

754

8805

0.84

4.77

2.3

2.4

35.57

48.25

u/l

0.80

633

7474

Cushing syndrome

299

1.97

4.77

3.1

2.3

30.55

33.97

u/l

0.31

256

Other disorders of peripheral nervous system

162

2.39

4.76

2.7

2.3

90.37

29.88

u/l

0.47

137

Other diseases of peritoneum

182

1312

1.43

4.74

3.4

2.1

39.22

37.12

u/l

0.09

158

1124

Malignant neoplasm of thyroid gland, excluding all cancers (controls excluding all cancers)

265

2020

1.34

4.74

2.6

2.2

30.24

37.58

u/l

1.94

227

1706

Circumscribed brain atrophy

516

1.71

4.73

2.6

2.5

33.23

33.05

u/l

0.02

435

Tonsillectomy and adenotomy

2526

16100

1.10

4.73

2.5

53.54

40.39

u/l

0.32

2184

13893

Hyperplasia of prostate

1490

7559

1.13

4.71

2.5

2.7

36.19

64.85

u/l

1.63

1285

6552

Polymyositis

223

2.14

4.71

2.3

518.73

33.03

u/l

0.49

187

Infectious mononucleosis

314

2449

1.31

4.69

2.3

2.4

35.50

56.70

u/l

0.55

269

2110

Focal epilepsy, mode (most common among epilepsy diagnosis)

715

6075

1.19

4.69

2.6

2.5

38.24

44.85

u/l

0.37

611

5206

Other and unspecified rosacea

329

2587

1.30

4.69

2.6

2.4

48.06

39.09

u/l

0.35

285

2213

Effects of other external causes

119

793

1.56

4.68

2.7

2.5

32.97

100.00

u/l

0.59

103

687

Polyarthrosis

782

6418

1.18

4.67

2.5

2.4

39.48

38.91

u/l

0.04

654

5442

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS